-DOCSTART- -X- N

methotrexate NN Pharmocological
methotrexate NN Pharmocological
methotrexate NN Pharmocological
double-dose JJ None
( ( None
50mg/m CD None
( ( None
2 CD None
) ) None
intramuscularly RB None
on IN None
days NNS None
0 CD None
and CC None
4 CD None
; : None
group NN None
1 CD None
) ) None
or CC None
single-dose JJ None
( ( None
50mg/m CD None
( ( None
2 CD None
) ) None
intramuscularly RB None
on IN None
day NN None
0 CD None
; : None
group NN None
2 CD None
) ) None
methotrexate NN Pharmocological
. . None
double-dose JJ None
methotrexate NN None
had VBD None
-DOCSTART- -X- N

nonpharmacologic JJ Control
treatments NNS Control
topical JJ Control
antiallergic JJ Control
medication NN Control
. . None
INTERVENTION NNP None
Controlled VBD None
exposure NN None
to TO None
grass VB None
pollen NN None
using VBG None
an DT None
environmental JJ None
chamber NN None
to TO None
stimulate VB None
an DT None
ocular JJ None
allergic NN None
reaction NN None
followed VBN None
by IN None
application NN None
of IN None
artificial JJ None
tears NNS None
( ( None
ATs NNP None
) ) None
, , None
5 CD None
minutes NNS None
of IN None
cold JJ None
compress NN None
( ( None
CC NNP None
) ) None
, , None
ATs NNP None
combined VBD None
with IN None
CC NNP None
, , None
or CC None
no DT None
treatment NN None
applied VBN None
at IN None
each DT None
separate JJ None
visit NN None
in IN None
random JJ None
order NN None
. . None
had VBD None
epinastine JJ Pharmocological
hydrochloride NN Pharmocological
( ( None
EH NNP None
) ) None
applied VBD None
alone RB None
and CC None
combined VBN None
with IN None
CC NNP None
in IN None
random JJ None
order NN None
or CC None
instillation NN None
of IN None
a DT None
volume-matched JJ None
saline NN None
control NN None
. . None
with IN None
nonpharmaceutical JJ None
treatments NNS None
with IN None
no DT None
treatment NN None
with IN None
CC NNP None
effect NN None
of IN None
EH NNP None
was VBD None
combined VBN None
with IN None
ATs NNP None
or CC None
EH NNP None
or CC None
CC NNP None
with IN None
ATs NNP None
or CC None
EH NNP None
had VBD None
of IN None
a DT None
CC NNP None
in IN None
combination NN None
with IN None
ATs NNP None
or CC None
EH NNP None
. . None
-DOCSTART- -X- N

duplex JJ Physical
US NNP Physical
scanning VBG Physical
SEPS NNP Physical
saphenous JJ Physical
vein NN Physical
ligation NN Physical
and CC Physical
stripping NN Physical
-DOCSTART- -X- N

pooled VBN Pharmocological
human JJ Pharmocological
milk NN Pharmocological
( ( Pharmocological
BM NNP Pharmocological
) ) Pharmocological
; : Pharmocological
formula $ Pharmocological
1 CD Pharmocological
( ( Pharmocological
F1 NNP Pharmocological
) ) Pharmocological
= VBD Pharmocological
1.5 CD Pharmocological
gm/dl NN Pharmocological
protein NN Pharmocological
, , Pharmocological
60 CD Pharmocological
parts NNS Pharmocological
bovine NN Pharmocological
whey NN Pharmocological
proteins NNS Pharmocological
: : Pharmocological
40 CD Pharmocological
parts NNS Pharmocological
bovine NN Pharmocological
caseins NNS Pharmocological
; : Pharmocological
F2 NNP Pharmocological
= VBD Pharmocological
3.0 CD Pharmocological
gm/dl NN Pharmocological
, , Pharmocological
60:40 CD Pharmocological
; : Pharmocological
F3 NNP Pharmocological
= VBD Pharmocological
1.5 CD Pharmocological
gm/dl NN Pharmocological
, , Pharmocological
18:82 CD Pharmocological
; : Pharmocological
F4 NNP Pharmocological
= VBD Pharmocological
3.0 CD Pharmocological
gm/dl NN Pharmocological
-DOCSTART- -X- N

Neoton NNP Pharmocological
thrombolytic JJ Pharmocological
therapy NN Pharmocological
neoton JJ Pharmocological
TLT NNP Control
neoton NN Control
TLT NNP Pharmocological
streptokinase JJ Pharmocological
streptokinase JJ Pharmocological
preparations NNS Pharmocological
neoton NN Pharmocological
neoton NNS Pharmocological
neoton NN Pharmocological
Neoton NNP Pharmocological
-DOCSTART- -X- N

m-chlorophenylpiperazine NN Pharmocological
m-chlorophenylpiperazine NN Pharmocological
( ( Pharmocological
mCPP NN Pharmocological
) ) Pharmocological
mCPP NN Pharmocological
placebo $ Control
-DOCSTART- -X- N

KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
placebo NN Control
. . None
KC NNP Pharmocological
11458 CD Pharmocological
-DOCSTART- -X- N

induction VB Pharmocological
chemotherapy NN Pharmocological
utilized JJ Pharmocological
bleomycin NN Pharmocological
, , None
Cytoxan NNP Pharmocological
, , None
methotrexate NN Pharmocological
and CC None
5-fluorouracil JJ Pharmocological
in IN None
two CD None
cycles NNS None
( ( None
one CD None
cycle NN None
if IN None
no DT None
tumor NN None
response NN None
) ) None
, , None
followed VBN Pharmocological
by IN Pharmocological
standard NN Pharmocological
treatment NN Pharmocological
which WDT Pharmocological
consisted VBD Pharmocological
of IN Pharmocological
combined JJ Pharmocological
irradiation NN Pharmocological
and CC Pharmocological
surgery NN Pharmocological
or CC Pharmocological
, , Pharmocological
in IN Pharmocological
some DT Pharmocological
instances NNS Pharmocological
, , Pharmocological
primary JJ Pharmocological
irradiation NN Pharmocological
alone RB None
. . None
The DT None
second JJ None
study NN None
utilized VBD None
cisplatin NN Pharmocological
and CC Pharmocological
5-fluorouracil NN Pharmocological
in IN Pharmocological
three CD None
cycles NNS None
prior RB Control
to TO Control
standard VB Control
treatment NN Control
. . None
-DOCSTART- -X- N

ozone NN Physical
application NN Physical
ozone NN Physical
and CC None
sodium NN Physical
ascorbate NN Physical
not RB None
treated VBN None
with IN None
ozone NN None
; : None
ozone NN None
application NN None
followed VBN None
by IN None
acid NN None
etching NN None
; : None
acid NN None
etching VBG None
followed VBN None
by IN None
ozone NN None
application NN None
; : None
ozone NN None
and CC None
application NN None
of IN None
sodium NN None
ascorbate NN None
. . None
-DOCSTART- -X- N

Conservative JJ Control
treatment NN Control
conservative JJ Physical
therapy NN Physical
mechanical JJ Control
treatment NN Control
with IN Control
taping VBG Control
and CC Control
orthoses NNS Control
anti-inflammatory JJ Other
accommodative JJ Other
modalities NNS Other
. . Other
-DOCSTART- -X- N

disclaimer NN Educational
versus NN None
warning VBG Educational
label NN Educational
. . None
groups NNS None
: : None
( ( None
a DT None
) ) None
disclaimer NN Educational
, , None
( ( None
b NN None
) ) None
warning NN Educational
, , None
( ( None
c NN None
) ) None
model NN Control
control NN Control
, , None
or CC None
( ( None
d NN None
) ) None
car NN Control
control NN Control
. . None
-DOCSTART- -X- N

levocetirizine NN Pharmocological
and CC None
diphenhydramine NN Pharmocological
Levocetirizine NNP Pharmocological
levocetirizine NN Pharmocological
diphenhydramine NN Pharmocological
and CC Control
placebo NN Control
placebo-controlled JJ Control
diphenhydramine NN Physical
diphenhydramine NN Pharmocological
levocetirizine NN Pharmocological
levocetirizine NN Pharmocological
diphenhydramine NN Pharmocological
-DOCSTART- -X- N

heparin NN Pharmocological
. . Pharmocological
heparin NNS Pharmocological
Heparin NNP Pharmocological
heparin NN Pharmocological
. . Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

Chloroprocaine NNP Pharmocological
and CC Pharmocological
lidocaine JJ Pharmocological
Lumbar NNP None
epidural JJ None
anesthesia NN None
with IN None
20 CD None
ml NN None
of IN None
either DT None
3 CD Pharmocological
% NN Pharmocological
2-chloroprocaine JJ Pharmocological
( ( Pharmocological
C NNP Pharmocological
) ) Pharmocological
, , None
1.5 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
( ( Pharmocological
L NNP Pharmocological
) ) Pharmocological
, , None
or CC None
1.5 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
( ( Pharmocological
M NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
epinephrine NN Pharmocological
-DOCSTART- -X- N

Folic JJ Pharmocological
acid-based JJ Pharmocological
intervention NN Pharmocological
Folic NNP Pharmocological
acid NN Pharmocological
combined VBN None
with IN None
vitamins NNS Pharmocological
B NNP Pharmocological
( ( Pharmocological
6 CD Pharmocological
) ) Pharmocological
and CC Pharmocological
B NNP Pharmocological
( ( Pharmocological
12 CD Pharmocological
) ) Pharmocological
placebo-controlled JJ Pharmocological
folic JJ Pharmocological
acid-based JJ Pharmocological
supplement NN Pharmocological
folate NN Pharmocological
placebo NN Control
group NN Control
folic JJ Pharmocological
acid RB Pharmocological
vitamin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
12 CD Pharmocological
) ) Pharmocological
vitamin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
6 CD Pharmocological
) ) Pharmocological
Folic JJ Pharmocological
acid-based JJ Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

evaluating VBG None
-DOCSTART- -X- N

aerobic VB Physical
training VBG Physical
aerobic JJ Physical
training VBG Physical
training NN Physical
aerobic JJ Physical
program NN Physical
above IN Physical
standard JJ Physical
treatment NN Physical
) ) None
control VB Control
group NN None
standard JJ Physical
treatment NN Physical
without IN Physical
special JJ Physical
advice NN Physical
for IN Physical
exercise NN Physical
) ) None
-DOCSTART- -X- N

azimilide NN Pharmocological
Azimilide NNP Pharmocological
dihydrochloride NN Pharmocological
electrocardiogram NN None
. . None
Azimilide NNP Pharmocological
-DOCSTART- -X- N

Direct JJ None
renin NN None
inhibition NN None
Direct JJ None
renin NN None
inhibition NN None
direct JJ None
renin NN None
inhibition NN None
placebo-controlled JJ Control
aliskiren NN Pharmocological
or CC None
placebo NN Pharmocological
aliskiren NNS Pharmocological
placebo NN Control
interaction NN None
( ( None
aliskiren VB None
? . None
visit NN None
on IN None
aliskiren NNS None
. . None
MCR NNP None
( ( None
aliskiren NN None
) ) None
and CC None
38.2 CD None
placebo NN None
-DOCSTART- -X- N

prednisolone NN Pharmocological
and CC Pharmocological
cytotoxics NNS Pharmocological
prednisolone NN Pharmocological
and CC Pharmocological
cytotoxic NN Pharmocological
agents NNS Pharmocological
low-dose JJ Pharmocological
cyclophosphamide NN Pharmocological
then RB None
azathioprine VB Pharmocological
, , None
and CC None
to TO None
control VB Control
groups NNS Control
. . Control
prednisolone NN Pharmocological
cytotoxic NN Pharmocological
agents NNS Pharmocological
; : Pharmocological
-DOCSTART- -X- N

Succinate NNP Pharmocological
sumatriptan JJ Pharmocological
sumatriptan JJ Pharmocological
sumatriptan NN Control
( ( Control
group NN Control
A NNP Control
) ) Control
or CC None
placebo NN Control
( ( Control
group NN Control
B NNP Control
) ) Control
. . None
After IN None
a DT None
2-week JJ None
complete JJ None
pharmacological NN None
washout NN None
, , None
clinical JJ None
examination NN None
, , None
electrocardiogram NN None
, , None
and CC None
Doppler NNP None
echocardiography NN None
were VBD None
performed VBN None
at IN None
baseline NN None
, , None
15 CD None
, , None
30 CD None
, , None
45 CD None
, , None
and CC None
60 CD None
min NN None
after IN None
sumatriptan NN None
or CC None
placebo JJ None
administration NN None
. . None
succinate JJ Pharmocological
sumatriptan NNS Pharmocological
-DOCSTART- -X- N

pyridostigmine NN Pharmocological
naloxone NN Pharmocological
TRH NNP None
tests NNS None
were VBD None
performed VBN None
after IN None
an DT None
overnight NN None
( ( None
8 CD None
hours NNS None
) ) None
fast RB None
, , None
placebo JJ Control
administrations NNS None
( ( None
control VB None
test NN None
) ) None
, , None
and CC None
after IN None
prolonged VBN None
( ( None
56 CD None
hours NNS None
) ) None
starvation NN None
. . None
were VBD None
performed VBN None
either RB None
after IN None
placebos NN Control
( ( None
in IN None
all DT None
subjects NNS None
) ) None
or CC None
the DT None
administration NN None
of IN None
pyridostigmine NN Pharmocological
( ( None
180 CD None
mg NNS None
orally RB None
) ) None
( ( None
in IN None
7 CD None
subjects NNS None
, , None
group NN None
1 CD None
) ) None
; : None
naloxone NN Pharmocological
( ( None
0.8 CD None
mg NN None
in IN None
an DT None
i.v NN None
. . None
bolus CC None
injection NN None
) ) None
( ( None
in IN None
7 CD None
subjects NNS None
, , None
group NN None
2 CD None
) ) None
; : None
or CC None
the DT None
combination NN None
of IN None
pyridostigmine NN Pharmocological
and CC Pharmocological
naloxone NN Pharmocological
( ( None
in IN None
7 CD None
subjects NNS None
, , None
group NN None
3 CD None
) ) None
. . None
TRH NNP Pharmocological
plus CC None
placebo NN Control
, , None
TRH NNP Pharmocological
plus CC Pharmocological
naloxone NN Pharmocological
, , Pharmocological
TRH NNP Pharmocological
plus CC Pharmocological
pyridostigmine NN Pharmocological
, , None
and CC None
TRH NNP Pharmocological
plus CC None
naloxone JJ Pharmocological
plus CC None
pyridostigmine NN Pharmocological
pyridostigmine JJ Pharmocological
naloxone JJ Pharmocological
pyridostigmine NN Pharmocological
TRH NNP Pharmocological
-DOCSTART- -X- N

low-tilt JJ Physical
biphasic JJ Physical
waveform NN Physical
low-tilt JJ Pharmocological
waveform NN Pharmocological
conventional JJ Pharmocological
waveform NN Pharmocological
low-tilt JJ Physical
waveform NN Physical
conventional JJ Physical
waveform NN Physical
. . None
low-tilt JJ Physical
waveform NN Physical
conventional JJ Pharmocological
waveform NN Pharmocological
low-tilt JJ Pharmocological
biphasic JJ Pharmocological
waveform NN Pharmocological
-DOCSTART- -X- N

[ JJ None
Radiotherapy NNP Physical
low- JJ Physical
versus NN Physical
high-dose JJ Physical
photon NN Physical
bean NN Physical
radiation NN Physical
] NN None
low-dose JJ Physical
radiation NN Physical
therapy NN Physical
10 CD Physical
Gy NNP Physical
10 CD Physical
Gy NNP Physical
36 CD Physical
Gy NNP Physical
. . None
10 CD Physical
or CC Physical
36 CD Physical
Gy NNP Physical
. . None
10 CD Physical
Gy NNP Physical
36 CD Physical
Gy NNP Physical
; : None
-DOCSTART- -X- N

Procalcitonin NNP Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
procalcitonin NN None
antibiotic JJ Pharmocological
therapy NN Pharmocological
Procalcitonin NNP Pharmocological
was VBD None
measured VBN None
daily RB None
by IN None
a DT None
semi-quantitative JJ None
immunoassay NN None
in IN None
the DT None
study NN None
group NN None
. . None
2 CD Educational
groups NNS Educational
including VBG Educational
a DT Educational
PCT-guided JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
study VB Pharmocological
group NN Pharmocological
) ) Pharmocological
and CC None
a DT Educational
prophylactic JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
( ( Educational
control VB Educational
group NN Educational
) ) Educational
Antibiotic JJ Pharmocological
therapy NN Pharmocological
in IN None
the DT None
study NN None
group NN None
was VBD None
not RB None
applied VBN None
until IN None
clinical JJ None
signs NNS None
and CC None
symptoms NNS None
of IN None
infection NN None
appeared VBN None
( ( None
PCT NNP None
value NN None
was VBD None
> JJ None
0.5ng/ml CD None
) ) None
antibiotic JJ Pharmocological
therapy NN Pharmocological
Procalcitonin NNP Pharmocological
-DOCSTART- -X- N

short JJ Educational
nurse-based JJ Educational
and CC Educational
a DT Educational
long JJ Educational
multidisciplinary JJ Educational
version NN Educational
of IN Educational
structured JJ Educational
patient JJ Educational
education NN Educational
Structured NNP Educational
multidisciplinary JJ Educational
patient NN Educational
group NN Educational
education NN Educational
long JJ Educational
multidisciplinary JJ Educational
group NN Educational
education NN Educational
short JJ Educational
nurse-based JJ Educational
group NN Educational
education NN Educational
short JJ Educational
nurse-based JJ Educational
or CC Educational
a DT Educational
long JJ Educational
multidisciplinary-based JJ Educational
education NN Educational
. . Educational
self-administered JJ Educational
questionnaires NNS Educational
short JJ Educational
, , Educational
nurse-based JJ Educational
educational JJ Educational
intervention NN Educational
longer RBR Educational
multidisciplinary JJ Educational
-DOCSTART- -X- N

received VBD None
7 CD None
weeks NNS None
wheelchair JJ Physical
training NN Physical
( ( None
3 CD None
week NN None
( ( None
-1 NN None
) ) None
, , None
70 CD None
min NN None
) ) None
at IN None
a DT None
low JJ None
intensity NN None
( ( None
30 CD None
% NN None
of IN None
the DT None
heart NN None
rate NN None
reserve NN None
) ) None
, , None
whereas IN None
the DT None
control NN Educational
group NN None
did VBD Educational
not RB Educational
receive VB Educational
training NN Educational
. . None
During IN None
pre- JJ None
and CC None
post-tests NNS None
, , None
submaximal JJ None
exercise NN None
was VBD None
performed VBN None
on IN None
a DT None
stationary JJ None
wheelchair NN Physical
ergometer NN None
at IN None
fixed JJ None
levels NNS None
of IN None
power NN None
output NN None
. . None
were VBD None
measured VBN None
. . None
-DOCSTART- -X- N

silicone NN Physical
intraocular NN Physical
lens NNS Physical
( ( Physical
IOL NNP Physical
) ) Physical
( ( None
SI40NB NNP Physical
, , Physical
Allergan NNP Physical
) ) None
or CC None
an DT None
AcrySof NNP Physical
IOL NNP Physical
IOL NNP Physical
optics NNS Physical
acrylic JJ Physical
IOLs NNP Physical
. . None
-DOCSTART- -X- N

home-visiting JJ Educational
program NN Educational
The DT Educational
intervention NN Educational
consisted VBD Educational
of IN Educational
44 CD Educational
home NN Educational
visits NNS Educational
from IN Educational
the DT Educational
third JJ Educational
trimester NN Educational
of IN Educational
pregnancy NN Educational
through IN Educational
to TO Educational
the DT Educational
child NN Educational
's POS Educational
second JJ Educational
birthday NN Educational
. . None
use NN Educational
of IN Educational
video NN Educational
during IN Educational
home-visits NNS Educational
. . None
-DOCSTART- -X- N

inhaled JJ Pharmocological
albuterol NN Pharmocological
powder NN Pharmocological
and CC Pharmocological
aerosol NN Pharmocological
aerosolized JJ Pharmocological
albuterol NN Pharmocological
with IN Pharmocological
the DT Pharmocological
dry JJ Pharmocological
powder NN Pharmocological
formulation NN Pharmocological
placebo NN Pharmocological
albuterol NN Pharmocological
aerosol NN Pharmocological
active JJ Pharmocological
albuterol NN Pharmocological
powder NN Pharmocological
active JJ Pharmocological
albuterol NN Pharmocological
aerosol NN Pharmocological
placebo NN Pharmocological
lactose JJ Pharmocological
powder NN Pharmocological
powder NN Pharmocological
aerosol JJ Pharmocological
albuterol NN Pharmocological
powder NN Pharmocological
albuterol NN Pharmocological
aerosol NN Pharmocological
. . None
-DOCSTART- -X- N

12-lead JJ Physical
ECG NNP Physical
, , Physical
and CC Physical
24-h JJ Physical
ambulatory NN Physical
ECG NNP Physical
monitoring NN Physical
. . None
L-thyroxine NNP Pharmocological
L-thyroxine NNP Pharmocological
. . None
L-tiroxine NNP Pharmocological
L-thyroxine JJ Pharmocological
-DOCSTART- -X- N

tetrabenazine NN Pharmocological
. . None
tetrabenazine JJ Pharmocological
100 CD Pharmocological
mg NN Pharmocological
in IN Pharmocological
divided JJ Pharmocological
dosage NN Pharmocological
. . None
diazepam NN Pharmocological
Tetrabenazine NNP Pharmocological
-DOCSTART- -X- N

Sequential JJ Pharmocological
therapy NN Pharmocological
versus IN None
standard JJ Pharmocological
triple-drug JJ Pharmocological
therapy NN Pharmocological
sequential JJ Pharmocological
vs. FW None
standard JJ Pharmocological
triple-drug JJ Pharmocological
therapy NN Pharmocological
10-day JJ Pharmocological
sequential JJ Pharmocological
regimen NNS Pharmocological
( ( None
40 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
, , None
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
amoxicillin NN Pharmocological
, , None
each DT None
administered VBN None
twice RB None
daily RB None
for IN None
the DT None
first JJ None
5 CD None
days NNS None
, , None
followed VBN None
by IN None
40 CD Pharmocological
mg NNS Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
, , None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
clarithromycin NN Pharmocological
, , None
and CC None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
tinidazole NN Pharmocological
, , None
each DT None
administered VBN None
twice RB None
daily RB None
for IN None
the DT None
remaining VBG None
5 CD None
days NNS None
) ) None
or CC None
to TO None
standard VB Pharmocological
14-day JJ Pharmocological
therapy NN Pharmocological
( ( None
40 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
, , None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
clarithromycin NN Pharmocological
, , None
and CC None
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
amoxicillin NN Pharmocological
, , None
each DT None
administered VBN None
twice RB None
daily RB None
) ) None
. . None
sequential JJ Pharmocological
regimen NN Pharmocological
triple JJ Pharmocological
therapy NN Pharmocological
. . None
sequential JJ Pharmocological
therapy NN Pharmocological
standard JJ None
drug NN None
standard JJ None
and CC None
sequential JJ None
therapy NN None
groups NNS None
. . None
Sequential JJ None
therapy NN None
includes VBZ None
tinidazole NN None
standard JJ None
therapy NN None
. . None
CONCLUSIONS NNP None
Sequential NNP None
therapy NN None
was VBD None
standard JJ None
therapy NN None
for IN None
-DOCSTART- -X- N

angiotensin-converting JJ Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
zofenopril NN Pharmocological
. . None
placebo NN Control
placebo NN None
zofenopril NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
-DOCSTART- -X- N

histamine-induced JJ Physical
mizolastine NN Pharmocological
. . None
Mizolastine NNP Pharmocological
once-daily JJ Pharmocological
mizolastine NN Pharmocological
placebo NN Control
Histamine NN Physical
tests NNS Physical
mizolastine NN Pharmocological
placebo NN Control
mizolastine NN Pharmocological
mizolastine NN Pharmocological
-DOCSTART- -X- N

pimecrolimus NN Pharmocological
pimecrolimus NN Pharmocological
pimecrolimus NNS Pharmocological
Pimecrolimus NNP Pharmocological
-DOCSTART- -X- N

dependence NN Educational
personal JJ Educational
persuasion NN Educational
abstinence NN Educational
control NN Educational
. . Educational
abstinence NN Educational
-DOCSTART- -X- N

and/or JJ Pharmocological
antioxidants NNS Pharmocological
. . Pharmocological
-DOCSTART- -X- N

irinotecan JJ Pharmocological
irinotecan JJ Pharmocological
Irinotecan NNP Pharmocological
high-fat JJ Other
, , Other
high-calorie JJ Other
breakfast NN Other
irinotecan JJ Pharmocological
irinotecan JJ Pharmocological
irinotecan JJ Pharmocological
-DOCSTART- -X- N

breast-feeding JJ Educational
promotion NN Educational
with IN Physical
duplicate JJ Physical
measurements NNS Physical
of IN Physical
height NN Physical
, , Physical
weight NN Physical
, , Physical
waist JJ Physical
circumference NN Physical
, , Physical
triceps NNS Physical
and CC Physical
subscapular JJ Physical
skinfold NN Physical
thicknesses NNS Physical
, , Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
BP NNP Physical
. . None
breast-feeding JJ None
promotion NN None
intervention NN None
-DOCSTART- -X- N

Gamma-hydroxybutyric JJ Pharmocological
acid NN Pharmocological
clomethiazole NN Pharmocological
Clomethiazole NNP Pharmocological
( ( Pharmocological
CLO NNP Pharmocological
) ) Pharmocological
Gamma-Hydroxybutyric JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
GHB NNP Pharmocological
) ) Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
GHB NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
-DOCSTART- -X- N

5 CD Pharmocological
alpha-reductase JJ Pharmocological
inhibitor NN Pharmocological
finasteride NN Pharmocological
. . None
Finasteride NNP Pharmocological
-DOCSTART- -X- N

formoterol NN Pharmocological
formoterol NN Pharmocological
placebo NN Control
formoterol NN Pharmocological
12 CD Pharmocological
microg NN Pharmocological
dry JJ Pharmocological
powder NN Pharmocological
inhalation NN Pharmocological
or CC None
matching VBG None
placebo JJ Control
twice RB None
daily RB None
for IN None
8 CD None
weeks NNS None
. . None
Twenty CD Physical
four-hour JJ Physical
continuous JJ Physical
electrocardiography NN Physical
( ( Physical
Holter NNP Physical
monitoring NN Physical
) ) Physical
formoterol NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Viozan NNP Pharmocological
( ( Pharmocological
sibenadet JJ Pharmocological
HCl NNP Pharmocological
) ) Pharmocological
Viozan NNP Pharmocological
( ( None
sibenadet JJ Pharmocological
HCl NNP Pharmocological
, , None
AR-C68397AA NNP Pharmocological
) ) None
sibenadet NN Pharmocological
500 CD Pharmocological
microg NN Pharmocological
sibenadet NN Pharmocological
or CC None
placebo NN Control
Sibenadet NNP Pharmocological
therapy NN None
placebo NN Control
-DOCSTART- -X- N

cementless NN Surgical
implant NN Surgical
-DOCSTART- -X- N

by IN None
a DT None
direct JJ None
PCR NNP None
method NN None
in IN None
fecal JJ None
samples NNS None
from IN None
mothers NNS None
breast-milk JJ Physical
samples NNS Physical
1 CD None
month NN None
post-partum NN None
. . None
-DOCSTART- -X- N

intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
Intensive NNP Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
IIT NNP Pharmocological
) ) Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
CIT NNP Pharmocological
) ) Pharmocological
. . None
IIT NNP Pharmocological
IIT NNP Pharmocological
. . None
IIT NNP Pharmocological
CIT NNP Pharmocological
IIT NNP Pharmocological
IIT NNP Pharmocological
IIT NNP Pharmocological
-DOCSTART- -X- N

N-acetylcysteine NNP Pharmocological
N-acetylcysteine NNP Pharmocological
3 CD None
g NN None
acetaminophen NN Pharmocological
one CD None
hour NN None
later RB None
by IN None
the DT None
normal JJ None
loading VBG None
dose NN None
of IN None
N-acetylcysteine NNP Pharmocological
3 CD None
g NN None
acetaminophen NN Pharmocological
60 CD None
g NNS None
activated VBN Pharmocological
charcoal NN Pharmocological
and CC None
a DT None
supranormal JJ Pharmocological
loading NN Pharmocological
dose NN Pharmocological
of IN Pharmocological
N-acetylcysteine NNP Pharmocological
N-acetylcysteine NNP Pharmocological
N-acetylcysteine NNP Pharmocological
N-acetylcysteine JJ Pharmocological
-DOCSTART- -X- N

Aspirin NNP Pharmocological
aspirin NNS Pharmocological
aspirin NN Pharmocological
or CC None
placebo NN Control
and CC None
clonidine NN None
or CC None
placebo NN None
. . None
aspirin JJ Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
aspirin NN Pharmocological
placebo VB Control
aspirin JJ Pharmocological
aspirin NN Pharmocological
placebo NN Control
placebo NN Control
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

Extra JJ Educational
prompts NNS Educational
no DT Educational
extra JJ Educational
prompts NNS Educational
color-coded JJ Educational
extra JJ Educational
prompt JJ Educational
procedure NN Educational
was VBD None
compared VBN Educational
to TO Educational
a DT Educational
no DT Educational
extra JJ Educational
prompt JJ Educational
procedure NN Educational
learned VBD Educational
to TO Educational
lace VB Educational
shoes NNS Educational
whose WP$ Educational
laces NNS Educational
and CC Educational
eyelets NNS Educational
were VBD Educational
color-coded JJ Educational
red JJ Educational
and CC Educational
white JJ Educational
, , None
and CC None
then RB None
encountered VBD Educational
the DT Educational
no DT Educational
extra JJ Educational
prompt JJ Educational
condition NN Educational
in IN Educational
which WDT Educational
color NN Educational
codes NNS Educational
could MD Educational
no RB Educational
longer RB Educational
be VB Educational
depended VBN Educational
upon IN Educational
to TO Educational
solve VB Educational
the DT Educational
position NN Educational
discriminations NNS Educational
required VBN Educational
to TO Educational
lace VB Educational
properly RB Educational
. . None
-DOCSTART- -X- N

microcrystalline NN Pharmocological
sustained-release JJ Pharmocological
preparations NNS Pharmocological
theophylline NN Pharmocological
theophylline JJ Pharmocological
therapy NN None
. . None
Nuelin NNP Pharmocological
Retard NNP Pharmocological
-DOCSTART- -X- N

degarelix NN Pharmocological
: : None
degarelix NN Pharmocological
gonadotropin-releasing JJ None
hormone NN None
antagonist NN None
. . None
leuprolide JJ Pharmocological
acetate NN Pharmocological
vs NN None
degarelix NN Pharmocological
. . None
degarelix NN Pharmocological
leuprolide NN Pharmocological
degarelix NN Pharmocological
leuprolide NN Pharmocological
degarelix NN Pharmocological
leuprolide NN Pharmocological
. . None
degarelix NN Pharmocological
leuprolide NN Pharmocological
-DOCSTART- -X- N

intraocular JJ Surgical
lens NNS Surgical
( ( Surgical
IOL NNP Surgical
) ) Surgical
was VBD Surgical
implanted VBN Surgical
left VBN Physical
aphakic NN Physical
, , Physical
treated VBD Physical
with IN Physical
contact NN Physical
lens NNS Physical
( ( Physical
CL NNP Physical
) ) Physical
. . None
IOL NNP Surgical
CL NNP Physical
IOL NNP Surgical
CL NNP Physical
-DOCSTART- -X- N

rectal JJ Physical
distension NN Physical
rectal JJ Physical
distension NN Physical
with IN Physical
and CC Physical
without IN Physical
rectal JJ Physical
balloon NN Physical
distension NN Physical
. . Physical
with IN None
rectal JJ None
distention NN None
as IN None
CONCLUSION NNP None
Rectal NNP None
distention NN None
in IN None
-DOCSTART- -X- N

nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
nitric-oxidegenerating JJ Pharmocological
gel NN Pharmocological
We PRP None
prepared VBD None
the DT None
nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
by IN None
mixing VBG None
a DT None
solution NN None
of IN None
KY NNP Pharmocological
jelly RB Pharmocological
and CC Pharmocological
sodium JJ Pharmocological
nitrite NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
% NN Pharmocological
weight/volume NN Pharmocological
) ) Pharmocological
, , Pharmocological
with IN Pharmocological
a DT Pharmocological
solution NN Pharmocological
of IN Pharmocological
KY NNP Pharmocological
jelly RB Pharmocological
and CC Pharmocological
ascorbic JJ Pharmocological
acid NN Pharmocological
( ( None
5 CD None
% NN None
weight/volume NN None
) ) None
About IN None
0.5 CD None
mL NNS None
of IN None
each DT None
solution NN None
was VBD None
separately RB None
applied VBN Pharmocological
to TO Pharmocological
the DT Pharmocological
skin NN Pharmocological
of IN Pharmocological
the DT Pharmocological
forearm NN Pharmocological
( ( None
3 CD None
cm2 NN None
) ) None
, , None
and CC None
then RB None
mixed JJ None
with IN None
a DT None
sterile JJ None
cotton NN None
bud NN None
. . None
A DT None
similar JJ None
procedure NN None
was VBD None
done VBN None
simultaneously RB None
on IN None
the DT None
other JJ None
arm NN None
with IN None
KY NNP Control
jelly RB Control
only RB Control
( ( Control
placebo NN Control
) ) Control
nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
-DOCSTART- -X- N

Aerobic NNP Physical
exercise NN Physical
moderate JJ Physical
aerobic JJ Physical
physical JJ Physical
activity NN Physical
comparing VBG None
16 CD None
weeks NNS None
of IN None
aerobic JJ None
physical JJ None
activity NN None
plus CC None
sleep JJ None
hygiene NN None
to TO None
non-physical JJ None
activity NN None
plus CC None
sleep JJ None
hygiene NN None
. . None
-DOCSTART- -X- N

triple JJ Pharmocological
intrathecal JJ Pharmocological
therapy NN Pharmocological
triple JJ Pharmocological
IT NNP Pharmocological
therapy NN Pharmocological
triple NN Pharmocological
IT NNP Pharmocological
therapy NN Pharmocological
group NN Pharmocological
IT NNP Pharmocological
methotrexate NN Pharmocological
triple VB Pharmocological
IT NNP Pharmocological
therapy NN Pharmocological
IT NNP Pharmocological
methotrexate NNP Pharmocological
group NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

interferon NN Pharmocological
gamma NN Pharmocological
Recombinant NNP Physical
human JJ Physical
interferon NN Physical
gamma NN Physical
, , Physical
100 CD Physical
micrograms NNS Physical
, , Physical
was VBD Physical
administered VBN Physical
subcutaneously RB Physical
once RB Physical
daily JJ Physical
for IN Physical
21 CD Physical
days NNS Physical
( ( Physical
or CC Physical
until IN Physical
patient JJ Physical
discharge NN Physical
if IN Physical
prior JJ Physical
to TO Physical
21 CD Physical
days NNS Physical
) ) Physical
as IN Physical
an DT Physical
adjunct NN Physical
to TO Physical
standard VB Physical
antibiotic JJ None
and CC None
supportive JJ Physical
therapy NN Physical
. . None
interferon JJ Pharmocological
gamma-treated JJ Pharmocological
-DOCSTART- -X- N

betamethasone NN Pharmocological
vecuronium NN Pharmocological
corticosteroid NN Pharmocological
( ( Pharmocological
betamethasone NN Pharmocological
) ) Pharmocological
and CC Pharmocological
vecuronium NN Pharmocological
nondepolarizing JJ Pharmocological
muscle NN Pharmocological
relaxant NN Pharmocological
. . None
vecuronium NN Pharmocological
vecuronium NN Pharmocological
betamethasone CD Pharmocological
Corticosteroids NNS Pharmocological
non-depolarizing JJ None
muscle NN None
relaxants NNS None
-DOCSTART- -X- N

stereotactic JJ None
radiotherapy NN None
stereotactic JJ None
radiotherapy NN None
stereotactic JJ None
radiotherapy NN None
stereotactic JJ Physical
radiotherapy NN Physical
literature NN None
survey NN None
advanced JJ None
algorithm NN None
stereotactic JJ None
radiotherapy NN None
-DOCSTART- -X- N

Soluble JJ Pharmocological
intercellular JJ Pharmocological
adhesion NN Pharmocological
molecule-1 NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
immunosuppressive JJ Pharmocological
therapy NN Pharmocological
. . None
Soluble JJ None
intercellular JJ None
adhesion NN None
molecule-1 NN None
( ( None
sICAM-1 JJ None
) ) None
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
alone RB Pharmocological
azathioprine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
prednisone NN Pharmocological
and CC Pharmocological
azathioprine NN Pharmocological
, , None
or CC None
placebo NN Control
in IN None
addition NN None
to TO None
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
. . None
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
azathioprine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
. . None
prednisone NN Pharmocological
and CC Pharmocological
azathioprine NN Pharmocological
. . None
-DOCSTART- -X- N

enalapril NN Pharmocological
and CC None
indapamide NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitor NN Pharmocological
enalapril NN Pharmocological
and CC None
diuretic JJ Pharmocological
indapamide NN Pharmocological
placebo JJ Control
enalapril NN Pharmocological
or CC None
indapamide NN Pharmocological
indapamide JJ Pharmocological
enalapril NN Pharmocological
indapamide JJ Pharmocological
enalapril JJ Pharmocological
indapamide JJ Pharmocological
Enalapril NNP Pharmocological
and CC None
indapamide NN Pharmocological
enalapril NN Pharmocological
indapamide NN Pharmocological
. . None
enalapril NN Pharmocological
. . None
-DOCSTART- -X- N

ORG-2766 NNP Pharmocological
adrenocorticotropin4-9 JJ Pharmocological
analogue NN Pharmocological
ORG-2766 NNP Pharmocological
-DOCSTART- -X- N

mitomycin-C JJ Pharmocological
vs. FW Pharmocological
5 CD Pharmocological
FU NNP Pharmocological
infusion NN Pharmocological
with IN Pharmocological
methyl-CCNU NN Pharmocological
5-fluorouracil JJ Pharmocological
96-hour CD Pharmocological
continuous JJ Pharmocological
infusions NNS Pharmocological
bolus JJ Pharmocological
mitomycin-C NN Pharmocological
or CC Pharmocological
oral JJ Pharmocological
methyl-CCNU JJ Pharmocological
. . None
Mitomycin-C JJ Pharmocological
and CC Pharmocological
methyl-CCNU JJ Pharmocological
5 CD Pharmocological
FU-mitomycin JJ Pharmocological
combination NN Pharmocological
combination NN Pharmocological
of IN Pharmocological
infusion NN Pharmocological
5 CD Pharmocological
FU NNP Pharmocological
and CC Pharmocological
methyl-CCNU JJ Pharmocological
5 CD Pharmocological
FU-mitomycin JJ Pharmocological
5 CD Pharmocological
FU-METHYL-CCNU JJ Pharmocological
methyl-CCNU JJ Pharmocological
mitomycin NN Pharmocological
5 CD Pharmocological
FU NNP Pharmocological
infusion NN Pharmocological
-DOCSTART- -X- N

acetaminophen NN Pharmocological
codeine NN Pharmocological
acetaminophen NN Pharmocological
, , Pharmocological
1000 CD Pharmocological
mg NN Pharmocological
, , None
and CC None
codeine NN Pharmocological
, , Pharmocological
60 CD Pharmocological
mg NN Pharmocological
acetaminophen NN Pharmocological
codeine NN None
acetaminophen NN Pharmocological
plus CC Pharmocological
60 CD Pharmocological
mg NN Pharmocological
codeine NN Pharmocological
placebo NN Control
. . Control
acetaminophen NN Pharmocological
codeine NN Pharmocological
placebo NN None
. . None
-DOCSTART- -X- N

operative JJ Physical
skills NNS Physical
( ( Physical
SATOS NNP Physical
) ) Physical
: : None
porcine JJ Educational
training NN Educational
model NN Educational
stepwise NN Physical
assessment JJ Physical
tool NN Physical
of IN Physical
operative JJ Physical
skills NNS Physical
( ( Physical
SATOS NNP Physical
) ) Physical
-DOCSTART- -X- N

isotonic JJ Educational
& CC Educational
isometric JJ Educational
training NN Educational
short-term JJ Physical
exercises NNS Physical
isotonic JJ Physical
training NN Physical
( ( Physical
5BX CD Physical
programme NN Physical
) ) Physical
and CC Educational
isometric JJ Physical
training NN Physical
( ( Educational
a DT Educational
programme NN Educational
of IN Educational
isometric JJ Educational
exercises NNS Educational
working VBG Educational
all DT Educational
major JJ Educational
groups NNS Educational
of IN Educational
muscles NNS Educational
) ) Educational
with IN None
a DT None
control NN Control
group NN None
isotonic JJ Educational
and CC Educational
isometric JJ Physical
training NN Physical
Isotonic JJ Physical
training NN Physical
isotonic JJ Educational
or CC Educational
isometric JJ Educational
training NN Educational
-DOCSTART- -X- N

random JJ Physical
modulation NN Physical
of IN Physical
functional JJ Physical
electrical JJ Physical
stimulation NN Physical
parameters NNS Physical
functional JJ Physical
electrical JJ Physical
stimulation NN Physical
-DOCSTART- -X- N

methylphenidate NN Pharmocological
methylphenidate JJ Pharmocological
placebo NN Control
doses NNS Pharmocological
of IN Pharmocological
methylphenidate NN Pharmocological
methylphenidate NN Pharmocological
hydrochloride NN Pharmocological
placebo NN Control
methylphenidate NN Pharmocological
Methylphenidate NNP Pharmocological
placebo VB Control
methylphenidate NN Pharmocological
Methylphenidate NNP Pharmocological
-DOCSTART- -X- N

Pentaglobin NNP Pharmocological
( ( None
Pentaglobin NNP Pharmocological
) ) None
12.5 CD Pharmocological
g JJ Pharmocological
human JJ Pharmocological
albumin NN Pharmocological
-DOCSTART- -X- N

in-person NN Educational
recall NN Educational
with IN Educational
an DT Educational
obese JJ Educational
interviewer NN Educational
in-person NN Educational
recall NN Educational
with IN Educational
a DT Educational
lean JJ Educational
interviewer NN Educational
telephone NN Educational
recall NN Educational
with IN Educational
an DT Educational
unknown JJ Educational
interviewer NN Educational
. . None
telephone-administered JJ Educational
multiple-pass JJ Educational
24-hour JJ Educational
recall NN Educational
unknown JJ None
interviewer NN None
in-person JJ Educational
MP24R NNP Educational
with IN Educational
either CC Educational
a DT Educational
lean JJ Educational
or CC Educational
obese JJ Educational
interviewer NN Educational
to TO Educational
gather VB Educational
Caltrac NNP None
accelerometer NN None
. . None
-DOCSTART- -X- N

alfentanil NN Pharmocological
, , None
fentanyl NN Pharmocological
sufentanil NN Pharmocological
propofol NN Pharmocological
alfentanil NN Pharmocological
, , None
fentanyl NN Pharmocological
sufentanil VB Pharmocological
propofol NN Pharmocological
. . None
alfentanil NN Pharmocological
, , None
fentanyl NN Pharmocological
and CC None
sufentanil NN Pharmocological
fentanyl NN Pharmocological
sufentanil NN Pharmocological
alfentanil NN Pharmocological
fentanyl NN Pharmocological
alfentanil NN Pharmocological
sufentanil NN Pharmocological
fentanyl NN Pharmocological
propofol NN Pharmocological
alfentanil NN Pharmocological
sufentanil NN Pharmocological
propofol NN Pharmocological
. . None
alfentanil NN Pharmocological
fentanyl NN Pharmocological
-DOCSTART- -X- N

testicular JJ Physical
biopsy NN Physical
local JJ Physical
testicular JJ Physical
irradiation NN Physical
systemic JJ Pharmocological
re-treatment NN Pharmocological
; : None
biopsy NN Surgical
testicular JJ Surgical
biopsies NNS Surgical
-DOCSTART- -X- N

p16 FW Physical
( ( Physical
INK4a NNP Physical
) ) Physical
immunohistochemical JJ Physical
staining NN Physical
. . None
p16 NN Physical
( ( Physical
INK4a NNP Physical
) ) Physical
-negative NN Physical
and CC None
-positive JJ None
-DOCSTART- -X- N

topical JJ Pharmocological
boswellic JJ Pharmocological
acid NN Pharmocological
Boswellic NNP Pharmocological
acids NNS Pharmocological
( ( Pharmocological
BAs NNP Pharmocological
) ) Pharmocological
base NN Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
BAs NNP Pharmocological
the DT Pharmocological
same JJ Pharmocological
cream NN Pharmocological
without IN Pharmocological
these DT Pharmocological
active JJ Pharmocological
ingredients NNS Pharmocological
BAs NNP Pharmocological
; : Pharmocological
BAs NNP Pharmocological
-DOCSTART- -X- N

tropisetron NN Pharmocological
and CC Pharmocological
granisetron NN Pharmocological
Tropisetron NNP Pharmocological
and CC None
granisetron NN Pharmocological
tropisetron RP Pharmocological
granisetron NN Pharmocological
chemotherapy NN Pharmocological
. . Physical
tropisetron NN Pharmocological
granisetron NN Pharmocological
tropisetron NN Pharmocological
granisetron NN Pharmocological
granisetron NN Pharmocological
tropisetron RB Pharmocological
granisetron NN Pharmocological
ganisetron NN Pharmocological
-DOCSTART- -X- N

bumetanide NN Pharmocological
benzodiazepines NNS Pharmocological
bumetanide IN Pharmocological
placebo NN Control
bumetanide NN Pharmocological
Bumetanide NNP Pharmocological
placebo NN Control
) ) None
placebo NN Control
) ) None
Therefore RB None
, , None
bumetanide NN None
is VBZ None
-DOCSTART- -X- N

( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

metronidazole JJ Pharmocological
placebo-controlled JJ Control
metronidazole NN Pharmocological
single JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
metronidazole NN Pharmocological
seven-day JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metronidazole JJ Pharmocological
metronidazole JJ Pharmocological
-DOCSTART- -X- N

BCG NNP Pharmocological
( ( Pharmocological
RIVM NNP Pharmocological
) ) Pharmocological
mitomycin JJ Pharmocological
intravesical JJ Pharmocological
therapy NN Pharmocological
bacillus JJ None
Calmette-Gu?rin NNP None
( ( None
BCG NNP None
) ) None
RIVM NNP None
, , None
a DT None
Dutch JJ None
BCG NNP None
with IN None
mitomycin JJ None
C NNP None
BCG NNP None
RIVM NNP None
and CC None
mitomycin VB None
C NNP None
for IN None
BCG-treated JJ None
for IN None
MMC-treated JJ None
-DOCSTART- -X- N

composite JJ Physical
cements NNS Physical
phosphoric JJ Pharmocological
acid NN Pharmocological
coating NN Physical
with IN Physical
a DT Physical
self-etching JJ Physical
adhesive NN Physical
( ( Physical
Linkmax NNP Physical
) ) Physical
and CC Physical
its PRP$ Physical
respective JJ Physical
cement NN Physical
, , None
coating VBG Physical
with IN Physical
a DT Physical
conventionally RB Physical
etched VBN Physical
adhesive NN Physical
( ( Physical
RelyX NNP Physical
ARC NNP Physical
) ) Physical
and CC Physical
its PRP$ Physical
cement NN Physical
, , None
or CC None
no DT None
treatment NN None
self-etching JJ Physical
adhesive NN Physical
and CC Physical
its PRP$ Physical
respective JJ Physical
cement NN Physical
etched VBN Physical
adhesive JJ Physical
and CC Physical
its PRP$ Physical
cement NN Physical
Linkmax NNP Physical
treatment NN None
-DOCSTART- -X- N

allograft NN Pharmocological
experimental JJ Physical
putty NN Physical
carrier NN Physical
and CC Physical
a DT Physical
bovine-derived JJ Physical
xenograft NN Physical
graft NN Physical
materials NNS Physical
. . None
ridge NN None
preservation NN None
treatment NN None
with IN None
either DT None
an DT None
allograft NN None
in IN None
an DT None
experimental JJ None
putty NN None
carrier NN None
plus CC None
a DT None
calcium NN Pharmocological
sulfate NN Pharmocological
barrier NN Pharmocological
( ( None
PUT NNP None
) ) None
or CC None
a DT None
bovine-derived JJ Pharmocological
xenograft NN Pharmocological
( ( Pharmocological
BDX NNP Pharmocological
) ) Pharmocological
plus CC None
a DT None
collagen NN None
membrane NN None
. . None
BDX NNP Pharmocological
PUT NNP None
BDX NNP Physical
PUT NNP None
xenograft NN Pharmocological
-DOCSTART- -X- N

5-fluorouracil JJ Pharmocological
plus CC Pharmocological
folinic JJ Pharmocological
acid NN Pharmocological
ifosfamide NN Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
plus CC None
folinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
FA NNP Pharmocological
) ) Pharmocological
with IN None
or CC None
without IN None
ifosfamide JJ Pharmocological
( ( Pharmocological
IFO NNP Pharmocological
) ) Pharmocological
FA NNP Pharmocological
5-FU JJ Pharmocological
FA NNP Pharmocological
5-FU JJ Pharmocological
IFO NNP Pharmocological
-DOCSTART- -X- N

leukocyte JJ Pharmocological
IFN-alpha NN Pharmocological
HBV NNP Pharmocological
vaccine NN Pharmocological
IFN-alpha NNP Pharmocological
adjuvant NN Pharmocological
of IN Pharmocological
HBV NNP Pharmocological
vaccine NN Pharmocological
IFN-alpha NNP Pharmocological
-DOCSTART- -X- N

stenting VBG Physical
. . Surgical
stenting VBG Physical
or CC None
no DT Control
further JJ Control
treatment NN Control
. . None
-DOCSTART- -X- N

toothbrushes NNS Physical
and CC Physical
dentifrice NN Physical
regular JJ Physical
brushing NN Physical
with IN Physical
dentifrices NNS Physical
toothbrush NN Physical
and CC Physical
dentifrice NN Physical
) ) None
introduction NN Physical
of IN Physical
toothbrushes NNS Physical
and CC Physical
dentifrices NNS Physical
-DOCSTART- -X- N

ponezumab NN Pharmocological
placebo-controlled JJ Control
Ponezumab NNP Pharmocological
mg/kg NN None
ponezumab NN None
versus NN None
placebo NN None
Ponezumab NNP None
0.002 CD None
vs NN None
placebo NN None
) ) None
. . None
CONCLUSIONS VB None
mg/kg NNS None
ponezumab NN None
was VBD None
intravenous JJ None
ponezumab NN None
alters NNS None
-DOCSTART- -X- N

auscultation NN Physical
oesophageal JJ Surgical
intubation NN Surgical
intubation NN Surgical
. . None
-DOCSTART- -X- N

Tongbu NNP Physical
No NNP Physical
. . Educational
1 CD None
( ( None
TB1 NNP Pharmocological
, , None
a DT None
prescription NN None
for IN None
reinforcing VBG None
Kidney NNP None
and CC None
Spleen NNP None
, , None
clearing VBG None
up RP None
the DT None
bowel NN None
viscera NN None
to TO None
send VB None
Turbid NNP None
downward NN None
and CC None
regulating NN None
Qi NNP None
and CC None
blood NN None
) ) None
-DOCSTART- -X- N

routine JJ Psychological
bedside NN Psychological
questioning VBG Psychological
and CC Psychological
examination NN Psychological
by IN Psychological
the DT Psychological
visiting NN Psychological
doctor NN Psychological
Thromboprophylaxis NNP Pharmocological
( ( Pharmocological
dextran-70 JJ Pharmocological
, , Pharmocological
low JJ Pharmocological
molecular JJ Pharmocological
weight NN Pharmocological
heparin NN Pharmocological
and CC Pharmocological
graded VBD Physical
elastic JJ Physical
stockings NNS Physical
) ) Pharmocological
Bilateral NNP Physical
venography NN Physical
-DOCSTART- -X- N

amlodipine NN Pharmocological
amlodipine NN Pharmocological
current JJ None
antianginal JJ Control
therapy NN Control
amlodipine/day NN Pharmocological
amlodipine NN Pharmocological
Amlodipine NNP Pharmocological
-DOCSTART- -X- N

slush NN Pharmocological
nitrogen NN Pharmocological
vitrification NN Pharmocological
vitrified VBN Physical
with IN Physical
or CC Physical
without IN Physical
cumulus JJ Physical
cells NNS Physical
slush NN Pharmocological
nitrogen NN Pharmocological
vitrification NN Pharmocological
with IN Physical
or CC Physical
without IN Physical
cumulus JJ Physical
cells NNS Physical
vitrified VBD Physical
with IN Physical
and CC Physical
without IN Physical
cumulus JJ Physical
cells NNS Physical
-DOCSTART- -X- N

Ho'ouna NNP Educational
Pono NNP Educational
substance NN Educational
use NN Educational
prevention NN Educational
curriculum NN Educational
: : None
called VBN Educational
Ho'ouna NNP Educational
Pono NNP Educational
. . None
Ho'ouna NNP Educational
Pono NNP Educational
-DOCSTART- -X- N

Poylmerized VBN Pharmocological
whole JJ Pharmocological
ragweed NN Pharmocological
: : None
glutaraldehyde-treated JJ Pharmocological
polymerized NNS Pharmocological
ragweed VBP Pharmocological
nonpolymerized JJ Pharmocological
monomeric JJ Pharmocological
ragweed NN Pharmocological
. . Pharmocological
ragweed NN Pharmocological
serum-specific JJ None
IgE NNP None
polymerized JJ Pharmocological
ragweed NN Pharmocological
. . None
-DOCSTART- -X- N

IMVAMUNE NNP Pharmocological
third JJ Pharmocological
generation NN Pharmocological
smallpox VBD Pharmocological
vaccine JJ Pharmocological
MVA-BN NNP Pharmocological
( ( Pharmocological
IMVAMUNE NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
Lister-Elstree NNP Pharmocological
or CC None
Dryvax NNP Pharmocological
. . None
-DOCSTART- -X- N

pulse JJ Physical
oximetry NN Physical
pulse JJ Physical
oximetry NN Physical
infusion NN Physical
experiments NNS Physical
Ringer NNP None
's POS None
acetate NN None
( ( None
20 CD None
ml RB None
kg NN None
) ) None
, , None
hydroxyethyl VBD None
starch NN None
130/0.4 CD None
( ( None
10 CD None
ml RB None
kg NN None
) ) None
and CC None
a DT None
combination NN None
of IN None
both DT None
infusions NNS None
of IN None
Ringer NNP None
's POS None
acetate NN None
by IN None
pulse JJ None
oximetry NN None
is VBZ None
-DOCSTART- -X- N

diltiazem NN Pharmocological
] NN Pharmocological
diltiazem JJ Pharmocological
placebo NN Control
diltiazem JJ Pharmocological
and CC None
placebo NN Control
( ( None
diltiazem JJ Pharmocological
placebo NN Control
. . None
diltiazem NN Pharmocological
placebo NN Control
diltiazem NN Pharmocological
. . None
Diltiazem NNP Pharmocological
-DOCSTART- -X- N

gonadotropin NN Pharmocological
recombinant JJ None
follicle NN None
stimulating VBG None
hormone NN None
( ( None
rFSH NN None
) ) None
GnRH-agonist JJ Physical
followed VBN None
by IN None
rFSH JJ Physical
administration NN Physical
. . None
GnRH-a NNP Pharmocological
rFSH NN Physical
rFSH NN None
rFSH NN None
rFSH JJ None
rFSH NN None
rFSH NN None
rFSH NN None
-DOCSTART- -X- N

right JJ Physical
ventricular JJ Physical
myocardial JJ Physical
isovolumic JJ Physical
relaxation NN Physical
time NN Physical
. . None
RV NNP Physical
IVRT NNP Physical
( ( Physical
IVRT NNP Physical
' POS Physical
) ) Physical
invasively RB Surgical
measured VBN Surgical
PAP NNP Surgical
. . Surgical
Transthoracic NNP Physical
echocardiography NN Physical
with IN Physical
myocardial JJ Physical
velocity NN Physical
imaging NN Physical
and CC Physical
right JJ Surgical
heart NN Surgical
catheterization NN Surgical
-DOCSTART- -X- N

interferon-omega JJ Pharmocological
antiviral JJ Pharmocological
therapies NNS Pharmocological
recombinant JJ Pharmocological
feline NN Pharmocological
interferon NN Pharmocological
( ( Pharmocological
type JJ Pharmocological
omega NN Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
IFN NNP Pharmocological
) ) None
rFeIFN-omega JJ Pharmocological
placebo NN Control
saline NN Pharmocological
rFeIFN-omega JJ Pharmocological
-DOCSTART- -X- N

behavioral JJ Educational
intervention NN Educational
project NN Educational
. . None
web-based JJ Educational
communication NN Educational
and CC Educational
support NN Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

Qigong JJ Physical
massage NN Physical
treatment NN Physical
Qigong NNP Other
Sensory NNP Other
Training NNP Other
( ( Other
QST NNP Other
) ) Other
qigong JJ Physical
massage NN Physical
intervention NN Physical
-DOCSTART- -X- N

secretin NN Pharmocological
secretin NN Pharmocological
placebo NN Control
2.0 CD Pharmocological
clinical JJ Pharmocological
units NNS Pharmocological
of IN Pharmocological
secretin NN Pharmocological
per IN Pharmocological
kilogram NN Pharmocological
of IN Pharmocological
body NN Pharmocological
weight NN Pharmocological
placebo NN Control
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
. . None
secretin NN Pharmocological
-DOCSTART- -X- N

walnut NN Pharmocological
consumption NN Pharmocological
walnut NN Pharmocological
consumption NN Pharmocological
ad NN Pharmocological
libitum NN Pharmocological
diet JJ Pharmocological
enriched VBD Pharmocological
with IN Pharmocological
56 CD Pharmocological
g NNS Pharmocological
( ( Pharmocological
366 CD Pharmocological
kcal NN Pharmocological
) ) Pharmocological
walnuts/day NN Pharmocological
and CC None
an DT None
ad NN Control
libitum NN Control
diet NN Control
without IN Control
walnuts NNS Control
for IN Control
8 CD Control
weeks NNS Control
. . None
endothelial JJ Physical
function NN Physical
testing VBG Physical
-DOCSTART- -X- N

An DT None
rating NN Physical
method NN Physical
checklist NN Other
containing VBG Educational
-DOCSTART- -X- N

stepwise NN None
screening NN None
strategy NN None
for IN None
type NN None
2 CD None
diabetes NNS None
; : None
intensive JJ Educational
multifactorial JJ Educational
treatment NN Educational
for IN None
no DT Control
screening NN Control
( ( Control
control NN Control
) ) Control
, , None
screening VBG Educational
followed VBN Educational
by IN Educational
intensive JJ Educational
treatment NN Educational
( ( Educational
IT NNP Educational
) ) Educational
and CC None
screening VBG None
plus CC None
routine JJ None
care NN None
-DOCSTART- -X- N

PRL-8-53 NN Pharmocological
: : None
psychotropic NN Pharmocological
3- JJ Pharmocological
( ( Pharmocological
2-benzylmethylaminoethyl JJ Pharmocological
) ) Pharmocological
benzoic NN Pharmocological
acid JJ Pharmocological
methyl NN Pharmocological
ester NN Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
PRL-8-53 NNP Pharmocological
) ) Pharmocological
PRL-8-53 NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

acetaminophen NN Pharmocological
, , None
diclofenac NN Pharmocological
, , None
or CC None
naproxen RB Pharmocological
on IN None
aspirin-induced JJ None
Nonsteroidal NNP Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
aspirin NN Pharmocological
( ( Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
) ) Pharmocological
aspirin NN Pharmocological
NSAID NNP Pharmocological
aspirin JJ Pharmocological
3 CD None
x VBD None
1 CD None
g NN None
acetaminophen NN Pharmocological
, , None
3 CD None
x NN None
50 CD None
mg NN None
diclofenac NN Pharmocological
, , None
3 CD None
x NN None
250 CD None
mg NN None
naproxen NN Pharmocological
, , None
or CC None
3 CD None
x JJ None
1 CD None
placebo NN Control
. . None
Naproxen NNP Pharmocological
aspirin NN Pharmocological
Diclofenac NNP Pharmocological
aspirin NN Pharmocological
Acetaminophen NNP Pharmocological
placebo NN Control
. . None
NSAID NNP Pharmocological
aspirin NN Pharmocological
naproxen JJ Pharmocological
diclofenac NN Pharmocological
. . None
NSAID NNP Pharmocological
aspirin NN Pharmocological
. . None
-DOCSTART- -X- N

embolization NN Pharmocological
using VBG Pharmocological
an DT Pharmocological
n-BCA/Tantalum JJ Pharmocological
Powder/Ethiodol NNP Pharmocological
mixture NN Pharmocological
or CC None
Trufill NNP Pharmocological
PVA NNP Pharmocological
. . None
-DOCSTART- -X- N

lidocaine NN Pharmocological
hyaluronic JJ Pharmocological
acid NN Pharmocological
filler NN Pharmocological
alone RB Pharmocological
. . None
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
gel NN Pharmocological
HA NNP Pharmocological
gel NN Pharmocological
with IN Pharmocological
preincorporated JJ Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
-DOCSTART- -X- N

Relaxation NN Educational
and CC Educational
imagery NN Educational
and CC Educational
cognitive-behavioral JJ Educational
training NN Educational
-DOCSTART- -X- N

fenoterol NN Pharmocological
fenoterol NN Pharmocological
fenoterol NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
a DT None
placebo NN Pharmocological
fenoterol NN Pharmocological
fenoterol NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
ketoprofen NN Pharmocological
'controlled VBD Pharmocological
release NN Pharmocological
' '' Pharmocological
indomethacin JJ Pharmocological
suppository NN Pharmocological
'controlled-release NNP Pharmocological
' POS Pharmocological
ketoprofen NN Pharmocological
tablets NNS Pharmocological
indomethacin NN Pharmocological
suppositories NNS Pharmocological
ketoprofen JJ Pharmocological
indomethacin JJ Pharmocological
suppository NN Pharmocological
ketoprofen NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
olanzapine NN Pharmocological
placebo-controlled JJ Control
olanzapine NN Pharmocological
placebo-controlled JJ Control
olanzapine NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

lifestyle NN Educational
intervention NN Educational
lifestyle JJ Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

Drawtex NNP Physical
with IN Physical
standard JJ Physical
dressings NNS Physical
capillary JJ Physical
dressing NN Physical
( ( None
Drawtex NNP Physical
, , Physical
now RB Physical
rebranded VBN Physical
as IN Physical
Vibriant NNP Physical
RCD NNP Physical
[ NNP None
Vibriant NNP Physical
Technology NNP Physical
Services NNP Physical
] NNP None
) ) None
with IN Physical
routine JJ Physical
practice NN Physical
for IN Physical
-DOCSTART- -X- N

question-asking NN Educational
robot NN Educational
intervention NN Educational
human-trainer JJ Educational
intervention NN Educational
. . None
applied JJ Educational
behaviour NN Educational
analysis NN Educational
( ( Educational
ABA NNP Educational
) ) Educational
-based VBD Educational
intervention NN Educational
conducted VBN Educational
by IN Educational
a DT Educational
robot NN Educational
compared VBN Educational
to TO Educational
an DT Educational
ABA-based JJ Educational
intervention NN Educational
conducted VBN Educational
by IN Educational
a DT Educational
human JJ Educational
trainer NN Educational
in IN None
interventions NNS Educational
conducted VBN Educational
by IN Educational
a DT Educational
robot NN Educational
and CC Educational
a DT Educational
human JJ Educational
trainer NN Educational
-DOCSTART- -X- N

low-dose JJ Pharmocological
antacids NNS Pharmocological
. . None
low-dose JJ Pharmocological
antacid NN Pharmocological
( ( Pharmocological
Maalox NNP Pharmocological
70 CD Pharmocological
H2-receptor NNP Pharmocological
antagonist NN Pharmocological
cimetidine NN Pharmocological
( ( Pharmocological
Tagamet NNP Pharmocological
antacid JJ Pharmocological
containing VBG Pharmocological
Mg NNP Pharmocological
and CC Pharmocological
Al NNP Pharmocological
hydroxide NN Pharmocological
( ( Pharmocological
M NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
4 CD Pharmocological
cimetidine NN Pharmocological
-DOCSTART- -X- N

CHOP NNP Pharmocological
of IN None
CHOP NNP Pharmocological
followed VBN None
by IN None
a DT None
BEAM NNP Pharmocological
autograft NN Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
prednisolone NN Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
. . None
CHOP NNP Pharmocological
CHOP NNP Pharmocological
followed VBN None
by IN None
a DT None
BEAM NNP Pharmocological
( ( Pharmocological
carmustine NN Pharmocological
, , Pharmocological
etoposide RB Pharmocological
, , Pharmocological
cytarabine NN Pharmocological
, , Pharmocological
melphalan NN Pharmocological
) ) Pharmocological
autograft NN Pharmocological
. . None
CHOP NNP Pharmocological
CHOP NNP Pharmocological
CHOP NNP Pharmocological
-DOCSTART- -X- N

Pars NNS Surgical
plana VBP Surgical
vitrectomy NN Surgical
Internal NNP Surgical
limiting VBG Surgical
membrane NN Surgical
delamination NN Surgical
posterior JJ Surgical
hyaloid NN Surgical
removal NN Surgical
. . None
internal JJ Surgical
limiting VBG Surgical
membrane NN Surgical
( ( Surgical
ILM NNP Surgical
) ) Surgical
removal NN Surgical
25 CD None
) ) None
laser JJR None
coagulation NN None
was VBD None
permitted VBN None
underwent JJ None
surgical JJ None
induction NN None
of IN None
posterior JJ None
vitreous JJ None
detachment NN None
( ( None
PVD NNP None
) ) None
, , None
group NN None
patients NNS None
) ) None
PVD NNP None
and CC None
removal NN None
of IN None
the DT None
ILM NNP None
. . None
Eleven NNP None
ILM NNP None
removal NN None
. . None
CONCLUSION NNP None
Vitrectomy NNP None
, , None
PVD NNP None
with IN None
or CC None
without IN None
ILM NNP None
removal NN None
does VBZ None
-DOCSTART- -X- N

Kang NNP Pharmocological
Gang NNP Pharmocological
Qian NNP Pharmocological
Granule NNP Pharmocological
( ( Pharmocological
KGQG NNP Pharmocological
) ) Pharmocological
KGQG NNP Pharmocological
KGQG NNP Pharmocological
KGQG NNP Pharmocological
and CC Pharmocological
routine JJ Pharmocological
medications NNS Pharmocological
; : None
KGQG NNP Pharmocological
KGQG NNP Pharmocological
-DOCSTART- -X- N

to TO Educational
receive VB Educational
either CC Educational
a DT Educational
cessation NN Educational
advice NN Educational
report NN Educational
and CC Educational
progress JJ Educational
report NN Educational
that WDT Educational
were VBD Educational
tailored VBN Educational
to TO Educational
individual-level JJ Educational
characteristics NNS Educational
or CC Educational
a DT Educational
cessation NN Educational
advice NN Educational
report NN Educational
that WDT Educational
presented VBD Educational
standardized JJ Educational
( ( Educational
non-tailored JJ Educational
) ) Educational
content NN Educational
. . Educational
baseline NN Educational
assessments NNS Educational
-DOCSTART- -X- N

propofol NN Pharmocological
, , None
isoflurane NN Pharmocological
, , None
and CC None
sevoflurane NN Pharmocological
group NN None
received VBD None
100 CD None
microg NNS None
x JJ None
kg NN None
( ( None
-1 NNP None
) ) None
x VBP None
min NN None
( ( None
-1 NNP None
) ) None
propofol NN Pharmocological
, , None
the DT None
other JJ None
groups NNS None
received VBD None
one CD None
minimum NN None
alveolar JJ None
concentration NN None
of IN None
sevoflurane NN Pharmocological
or CC None
isoflurane NN Pharmocological
for IN None
anesthesia JJ Pharmocological
maintenance NN Pharmocological
. . None
-DOCSTART- -X- N

Maillard NNP Pharmocological
reaction NN Pharmocological
products NNS Pharmocological
Maillard NNP Physical
reaction NN Physical
products NNS Physical
( ( None
MRP NNP None
) ) None
white JJ Pharmocological
diet NN Pharmocological
( ( Pharmocological
WD NNP Pharmocological
) ) Pharmocological
brown JJ Pharmocological
diet NN Pharmocological
( ( Pharmocological
BD NNP Pharmocological
) ) Pharmocological
MRP NNP Pharmocological
MRP NNP Pharmocological
-DOCSTART- -X- N

tramadol JJ Pharmocological
] NN None
Tramal NNP Pharmocological
Tramal NNP Pharmocological
Tramal JJ Pharmocological
-DOCSTART- -X- N

dazmegrel NN Pharmocological
was VBD None
orally RB None
administered VBN None
to TO None
-DOCSTART- -X- N

naltrexone NN Pharmocological
opiate JJ Pharmocological
antagonist NN Pharmocological
naltrexone NN Pharmocological
placebo NN Control
naltrexone NN Pharmocological
-DOCSTART- -X- N

endurance NN Physical
training NN Physical
interval NN Physical
and CC Physical
continuous JJ Physical
training NN Physical
In IN Physical
the DT Physical
last JJ Physical
week NN Physical
of IN Physical
training VBG Physical
the DT Physical
exercise NN Physical
intensity NN Physical
in IN Physical
the DT Physical
group NN Physical
of IN Physical
patients NNS Physical
who WP Physical
were VBD Physical
trained VBN Physical
by IN Physical
the DT Physical
continuous JJ Physical
method NN Physical
was VBD Physical
at IN Physical
83 CD Physical
watts NN Physical
, , Physical
and CC Physical
at IN Physical
20:121 CD Physical
watts NN Physical
in IN Physical
the DT Physical
group NN Physical
of IN Physical
patients NNS Physical
who WP Physical
were VBD Physical
trained VBN Physical
by IN Physical
interval JJ Physical
method NN Physical
( ( Physical
rest NN Physical
: : Physical
work NN Physical
each DT Physical
1:1 CD Physical
min NN Physical
) ) Physical
. . None
-DOCSTART- -X- N

naltrexone CD Pharmocological
or CC None
to TO None
placebo VB Control
Naltrexone NNP Pharmocological
naltrexone NN Pharmocological
-DOCSTART- -X- N

Argon NNP Physical
laser NN Physical
trabeculoplasty NN Physical
Argon NNP Surgical
laser NN Surgical
trabeculoplasty NN Surgical
( ( Surgical
ALT NNP Surgical
) ) Surgical
ALT NNP Physical
Argon NNP Physical
laser NN Physical
trabeculoplasty NN Physical
-DOCSTART- -X- N

Single-needle JJ Physical
acupuncture NN Physical
single-needle JJ Physical
acupuncture NN Physical
single-needle JJ Physical
acupuncture NN Physical
no DT Physical
acupuncture NN Physical
Acupuncture NNP Physical
of IN Physical
CV24 NNP Physical
-DOCSTART- -X- N

metoprolol NN Pharmocological
hydrochlorothiazide NN Pharmocological
hydralazine NN Pharmocological
200 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metoprolol JJ Pharmocological
plus CC Pharmocological
placebo NN Pharmocological
; : None
200 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metoprolol NN Pharmocological
plus CC None
25 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
hydrochlorothiazide NN Pharmocological
; : None
200 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metoprolol NN Pharmocological
plus CC None
50 CD Pharmocological
mg NN Pharmocological
hydrochlorothiazide NN Pharmocological
, , None
or CC None
; : None
200 CD Pharmocological
mg NN Pharmocological
metoprolol NN Pharmocological
plus CC None
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
hydralazine NN Pharmocological
. . None
metoprolol NN Pharmocological
hydralazine NN Pharmocological
. . None
beta-blocker NN None
hydralazine NN Pharmocological
. . None
-DOCSTART- -X- N

R-salbutamol NNP Pharmocological
R-salbutamol NNP Pharmocological
sulphate NN Pharmocological
R-salbutamol NNP Pharmocological
cream NN Pharmocological
vs. FW None
placebo NN Control
randomized VBN None
- : None
19 CD Pharmocological
to TO Pharmocological
the DT Pharmocological
R-salbutamol NNP Pharmocological
cream NN Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
and CC None
18 CD None
to TO None
placebo VB Control
- : None
and CC None
treated JJ None
twice RB None
daily RB None
for IN None
8 CD None
weeks NNS None
. . None
placebo NN Control
-DOCSTART- -X- N

810-nm JJ Physical
diode NN Physical
laser NN Physical
Laser NNP Physical
therapy NN Physical
810-nm JJ Physical
diode NN Physical
laser RBR Physical
treatment NN Physical
non-invasive JJ Physical
techniques NNS Physical
single-session JJ Physical
diode NN Physical
laser NN Physical
therapy NN Physical
. . None
diode NN Physical
laser NN Physical
can MD Physical
-DOCSTART- -X- N

Mexiletine NN Pharmocological
mexiletine NN Pharmocological
mexiletine NN Pharmocological
receive VB None
mexiletine NN Pharmocological
( ( Pharmocological
maximum JJ Pharmocological
dose NN Pharmocological
, , Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
for IN None
6 CD None
weeks NNS None
, , None
followed VBN Pharmocological
by IN Pharmocological
the DT Pharmocological
alternative JJ Pharmocological
intervention NN Pharmocological
for IN None
6 CD None
weeks NNS None
after IN None
a DT None
1-week JJ None
washout NN None
period NN None
. . None
in IN None
mexiletine JJ Pharmocological
mexiletine NN Pharmocological
placebo VB Pharmocological
placebo NN Pharmocological
mexiletine VB Pharmocological
placebo NN Pharmocological
. . None
mexiletine NN Pharmocological
placebo NN Pharmocological
. . None
Mexiletine NNP Pharmocological
-DOCSTART- -X- N

nitrogen VB Pharmocological
dioxide NN Pharmocological
nitrogen VB Pharmocological
dioxide NN Pharmocological
( ( Pharmocological
NO2 NNP Pharmocological
) ) Pharmocological
air NN Control
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
placebo NN Control
morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
. . None
morphine NN Pharmocological
-DOCSTART- -X- N

National NNP Educational
Survey NNP Educational
for IN Educational
Children NNP Educational
's POS Educational
Health NNP Educational
2003-2004 CD Educational
telephone NN Educational
interview NN Educational
. . None
-DOCSTART- -X- N

oxytocin PRP Pharmocological
oxytocin RP Pharmocological
nasal JJ Pharmocological
spray NN Pharmocological
placebo NN Control
placebo NN Control
, , None
oxytocin JJ Pharmocological
oxytocin JJ Pharmocological
-DOCSTART- -X- N

interventions NNS None
intended VBN None
outreach NN Educational
interventions NNS Educational
( ( Educational
a DT Educational
mail NN Educational
reminder NN Educational
and CC Educational
a DT Educational
telephone NN Educational
reminder NN Educational
plus CC Educational
appointment JJ Educational
scheduling NN Educational
) ) Educational
routine JJ Educational
publicity NN Educational
campaign NN Educational
a DT Educational
mail NN Educational
reminder NN Educational
, , Educational
( ( Educational
2 CD Educational
) ) Educational
a DT Educational
telephone NN Educational
reminder NN Educational
, , Educational
or CC Educational
( ( Educational
3 CD Educational
) ) Educational
routine JJ Educational
publicity NN Educational
on IN Educational
mammography NN Educational
for IN Educational
all DT Educational
women NNS Educational
. . Educational
routine JJ Educational
publicity NN Educational
campaign NN Educational
. . Educational
Telephone NNP Educational
contact NN Educational
-DOCSTART- -X- N

ketamine NN Pharmocological
ketamine NN Pharmocological
ketamine JJ Pharmocological
0.15 CD Pharmocological
mg/kg NN Pharmocological
as IN Pharmocological
a DT Pharmocological
5-mL JJ Pharmocological
i.v NN Pharmocological
. . Pharmocological
injection NN Surgical
5 CD Surgical
min NN Surgical
before IN Surgical
surgery NN Surgical
and CC None
isotonic JJ Pharmocological
saline NN Pharmocological
5 CD Pharmocological
mL NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
5 CD Pharmocological
mL NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
of IN Pharmocological
isotonic JJ Pharmocological
saline NN Pharmocological
, , Pharmocological
then RB None
0.15 CD Pharmocological
mg/kg NNS Pharmocological
i.v NN Pharmocological
. . Pharmocological
ketamine NN Pharmocological
. . None
ketamine VBP Pharmocological
ketamine NN Pharmocological
ketamine NN Pharmocological
ketamine NN Pharmocological
Ketamine VB Pharmocological
-DOCSTART- -X- N

itraconazole JJ Pharmocological
versus NN None
fluconazole NN Pharmocological
Fluconazole NNP Pharmocological
Itraconazole NNP Pharmocological
itraconazole JJ Pharmocological
oral JJ Pharmocological
solution NN Pharmocological
fluconazole NN Pharmocological
itraconazole NN Pharmocological
( ( Pharmocological
itra JJ Pharmocological
) ) Pharmocological
fluconazole JJ Pharmocological
suspension NN Pharmocological
( ( Pharmocological
flu NN Pharmocological
) ) Pharmocological
Itraconazole NNP Pharmocological
solution NN None
fluconazole JJ Pharmocological
-DOCSTART- -X- N

limbal JJ None
pars NNS None
plana VBP None
approach NN None
primary JJ Physical
posterior JJ Physical
capsulectomy NN Physical
and CC None
anterior JJ Physical
vitrectomy NN Physical
Primary JJ Physical
posterior JJ Physical
capsulectomy NN Physical
and CC None
anterior JJ Physical
vitrectomy NN Physical
posterior JJ Physical
capsulectomy NN Physical
and CC None
anterior JJ Physical
vitrectomy NN Physical
lensectomy NN Surgical
and CC Surgical
PC NN Surgical
IOL NNP Surgical
implantation NN Surgical
-DOCSTART- -X- N

prostate-specific JJ Pharmocological
antigen NN Pharmocological
corrected VBN Pharmocological
for IN Pharmocological
total JJ Pharmocological
prostate NN Pharmocological
volume NN Pharmocological
and CC None
transition NN Pharmocological
zone NN Pharmocological
volume NN Pharmocological
screening NN None
study NN None
, , None
of IN None
serum JJ None
prostate-specific JJ None
antigen NN None
levels NNS None
( ( None
PSA NNP None
) ) None
and CC None
PSA NNP None
corrected VBD None
for IN None
both DT None
the DT None
total JJ None
prostate NN None
volume NN None
( ( None
PSA-D NNP None
) ) None
and CC None
the DT None
transition NN None
zone NN None
volume NN None
( ( None
PSA-T NNP None
) ) None
. . None
Planimetric NNP Physical
and CC Physical
prolate VB Physical
ellipsoid JJ Physical
volumes NNS Physical
of IN Physical
the DT Physical
total JJ Physical
prostate NN Physical
as RB Physical
well RB Physical
as IN Physical
of IN Physical
the DT Physical
transition NN Physical
zone NN Physical
were VBD None
measured VBN None
. . None
volumes NNS Physical
of IN Physical
57 CD Physical
radical JJ Physical
prostatectomy NN Physical
specimens NNS Physical
PSA NNP None
and CC None
PSA NNP None
corrected VBD None
for IN None
the DT None
volumes NNS None
measured VBN None
transition NN Physical
zone NN Physical
volume NN Physical
total JJ Physical
prostate NN Physical
volume NN Physical
; : None
-DOCSTART- -X- N

nitric JJ Pharmocological
oxide IN Pharmocological
synthase JJ Pharmocological
( ( None
60 CD None
min NN None
of IN None
seated JJ Physical
upright JJ Physical
rest NN Physical
) ) None
( ( None
60 CD Physical
min NN Physical
of IN Physical
upright JJ Physical
cycling NN Physical
at IN None
60 CD None
% NN None
peak NN None
aerobic JJ None
capacity NN None
) ) None
-DOCSTART- -X- N

cetuximab NN Pharmocological
, , None
capecitabine NN Pharmocological
radiotherapy NN Pharmocological
chemoradiotherapy NN Pharmocological
( ( Pharmocological
CRT NNP Pharmocological
) ) Pharmocological
capecitabine JJ Pharmocological
intravenous JJ Pharmocological
cetuximab NNS Pharmocological
cetuximab NN Pharmocological
plus CC Pharmocological
CRT NNP Pharmocological
capecitabine NN Pharmocological
radiotherapy NN Pharmocological
cetuximab NN Pharmocological
with IN Pharmocological
capecitabine-based JJ Pharmocological
CRT NNP Pharmocological
-DOCSTART- -X- N

atomoxetine JJ Pharmocological
placebo NN Control
atomoxetine NN Pharmocological
atomoxetine NN Pharmocological
or CC None
placebo NN Control
atomoxetine JJ Pharmocological
placebo NN Control
atomoxetine NN Pharmocological
placebo NN Control
atomoxetine NN Pharmocological
placebo NN Control
atomoxetine JJ Pharmocological
placebo NN None
Atomoxetine NNP Pharmocological
Atomoxetine NNP Pharmocological
Placebo NNP None
-DOCSTART- -X- N

radiotherapy NN Physical
chemoradiotherapy NN Pharmocological
Preoperative NNP Physical
chemoradiotherapy NN Physical
radiotherapy VB Physical
-DOCSTART- -X- N

soy JJ Pharmocological
soy JJ Pharmocological
soy NN Pharmocological
soy NN Pharmocological
soy JJ Pharmocological
beverage NN Pharmocological
soy JJ Pharmocological
soy JJ Pharmocological
-DOCSTART- -X- N

pharmacotherapy NN Pharmocological
olanzapine JJ Pharmocological
plus CC Pharmocological
sertraline JJ Pharmocological
vs. FW Pharmocological
olanzapine JJ Control
plus CC Control
placebo NN Control
. . Control
-DOCSTART- -X- N

metformin NN Pharmocological
and CC Pharmocological
insulin NN Pharmocological
metformin NN Pharmocological
placebo NN Control
metformin NN Pharmocological
treatment NN None
( ( None
850 CD None
mg RB None
b.i.d NN None
) ) None
vs NN None
placebo NN None
. . None
placebo NN Control
metformin NN Pharmocological
metformin NN Pharmocological
-DOCSTART- -X- N

Yufeining VBG Pharmocological
Yufeining NNP Pharmocological
Yufeining VBG Pharmocological
pills NNS Pharmocological
control NN Control
group NN Control
was VBD Control
not RB Control
given VBN Control
any DT Control
medicine NN Control
. . Control
-DOCSTART- -X- N

radiation NN Physical
breast NN Control
conserving NN Control
treatment NN Control
: : None
boost NN Physical
radiation NN Physical
breast NN Physical
conservative JJ Physical
therapy NN Physical
( ( Physical
BCT NNP Physical
) ) Physical
boost NN Physical
boost NN Physical
boost NN Physical
boost NN Physical
-DOCSTART- -X- N

torcetrapib NN Pharmocological
cholesteryl NN Pharmocological
ester NN Pharmocological
transfer NN Pharmocological
protein NN Pharmocological
( ( Pharmocological
CETP NNP Pharmocological
) ) Pharmocological
inhibitor NN Pharmocological
torcetrapib NN Pharmocological
placebo VB Control
torcetrapib NN Pharmocological
Torcetrapib NN Pharmocological
-DOCSTART- -X- N

vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
. . None
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
chemotherapy NN Pharmocological
without IN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
chemotherapy NN Pharmocological
. . None
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
vitamin JJ Pharmocological
E NNP Pharmocological
Vitamin NNP Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

sport-tinted JJ Physical
contact NN Physical
lenses NNS Physical
tinted JJ Physical
contact NN Physical
lenses NNS Physical
( ( Physical
CL NNP Physical
) ) Physical
two CD Physical
different JJ Physical
tinted VBN Physical
Nike NNP Physical
Maxsight NNP Physical
( ( Physical
Bausch NNP Physical
& CC Physical
Lomb NNP Physical
, , Physical
Rochester NNP Physical
, , Physical
NY NNP Physical
, , Physical
USA NNP Physical
) ) Physical
CL NNP Physical
in IN Physical
one CD Physical
eye NN Physical
, , None
while IN None
the DT None
contralateral JJ Control
eye NN Control
was VBD Control
fitted VBN Control
with IN Control
a DT Control
clear JJ Control
lens NNS Control
made VBN Control
of IN Control
the DT Control
same JJ Control
material NN Control
( ( None
Optima NNP None
38 CD None
, , None
Bausch NNP None
& CC None
Lomb NNP None
) ) None
. . None
-DOCSTART- -X- N

tegafur/uracil NN Pharmocological
and CC Pharmocological
oral JJ Pharmocological
leucovorin NN Pharmocological
versus IN Pharmocological
parenteral JJ Pharmocological
fluorouracil NN Pharmocological
and CC Pharmocological
leucovorin NN Pharmocological
dihydropyrimidine JJ Pharmocological
dehydrogenase NN Pharmocological
inhibitory NN Pharmocological
fluoropyrimidine NN Pharmocological
tegafur NN Pharmocological
and CC Pharmocological
uracil NN Pharmocological
leucovorin $ Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
IV NNP Pharmocological
) ) Pharmocological
fluorouracil NN Pharmocological
and CC Pharmocological
LV NNP Pharmocological
UFT NNP Pharmocological
LV NNP Pharmocological
5-FU JJ Pharmocological
LV NNP Pharmocological
-DOCSTART- -X- N

soft JJ Physical
contact NN Physical
lenses NNS Physical
rigid JJ Physical
gas NN Physical
permeable NN Physical
( ( Physical
RGP NNP Physical
) ) Physical
lenses VBZ Physical
regular JJ Physical
replacement NN Physical
extended VBN Physical
wear NN Physical
RGP NNP Physical
contact NN Physical
lenses VBZ Physical
. . None
wore NN Physical
extended VBD Physical
wear JJ Physical
Quantum NNP Physical
2 CD Physical
lenses NNS Physical
replaced VBD Physical
lenses NNS Physical
every DT Physical
3 CD Physical
months NNS Physical
not RB Other
scheduled VBN Other
to TO Other
replace VB Other
their PRP$ Other
lenses NNS Other
. . None
-DOCSTART- -X- N

clonidine NN Pharmocological
and CC None
clonidine NN Pharmocological
plus CC Pharmocological
naltrexone NN Pharmocological
. . None
clonidine NN Pharmocological
clonidine NN Pharmocological
plus CC Pharmocological
naltrexone NN Pharmocological
naltrexone NN Pharmocological
-DOCSTART- -X- N

Hysteroscopic NNP Surgical
morcellation NN Surgical
electrical JJ Pharmocological
resection NN Pharmocological
hysteroscopic JJ Surgical
morcellation NN Surgical
bipolar JJ Surgical
electrosurgical JJ Surgical
resection NN Surgical
office NN Surgical
hysteroscopic NN Surgical
morcellation NN Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
morcellation VB Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
morcellation NN Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
electrosurgical JJ Pharmocological
resection NN Pharmocological
morcellation NN Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
. . None
-DOCSTART- -X- N

Non-contrast-enhanced JJ Physical
4D CD Physical
MR NNP Physical
angiography NN Physical
and/or VBD None
contrast-enhanced JJ None
magnetic JJ None
resonance NN None
angiography NN None
NCE NNP Physical
4D CD Physical
on IN None
NCE NNP None
4D CD None
MRA NNP None
. . None
of IN None
NCE NNP None
4D CD None
MRA NNP None
-DOCSTART- -X- N

Phonophoresis NNP Pharmocological
ketoprofen NN Pharmocological
: : None
phonophoresis NN Pharmocological
of IN Pharmocological
a DT Pharmocological
ketoprofen NN Pharmocological
gel NN Pharmocological
continuous JJ Physical
ultrasound NN Physical
pulsed JJ Physical
ultrasound NN Physical
sham NN Control
ultrasound NN Control
with IN Control
the DT Control
ketoprofen NN Control
gel NN Control
. . None
-DOCSTART- -X- N

fluocinolone NN Pharmocological
acetonide NN Pharmocological
implant NN Pharmocological
: : None
fluocinolone NN Pharmocological
acetonide NN Pharmocological
-DOCSTART- -X- N

psychological JJ Educational
training NN Educational
program NN Educational
psychological JJ Educational
training NN Educational
programs NNS Educational
( ( Educational
P.T.P NNP Educational
. . Educational
) ) Educational
24-h JJ Educational
P.T.P NNP Educational
. . Educational
or CC Control
to TO Control
a DT Control
waiting VBG Control
list NN Control
period NN Control
. . None
assessed VBN Educational
by IN Educational
a DT Educational
was VBD Educational
assessed VBN Educational
by IN Educational
and CC Educational
were VBD Educational
assessed VBN Educational
by IN Educational
P.T.P NNP Educational
. . None
-DOCSTART- -X- N

simplified JJ Educational
simplified JJ Educational
neonatal JJ Educational
resuscitation NN Educational
protocol NN Educational
CCD NNP Physical
cameras NNS Physical
and CC Educational
pulse JJ Physical
oximeters NNS Physical
-DOCSTART- -X- N

cloxacillin NN Pharmocological
or CC None
carbenicillin NN Pharmocological
plus CC Pharmocological
gentamicin NN Pharmocological
-DOCSTART- -X- N

FEC NNP Pharmocological
epirubicin NN Pharmocological
fluorouracil/epirubicin/cyclophosphamide NN Pharmocological
( ( Pharmocological
FEC NNP Pharmocological
) ) Pharmocological
FEC NNP Pharmocological
FEC NNP Physical
FEC NNP Pharmocological
FEC NNP Pharmocological
pegfilgrastim JJ Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
-DOCSTART- -X- N

botulinum NN Pharmocological
neurotoxin NN Pharmocological
type IN Pharmocological
a DT Pharmocological
botulinum NN Pharmocological
neurotoxin NN Pharmocological
type NN Pharmocological
A DT Pharmocological
preparation NN Pharmocological
NT NNP Pharmocological
201 CD Pharmocological
single JJ Pharmocological
injections NNS Pharmocological
of IN Pharmocological
NT NNP Pharmocological
201 CD Pharmocological
extensor NN Pharmocological
digitorum NN Pharmocological
brevis NN Pharmocological
same JJ Pharmocological
dose NN Pharmocological
into IN Pharmocological
the DT Pharmocological
contralateral JJ Pharmocological
EDB NNP Pharmocological
. . None
NT NNP Pharmocological
201 CD Pharmocological
and CC Pharmocological
BTXCo NNP Pharmocological
NT CC Pharmocological
201 CD Pharmocological
BTXCo NNP Pharmocological
NT NNP Pharmocological
201 CD Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
chelation NN Pharmocological
succimer NN Pharmocological
succimer NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

lidocaine NN Pharmocological
epinephrine NN Pharmocological
mepivacaine NN Pharmocological
. . None
epinephrine NN None
mepivacaine NN None
topical JJ Pharmocological
anesthetic NN Pharmocological
P-ASA NNP Pharmocological
injections NNS Pharmocological
of IN Pharmocological
1.4 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
1:100,000 CD None
epinephrine NN Pharmocological
and CC None
1.4 CD None
mL NN None
of IN None
3 CD None
% NN None
mepivacaine NN Pharmocological
topical JJ Pharmocological
anesthetic JJ Pharmocological
gel NN Pharmocological
placebo NN Control
gel NN Control
. . None
mepivacaine JJ Pharmocological
placebo JJ Control
lidocaine JJ Pharmocological
mepivacaine JJ None
lidocaine JJ Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine JJ Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
epinephrine NN Pharmocological
mepivacaine NN Pharmocological
placebo NN Control
. . Control
lidocaine NN Pharmocological
epinephrine NN Pharmocological
mepivacaine NN Pharmocological
-DOCSTART- -X- N

tocainide NN Pharmocological
and CC None
prajmalium NN Pharmocological
bitartrate NN Pharmocological
tocainide NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
tocainide NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
-DOCSTART- -X- N

fluorescent JJ Pharmocological
tracers NNS Pharmocological
end-to-side JJ Physical
neurorrhaphy NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

Aztreonam NNP Pharmocological
versus NN None
gentamicin NN Pharmocological
aztreonam NN Pharmocological
gentamicin NN Pharmocological
aztreonam NN Pharmocological
gentamicin NN Pharmocological
. . Pharmocological
aztreonam JJ Pharmocological
aztreonam NN Pharmocological
-DOCSTART- -X- N

Iontophoretic JJ Physical
dexamethasone NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
placebo-controlled JJ Control
iontophoretic JJ Pharmocological
dexamethasone NN Pharmocological
placebo-controlled JJ Pharmocological
placebo JJ Pharmocological
Dexamethasone NNP Pharmocological
placebo NN Pharmocological
dexamethasone NN Pharmocological
placebo NN Control
Iontophoresis NNP Physical
-DOCSTART- -X- N

Allopurinol NNP Pharmocological
allopurinol NN Pharmocological
allopurinol JJ Pharmocological
6 CD Pharmocological
weeks NNS Pharmocological
' POS Pharmocological
treatment NN Pharmocological
with IN Pharmocological
high- NN Pharmocological
( ( Pharmocological
300 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
a DT Pharmocological
day NN Pharmocological
) ) Pharmocological
or CC Pharmocological
low- JJ Pharmocological
( ( Pharmocological
100 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
a DT Pharmocological
day NN Pharmocological
) ) Pharmocological
dose NN Pharmocological
allopurinol NN Pharmocological
allopurinol NN Pharmocological
Allopurinol NNP Pharmocological
allopurinol NN Pharmocological
-DOCSTART- -X- N

Amiodarone NNP Pharmocological
versus NN Pharmocological
digoxin NN Pharmocological
and CC None
metoprolol NN Pharmocological
combination NN Pharmocological
amiodarone NN Pharmocological
versus NN Pharmocological
digoxin NN Pharmocological
and CC None
metoprolol JJ Pharmocological
combination NN Pharmocological
metoprolol $ Pharmocological
100 CD Pharmocological
mg/24 NN Pharmocological
h NN Pharmocological
per IN Pharmocological
oral JJ Pharmocological
digoxin NN Pharmocological
intravenously RB Pharmocological
on IN Pharmocological
the DT Pharmocological
operating NN Pharmocological
day NN Pharmocological
and CC None
digoxin NN Pharmocological
0.25 CD Pharmocological
mg NN Pharmocological
P.O.+metoprolol NNP Pharmocological
100 CD Pharmocological
mg NN Pharmocological
P.O NNP Pharmocological
. . Pharmocological
amiodarone NN Pharmocological
amiodarone NN Pharmocological
control NN Control
group NN Control
-DOCSTART- -X- N

home-based JJ Physical
exercise NN Physical
program NN Physical
home-based JJ Physical
exercise NN Physical
intervention NN Physical
usual JJ Physical
care NN Physical
or CC Physical
incremental JJ Physical
walking NN Physical
and CC Physical
home-based JJ Physical
strength NN Physical
training NN Physical
. . Physical
physiotherapy NN Physical
CONCLUSION VB None
A DT None
home-based JJ None
exercise NN None
program NN None
-DOCSTART- -X- N

Oral JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
placebo-controlled JJ Control
S-adenosylmethionine JJ Pharmocological
oral JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
S-adenosylmethionine JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
S-adenosylmethionine NNP Pharmocological
S-adenosylmethionine NNP Pharmocological
oral JJ Pharmocological
S-adenosylmethionine NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

soy NN Pharmocological
isoflavones NNS Pharmocological
placebo-controlled JJ Control
isoflavones NNS Pharmocological
placebo NN Control
Isoflavone NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Discrete-trial JJ Physical
training NN Physical
DTkid NNP Educational
training NN Educational
or CC None
to TO None
a DT None
control NN Control
task NN Control
. . None
DTkid NNP Physical
training NN Physical
trials NNS None
-DOCSTART- -X- N

Concomitant NNP Pharmocological
radiochemotherapy NN Pharmocological
vs NN None
radiotherapy NN Pharmocological
alone RB Pharmocological
standard JJ Pharmocological
fractionated VBN Pharmocological
radiotherapy NN Pharmocological
( ( Pharmocological
RT NNP Pharmocological
) ) Pharmocological
with IN None
the DT None
same JJ None
RT NNP None
concomitantly RB None
with IN None
cisplatin NN Pharmocological
( ( Pharmocological
DDP NNP Pharmocological
) ) Pharmocological
or CC None
carboplatin NN Pharmocological
( ( Pharmocological
Cb NNP Pharmocological
) ) Pharmocological
. . None
RT NNP Pharmocological
monotherapy NN Pharmocological
RT NNP Pharmocological
concomitantly RB Pharmocological
with IN Pharmocological
DDP NNP Pharmocological
or CC None
Cb NNP Pharmocological
chemoradiotherapy NN Pharmocological
. . None
concomitant JJ Pharmocological
chemoradiotherapy NN Pharmocological
. . None
concomitant JJ Pharmocological
chemoradiotherapy NN Pharmocological
concomitant JJ Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
platinum NN Pharmocological
analogs NNS Pharmocological
-DOCSTART- -X- N

Diet NNP None
and CC None
vitamin NNP None
D NNP None
the DT None
dietary JJ None
intake NN None
of IN None
margarine NN None
, , None
of IN None
vitamin NN None
D NNP None
of IN None
vitamin NN None
D NNP None
, , None
-DOCSTART- -X- N

Rivaroxaban NNP Pharmocological
versus NN None
warfarin NN Pharmocological
warfarin NN Pharmocological
Rivaroxaban NNP Pharmocological
warfarin NN Pharmocological
. . None
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
. . None
rivaroxaban NN Pharmocological
warfarin VB Pharmocological
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
rivaroxaban NN Pharmocological
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
rivaroxaban NN Pharmocological
rivaroxaban NN Pharmocological
rivaroxaban NN Pharmocological
-DOCSTART- -X- N

Intervention NN Physical
for IN Physical
in IN Physical
and CC None
control NN None
) ) None
by IN None
change VB None
of IN None
positioning NN None
and CC None
stimulation NN None
of IN None
cough NN None
. . None
-DOCSTART- -X- N

primary JJ Psychological
prevention NN Psychological
program NN Psychological
school-based JJ Psychological
primary JJ Psychological
prevention NN Psychological
psychological JJ Psychological
program NN Psychological
-DOCSTART- -X- N

enflurane NN Pharmocological
halothane NN Pharmocological
sodium NN Pharmocological
thiopentone NN Pharmocological
, , None
suxamethonium NN Pharmocological
and CC None
d-tubocurarine JJ Pharmocological
chloride NN Pharmocological
. . None
nitrous JJ Pharmocological
oxide NN Pharmocological
, , None
oxygen NN Pharmocological
and CC None
either DT None
halothane NN Pharmocological
or CC None
enflurane NN Pharmocological
. . None
-DOCSTART- -X- N

donepezil NN Pharmocological
placebo-controlled JJ Control
donepezil NN Pharmocological
placebo NN Pharmocological
or CC None
donepezil NN None
donepezil JJ Pharmocological
donepezil RB Pharmocological
-DOCSTART- -X- N

angiotensin-converting JJ Physical
enzyme NN Physical
inhibitors NNS Physical
captopril NN Pharmocological
placebo-controlled JJ Control
Captopril NNP Pharmocological
captopril NN Pharmocological
ACE NNP Physical
inhibitors NNS Physical
-DOCSTART- -X- N

surgically RB Surgical
assisted VBN Surgical
rapid JJ Surgical
maxillary JJ Surgical
expansion NN Surgical
; : None
surgically RB Surgical
assisted VBN Surgical
rapid JJ Surgical
maxillary JJ Surgical
expansion NN Surgical
( ( Surgical
SARME NNP Surgical
) ) Surgical
bone-borne JJ Physical
and CC Other
tooth-borne JJ Physical
devices NNS Physical
SARME NNP Surgical
-DOCSTART- -X- N

sticking VBG Physical
needling NN Physical
group NN Physical
( ( None
150 CD None
cases NNS None
) ) None
and CC None
an DT Physical
acupuncture NN Physical
group NN Physical
sticking VBG Physical
needling NN Physical
the DT Physical
manual JJ Physical
sticking NN Physical
needling NN Physical
technique NN Physical
conventional JJ Physical
acupuncture NN Physical
therapy NN Physical
was VBD Physical
applied VBN Physical
acupuncture NN Physical
acupuncture NN Physical
manual JJ Physical
sticking NN Physical
needling NN Physical
technique NN Physical
-DOCSTART- -X- N

EEG NNP Physical
Recording VBG Physical
blocks NNS Physical
consisted VBN Physical
of IN Physical
targets NNS Physical
preceded VBN Physical
by IN Physical
randomized JJ Physical
sequences NNS Physical
of IN Physical
standards NNS Physical
and CC Physical
by IN Physical
sequences NNS Physical
of IN Physical
standards NNS Physical
that WDT Physical
included VBD Physical
a DT Physical
predictive JJ Physical
sequence NN Physical
signaling VBG Physical
the DT Physical
occurrence NN Physical
of IN Physical
a DT Physical
subsequent JJ Physical
target NN Physical
event NN Physical
. . None
controls NNS Physical
. . None
-DOCSTART- -X- N

alpha-7 JJ Pharmocological
nicotinic JJ Pharmocological
neurotransmission NN Pharmocological
Alpha7 NNP None
nicotinic JJ None
acetylcholine NN None
receptor NN None
( ( None
?7 NNP None
nAChR RB None
) ) None
agonists NNS None
combined VBD None
CDP-choline NNP None
, , None
with IN None
galantamine NN None
, , None
a DT None
positive JJ None
allosteric JJ None
modulator NN None
( ( None
PAM NNP None
) ) None
of IN None
nicotinic JJ None
acetylcholine NN None
receptors NNS None
, , None
comparing VBG None
galantamine/CDP-choline NN None
to TO None
placebos VB None
received VBN None
galantamine JJ None
and CC None
CDP-choline JJ None
matching JJ None
placebos NNS None
for IN None
galantamine/CDP-choline NN None
for IN None
placebo NN None
of IN None
?7 NNP None
nAChR JJ None
agonist/PAMs NN None
is VBZ None
-DOCSTART- -X- N

adjuvant JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
adjuvant JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
total JJ Physical
abdominal JJ Physical
hysterectomy NN Physical
and CC None
bilateral JJ Physical
salpingo-oophorectomy JJ Physical
plus CC None
complementary JJ Physical
radium NN Physical
therapy NN Physical
on IN Physical
the DT Physical
vaginal JJ Physical
stump NN Physical
. . None
adjuvant VB Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
or CC Pharmocological
no DT Pharmocological
further JJ Pharmocological
treatment NN Pharmocological
. . None
gestonorone NN Pharmocological
caproate NN Pharmocological
( ( Pharmocological
17 CD Pharmocological
alpha-hydroxy-19-norpregn-4-en JJ Pharmocological
3 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
dione NN Pharmocological
caproate NN Pharmocological
) ) Pharmocological
administered VBD Pharmocological
i.m NN Pharmocological
. . None
at IN Pharmocological
the DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
200 CD Pharmocological
mg/week NN Pharmocological
for IN Pharmocological
1 CD Pharmocological
year NN Pharmocological
. . None
adjuvant JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
no DT Other
further JJ Other
treatment NN Other
) ) None
adjuvant JJ Pharmocological
therapy NN Pharmocological
hormone NN Pharmocological
adjuvant JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

tetracycline-immobilized JJ Pharmocological
collagen NN Pharmocological
film NN Pharmocological
and CC Pharmocological
root NN Pharmocological
planing NN Pharmocological
tetracycline-immobilized JJ Pharmocological
cross-linked JJ Pharmocological
collagen NN Pharmocological
film NN Pharmocological
( ( Pharmocological
TC NNP Pharmocological
film NN Pharmocological
) ) Pharmocological
root NN Control
planing VBG Control
treatment NN Control
( ( Control
RP NNP Control
TC NNP Control
+ NNP Control
RP NNP Control
RP NNP Control
TC NNP Control
+ NNP Control
RP NNP Control
TC NNP Control
+ NNP Control
RP NNP Control
TC NNP Control
-DOCSTART- -X- N

induced VB Pharmocological
hypotension NN Pharmocological
propranolol NN Pharmocological
, , Pharmocological
thiopentone-vecuronium-isoflurane NN Pharmocological
hypotension NN Pharmocological
induced VBN Pharmocological
with IN Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
, , Pharmocological
trimetaphan JJ Pharmocological
camsylate NN Pharmocological
or CC Pharmocological
additional JJ Pharmocological
isoflurane NN Pharmocological
. . None
-DOCSTART- -X- N

colon NN Educational
cancer NN Educational
screening VBG Educational
usual JJ Educational
care NN Educational
; : None
( ( Educational
2 CD Educational
) ) Educational
physician JJ Educational
chart NN Educational
reminder NN Educational
; : None
( ( Educational
3 CD Educational
) ) Educational
physician JJ Educational
chart NN Educational
reminder NN Educational
, , None
mailed VBN Educational
education NN Educational
, , None
CRC NNP Educational
reminder NN Educational
magnet NN Educational
, , None
and CC None
fecal JJ Educational
immunochemical JJ Educational
test NN Educational
( ( Educational
FIT NNP Educational
) ) Educational
( ( Educational
mailed JJ Educational
education/FIT NN Educational
) ) Educational
; : None
or CC None
( ( Educational
4 CD Educational
) ) Educational
all PDT Educational
the DT Educational
preceding VBG Educational
plus CC Educational
a DT Educational
structured JJ Educational
telephone NN Educational
call NN Educational
to TO Educational
the DT Educational
patient NN Educational
from IN Educational
project JJ Educational
staff NN Educational
to TO Educational
provide VB Educational
education NN Educational
, , None
assess JJ Educational
interest NN Educational
in IN Educational
screening VBG Educational
, , Educational
explain VB Educational
the DT Educational
screening NN Educational
tests NNS Educational
, , Educational
and CC Educational
address JJ Educational
barriers NNS Educational
-DOCSTART- -X- N

relaxation NN Psychological
training NN Psychological
relaxation-training JJ Educational
sessions NNS Educational
relaxation-training JJ None
relaxation NN None
training NN None
-DOCSTART- -X- N

premedication NN Pharmocological
. . None
diazepam NN Pharmocological
water NN Pharmocological
diazepam NN Pharmocological
with IN Pharmocological
water NN Pharmocological
premedication NN Pharmocological
-DOCSTART- -X- N

ranitidine VB Pharmocological
Ranitidine NNP Pharmocological
ranitidine NN Pharmocological
placebo-controlled JJ Control
placebo NN Pharmocological
ranitidine NN Pharmocological
placebo NN Pharmocological
ranitidine NN Pharmocological
placebo NN Pharmocological
ranitidine NN Pharmocological
ranitidine NN Pharmocological
thoracotomy NN Surgical
. . None
placebo-controlled JJ Control
ranitidine NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

phenytoin NN Pharmocological
phenytoin NN Pharmocological
phenytoin NN Pharmocological
or CC None
placebo NN Control
phenytoin NNS Pharmocological
placebo NNS Control
phenytoin NN Pharmocological
phenytoin NN Pharmocological
phenytoin NN Pharmocological
) ) None
Phenytoin VB Pharmocological
-DOCSTART- -X- N

cytokine NN Physical
removal NN Physical
between IN Physical
online JJ Physical
hemodiafiltration NN Physical
( ( Physical
HDF NNP Physical
) ) Physical
, , Physical
which WDT Physical
combines VBZ Physical
convective NN Physical
and CC Physical
diffusive JJ Physical
solute NN Physical
removal NN Physical
, , Physical
and CC Physical
high-flux JJ Physical
hemodialysis NN Physical
( ( Physical
HD NNP Physical
) ) Physical
-DOCSTART- -X- N

Contingency NNP Educational
management NN Educational
Contingency NNP Educational
management NN Educational
( ( Educational
CM NNP Educational
) ) Educational
CM NNP Educational
The DT None
combination NN None
of IN None
a DT None
standardized JJ None
lifestyle NN None
modification NN None
( ( None
LM NNP None
) ) None
program NN None
payment NN None
for IN None
group NN None
attendance NN None
( ( None
CM NNP None
( ( None
attendance NN None
) ) None
) ) None
, , None
ii NN None
) ) None
The DT None
combination NN None
of IN None
LM NNP None
and CC None
payment NN None
for IN None
weight JJ None
loss NN None
( ( None
CM NNP None
( ( None
weight NN None
) ) None
) ) None
, , None
and CC None
iii NN None
) ) None
waitlist NN None
control NN None
( ( None
CON NNP None
) ) None
. . None
LM NNP None
group NN None
and CC None
received VBD None
payment NN None
for IN None
behavioral JJ None
change NN None
( ( None
CM NNP None
( ( None
behavior NN None
) ) None
) ) None
. . None
CONCLUSION NNP None
LM NNP None
supplemented VBD None
with IN None
CM NNP None
may MD None
-DOCSTART- -X- N

topical JJ Pharmocological
anesthesia NN Pharmocological
topical JJ Pharmocological
anesthesia NN Pharmocological
proparacaine NN Pharmocological
eye NN Pharmocological
drops NNS Pharmocological
receiving VBG None
saline JJ None
vs NN None
proparacaine NN None
eye NN None
drops NNS None
( ( None
respectively RB None
. . None
Proparacaine NNP None
use VBP None
Proparacaine NNP None
eye NN None
drops NNS None
proparacaine NN None
eye NN None
drops NNS None
-DOCSTART- -X- N

levocetirizine NN Pharmocological
levocetirizine NN Pharmocological
levocetirizine JJ Pharmocological
placebo NN Control
levocetirizine JJ Pharmocological
placebo NN Control
levocetirizine NN Pharmocological
levocetirizine NN Pharmocological
-DOCSTART- -X- N

health NN Educational
promotion NN Educational
Working NNP Educational
Well NNP Educational
with IN Educational
a DT Educational
Disability NNP Educational
health-promotion NN Educational
program NN Educational
Health-promotion NN Educational
interventions NNS Educational
Working NNP Educational
Well NNP Educational
health NN Educational
promotion NN Educational
program NN Educational
. . None
Intervention-group JJ Educational
Working NNP Educational
Well NNP Educational
Control-group NN Control
Working NNP Educational
Well NNP Educational
program NN Educational
-DOCSTART- -X- N

Na+ NNP Pharmocological
modeling VBG Pharmocological
Na+ NNP Pharmocological
standard JJ Pharmocological
Na+ NNP Pharmocological
dialysate NN Pharmocological
linear NN Physical
Na+ NNP Physical
program NN Physical
Na+ NNP Pharmocological
modeling VBG Pharmocological
Na+ NNP Pharmocological
modeling NN Pharmocological
: : None
Na+ NNP Pharmocological
modeling VBG Pharmocological
. . None
Na+ NNP Pharmocological
modeling VBG Pharmocological
. . None
Na+ NNP Pharmocological
modeling VBG Pharmocological
-DOCSTART- -X- N

cyclophosphamide VB Pharmocological
plasma NN None
exchanges NNS None
prednisone NN Pharmocological
and CC Pharmocological
PE NNP Pharmocological
prednisone VB Pharmocological
steroid NN Pharmocological
and CC Pharmocological
immunosuppressive JJ Pharmocological
therapy NN Pharmocological
: : None
short-term JJ Pharmocological
steroid NN Pharmocological
therapy NN Pharmocological
and CC Pharmocological
PE NNP Pharmocological
anti-viral JJ Pharmocological
therapy NN Pharmocological
prednisone NN Pharmocological
in IN Pharmocological
association NN Pharmocological
with IN Pharmocological
CYC NNP Pharmocological
anti-viral JJ Pharmocological
agents NNS Pharmocological
and CC Pharmocological
PE NNP Pharmocological
. . None
PE NNP Pharmocological
PE NN Pharmocological
PE NNP Pharmocological
-DOCSTART- -X- N

umbilical JJ Pharmocological
cord NN Pharmocological
serum NN Pharmocological
therapy NN Pharmocological
umbilical JJ Pharmocological
cord NN Pharmocological
serum NN Pharmocological
therapy NN Pharmocological
Umbilical NNP Pharmocological
cord NN Pharmocological
serum NN Pharmocological
or CC Pharmocological
autologous JJ Pharmocological
serum NN Pharmocological
drops NNS Pharmocological
cord NN Pharmocological
serum NN Pharmocological
autologous JJ Control
serum NN Control
control NN Control
group NN Educational
. . Educational
cord NN Pharmocological
serum NN Pharmocological
cord NN Pharmocological
serum NN Pharmocological
Umbilical NNP Pharmocological
cord NN Pharmocological
serum NN Pharmocological
autologous JJ Pharmocological
serum NN Pharmocological
. . None
-DOCSTART- -X- N

[ NN None
Statins VBZ Pharmocological
statin NN Pharmocological
treatment NN None
-DOCSTART- -X- N

Confidential JJ Educational
registration NN Educational
confidential JJ Educational
registration NN Educational
. . None
Binary NNP Other
choices NNS Other
ordinal JJ Other
visual JJ Other
analogue NN Other
validated JJ Educational
questionnaire NN Educational
on IN Educational
self NN Educational
reported VBN Educational
measures NNS Educational
: : None
screened JJ Other
area NN Other
Confidential JJ Other
registration NN Other
Confidential JJ Other
registration NN Other
-DOCSTART- -X- N

hands NNS Physical
and CC Physical
forearms NNS Physical
were VBD Physical
covered VBN Physical
for IN Physical
15 CD Physical
minutes NNS Physical
with IN Physical
a DT Physical
carbon NN Physical
fibre NN Physical
heating VBG Physical
mitt NN Physical
. . None
active JJ Physical
warming NN Physical
at IN Physical
52 CD Physical
degrees NNS Physical
C NNP Physical
or CC None
passive JJ Control
insulation NN Control
-DOCSTART- -X- N

Collagen NNP Pharmocological
cross-linking NN Pharmocological
with IN Pharmocological
photoactivated JJ Pharmocological
riboflavin NN Pharmocological
( ( Pharmocological
PACK-CXL NNP Pharmocological
) ) Pharmocological
corneal JJ Pharmocological
collagen NN Pharmocological
cross-linking NN Pharmocological
( ( Pharmocological
CXL NNP Pharmocological
) ) Pharmocological
photoactivated VBN Pharmocological
riboflavin NN Pharmocological
( ( Pharmocological
photoactivated VBN Pharmocological
chromophore NN Pharmocological
for IN Pharmocological
infectious JJ Pharmocological
keratitis NN Pharmocological
[ NNP Pharmocological
PACK NNP Pharmocological
] NNP Pharmocological
-CXL NNP Pharmocological
) ) Pharmocological
only RB Pharmocological
antimicrobial JJ Pharmocological
therapy NN Pharmocological
. . None
the DT None
PACK-CXL NNP None
PACK-CXL NNP None
group NN None
PACK-CXL NNP None
group NN None
PACK-CXL NNP None
group NN None
CONCLUSIONS NNP None
Corneal NNP None
CXL NNP None
with IN None
photoactivated JJ None
riboflavin NN None
did VBD None
PACK-CXL NNP None
may MD None
-DOCSTART- -X- N

OK-432 NNP Pharmocological
OK-432 NNP Pharmocological
( ( Pharmocological
receiving VBG Pharmocological
OK-432 NNP Pharmocological
) ) Pharmocological
control NN Control
OK-432 NNP Pharmocological
) ) None
OK-432 NNP Pharmocological
-DOCSTART- -X- N

predictive JJ Educational
model NN Educational
-DOCSTART- -X- N

calcium NN Pharmocological
carbasalate NN Pharmocological
plus CC None
metoclopramide JJ Pharmocological
versus NN None
ergotamine NN Pharmocological
tartrate NN Pharmocological
plus CC None
caffeine NN Pharmocological
calcium NN Pharmocological
carbasalate NN Pharmocological
( ( Pharmocological
equivalent JJ Pharmocological
to TO Pharmocological
900 CD Pharmocological
mg NNS Pharmocological
aspirin RB Pharmocological
) ) Pharmocological
plus CC None
metoclopramide $ Pharmocological
10 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
CM NNP Pharmocological
) ) Pharmocological
with IN None
ergotamine JJ Pharmocological
tartrate NN Pharmocological
1 CD Pharmocological
mg NN Pharmocological
plus CC Pharmocological
caffeine JJ Pharmocological
100 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
EC NNP Pharmocological
) ) Pharmocological
CM NNP Pharmocological
EC NNP Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
aspirin NN Pharmocological
and/or NN None
resistant JJ Pharmocological
starch NN Pharmocological
aspirin NNS Pharmocological
and CC None
resistant JJ Pharmocological
starch NN Pharmocological
( ( Pharmocological
RS NNP Pharmocological
) ) Pharmocological
( ( None
aspirin NN Pharmocological
and CC None
RS NNP Pharmocological
) ) None
( ( None
aspirin NN Pharmocological
) ) None
placebo-controlled JJ Control
aspirin NN Pharmocological
RS NNP Pharmocological
arms NNS None
: : None
aspirin NN None
plus CC None
RS NNP None
placebo NN None
; : None
RS NNP None
plus CC None
aspirin JJ None
placebo NN None
; : None
aspirin CC None
plus CC None
RS NNP None
; : None
RS NNP None
placebo NN None
plus CC None
aspirin JJ None
placebo NN None
; : None
of IN None
aspirin JJ None
-DOCSTART- -X- N

reinforcement NN None
or CC None
stimulus NN None
control NN None
family-based JJ Educational
behavioral JJ Educational
treatment NN Educational
that WDT None
included VBD None
either DT None
stimulus NN None
control NN None
or CC None
reinforcement NN None
stimulus JJ None
control NN None
and CC None
reinforcing VBG None
-DOCSTART- -X- N

[ JJ None
Intra-arterial JJ Pharmocological
chemotherapy NN Pharmocological
intra-arterially RB Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
and CC None
5-FU CD Pharmocological
systemically RB Pharmocological
with IN Pharmocological
the DT Pharmocological
CMFV-combination NNP Pharmocological
only RB Physical
systemically RB Physical
intra-arterial JJ Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

Methylphenidate NNP Pharmocological
nursing NN Educational
telephone NN Educational
intervention NN Educational
placebo-controlled JJ Control
methylphenidate NN Pharmocological
( ( Pharmocological
MP NNP Pharmocological
) ) Pharmocological
placebo NN Control
nursing NN Educational
telephone NN Educational
intervention NN Educational
( ( Educational
NTI NNP Educational
) ) Educational
control NN None
telephone NN None
intervention NN None
( ( None
PL+CTI NNP None
. . None
Methylphenidate NNP None
dose NN None
superior JJ None
to TO None
placebo VB None
in IN None
-DOCSTART- -X- N

drug-containing JJ Pharmocological
porcine-cornea NN Pharmocological
irradiated JJ Pharmocological
drug-containing NN Pharmocological
( ( Pharmocological
ofloxacin UH Pharmocological
, , Pharmocological
acetyl JJ Pharmocological
cysteine NN Pharmocological
and CC Pharmocological
reduced JJ Pharmocological
glutathione NN Pharmocological
) ) Pharmocological
porcine-cornea NN Pharmocological
. . None
porcine-cornea NN Physical
-DOCSTART- -X- N

didanosine JJ None
didanosine NN Pharmocological
( ( Pharmocological
ddI NN Pharmocological
) ) None
itraconazole NN Pharmocological
. . None
itraconazole JJ Pharmocological
alone NN Pharmocological
itraconazole JJ Pharmocological
with IN Pharmocological
simultaneous JJ Pharmocological
ddI NNS Pharmocological
single JJ Pharmocological
200-mg JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
itraconazole NN Pharmocological
or CC None
itraconazole NN Pharmocological
with IN Pharmocological
concomitant JJ Pharmocological
oral JJ Pharmocological
ddI NN Pharmocological
300 CD Pharmocological
mg NN Pharmocological
( ( None
two CD None
150-mg JJ None
tablets NNS None
) ) None
itraconazole NN Pharmocological
oral JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
ddI NNS Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
contraceptives NNS Pharmocological
( ( Pharmocological
OCs NNP Pharmocological
) ) Pharmocological
progestogens NNS Pharmocological
, , None
desogestrel NN Pharmocological
and CC None
gestodene NN Pharmocological
20 CD None
micrograms NNS None
ethinyl VBP Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
E2 NNP Pharmocological
) ) Pharmocological
150 CD None
micrograms NNS None
desogestrel VBD Pharmocological
ethinyl VBP Pharmocological
E2 NNP Pharmocological
plus CC Pharmocological
75 CD Pharmocological
micrograms NNS Pharmocological
gestodene VBP Pharmocological
-DOCSTART- -X- N

second JJ None
third JJ None
generation NN None
oral JJ Pharmocological
contraceptives NNS Pharmocological
second JJ Educational
third JJ Pharmocological
generation NN Pharmocological
combination NN Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
( ( Pharmocological
OCs NNP Pharmocological
) ) Pharmocological
ethinyl JJ Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/levonorgestrel NN Pharmocological
ethinyl VB Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl VB Pharmocological
estradiol/levonorgestrel NN Pharmocological
. . Pharmocological
desogestrel-containing JJ Pharmocological
contraceptive NN Pharmocological
levonorgestrel-containing JJ Pharmocological
contraceptive NN Pharmocological
. . Pharmocological
levonorgestrel NN Pharmocological
desogestrel NN Pharmocological
ethinyl JJ Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/levonorgestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/levonorgestrel NN Pharmocological
third JJ Educational
generation NN Educational
OCs NNP Physical
desogestrel NN Pharmocological
second JJ None
and CC None
third JJ None
generation NN None
OCs NNP Physical
-DOCSTART- -X- N

Rational-emotive JJ Psychological
therapy NN Psychological
rational-emotive JJ Psychological
therapy NN Psychological
and CC None
rational-emotive JJ Psychological
imagery NN Psychological
. . None
rational-emotive JJ Psychological
therapy NN Psychological
without IN Psychological
imagery NN Psychological
rational-emotive JJ Psychological
imagery NN Psychological
rational-emotive JJ Psychological
therapy NN Psychological
. . None
-DOCSTART- -X- N

Reciprocal NNP Educational
Imitation NNP Educational
Training NNP Educational
Reciprocal JJ Educational
Imitation NNP Educational
Training NNP Educational
( ( Educational
RIT NNP Educational
) ) Educational
-DOCSTART- -X- N

cognitive-behavioral JJ Psychological
group NN Psychological
therapy NN Psychological
cognitive-behavioral JJ Psychological
group NN Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
client-centered JJ Psychological
, , Psychological
supportive-experiential JJ Psychological
group NN Psychological
therapy NN Psychological
( ( Psychological
SET NNP Psychological
) ) Psychological
CBT NNP Psychological
. . None
CBT NNP Educational
SET NNP Educational
cognitive-behavioral JJ Educational
intervention NN Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

clopidogrel NN Pharmocological
clopidogrel NN Pharmocological
75 CD None
mg/day JJ None
plus CC None
aspirin JJ Pharmocological
81 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
89 CD None
) ) None
or CC None
placebo JJ Control
plus CC None
aspirin JJ Pharmocological
81 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
92 CD None
) ) None
for IN None
9 CD None
weeks NNS None
clopidogrel NN Pharmocological
plus CC None
aspirin JJ Pharmocological
placebo NN Control
plus CC None
aspirin NN Pharmocological
clopidogrel NN Pharmocological
-DOCSTART- -X- N

Low-fluence JJ Physical
photodynamic JJ Physical
therapy NN Physical
ranibizumab NN Pharmocological
low-fluence NN Physical
PDT NNP Physical
or CC None
3 CD Pharmocological
consecutive JJ Pharmocological
monthly JJ Pharmocological
injections NNS Pharmocological
of IN Pharmocological
ranibizumab NN Pharmocological
. . None
Rescue NNP Control
treatment NN Control
-DOCSTART- -X- N

Fadrozole NNP Pharmocological
HCL NNP Pharmocological
( ( Pharmocological
CGS-16949A NNP Pharmocological
) ) Pharmocological
megestrol NN Pharmocological
acetate VBP Pharmocological
fadrozole JJ Pharmocological
HCL NNP Pharmocological
randomized VBN None
to TO None
receive VB None
either DT None
fadrozole JJ Pharmocological
HCL NNP Pharmocological
, , Pharmocological
1 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , None
or CC None
megestrol NN Pharmocological
acetate NN Pharmocological
, , Pharmocological
40 CD Pharmocological
mg NN Pharmocological
4 CD Pharmocological
times NNS Pharmocological
daily RB Pharmocological
, , None
in IN None
a DT None
double JJ None
blind NN None
fashion NN None
after IN None
progression NN None
on IN None
first-line JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
. . None
Fadrozole NNP Pharmocological
HCL NNP Pharmocological
fadrozole NN Pharmocological
HCL NNP Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

laparoscopic NN Physical
surgery NN Physical
quyu JJ Pharmocological
jiedu NN Pharmocological
recipe NN Pharmocological
laparoscopic NN Physical
surgery NN Physical
Quyu NNP Pharmocological
Jiedu NNP Pharmocological
Recipe NNP Pharmocological
( ( Pharmocological
QYJDR NNP Pharmocological
) ) Pharmocological
progesterone NN Pharmocological
QYJDR NNP Pharmocological
laparoscopic NN Surgical
surgery NN Surgical
QYJDR NNP Surgical
QYJDR NNP Surgical
-DOCSTART- -X- N

diclofenac JJ Pharmocological
diethylamine JJ Pharmocological
Topical JJ Pharmocological
diclofenac NN Pharmocological
diethylamine NN Pharmocological
( ( Pharmocological
DDEA NNP Pharmocological
) ) Pharmocological
1.16 CD Pharmocological
% NN Pharmocological
gel NN Pharmocological
placebo NN Pharmocological
gel NN Pharmocological
lower JJR None
with IN None
DDEA NNP None
gel NN None
with IN None
DDEA NNP None
gel NN None
-DOCSTART- -X- N

zilpaterol NN Pharmocological
hydrochloride NN Pharmocological
of IN None
leptin JJ None
R25C NNP None
genotypes NNS None
and CC None
zilpaterol $ None
hydrochloride NN None
( ( None
ZH NNP None
) ) None
-DOCSTART- -X- N

lamivudine VB Pharmocological
. . None
lamivudine NN Pharmocological
lamivudine NN Pharmocological
-DOCSTART- -X- N

lithium NN Pharmocological
induction NN Physical
therapy NN Physical
oral JJ Pharmocological
lithium NN Pharmocological
carbonate NN Pharmocological
1200 CD Pharmocological
mg JJ Pharmocological
daily JJ Pharmocological
or CC None
no DT Pharmocological
lithium NN Pharmocological
. . None
lithium NN Pharmocological
lithium NN Pharmocological
lithium NN Pharmocological
-DOCSTART- -X- N

pentoxifylline NN Pharmocological
. . Pharmocological
pentoxifylline NN Pharmocological
placebo NN Control
or CC None
400 CD Pharmocological
mg JJ Pharmocological
tid NN Pharmocological
of IN Pharmocological
pentoxifylline NN Pharmocological
. . None
Pentoxifylline NNP Pharmocological
therapy VBZ Pharmocological
-DOCSTART- -X- N

misoprostol NN Pharmocological
oral JJ Pharmocological
misoprostol NN Pharmocological
400 CD Pharmocological
mug NN Pharmocological
or CC Pharmocological
intramuscular JJ Pharmocological
syntometrine NN Pharmocological
misoprostol NN Pharmocological
syntometrine NN Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
thyrotropin-stimulated JJ Pharmocological
radioiodine NN Pharmocological
therapy NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
( ( Pharmocological
rhTSH NN Pharmocological
) ) Pharmocological
radioiodine NN Physical
( ( Physical
131I CD Physical
) ) Physical
therapy NN Physical
rhTSH NN Pharmocological
0.1 CD None
mg NN None
rhTSH NN Pharmocological
thyroid JJ Physical
dose NN Physical
of IN Physical
50 CD Physical
Gy NNP Physical
or CC None
placebo NN Control
placebo NN Control
rhTSH NN Pharmocological
rhTSH NN Pharmocological
placebo NN Control
placebo NN Control
rhTSH NN Pharmocological
rhTSH NN Pharmocological
131I-therapy JJ Physical
-DOCSTART- -X- N

radiofrequency NN Physical
ablation NN Physical
conventional JJ Surgical
high JJ Surgical
ligation NN Surgical
radiofrequency NN Physical
ablation NN Physical
( ( Physical
RFA NNP Physical
) ) Physical
RFA NNP Physical
RFA NNP Physical
RFA NNP Physical
RFA NNP Physical
RFA NNP Physical
. . None
-DOCSTART- -X- N

furosemide NN Pharmocological
no DT Control
therapeutic JJ Control
intervention NN Control
mometasone NN Pharmocological
furoate NN Pharmocological
, , Pharmocological
a DT Pharmocological
corticosteroid NN Pharmocological
treatment NN None
with IN None
intranasal JJ Pharmocological
furosemide NN Pharmocological
received VBD Control
no DT Control
therapeutic JJ Control
treatment NN Control
treated VBN None
with IN None
mometasone NN Pharmocological
. . None
furosemide JJ Pharmocological
-DOCSTART- -X- N

frusemide NN Pharmocological
Diuretic NNP Pharmocological
40 CD Pharmocological
mg NNS Pharmocological
frusemide JJ Pharmocological
daily RB Pharmocological
or CC Pharmocological
placebo VB Pharmocological
frusemide JJ Pharmocological
placebo NN Pharmocological
frusemide NN Pharmocological
placebo NN Pharmocological
frusemide NN Pharmocological
placebo NN Pharmocological
. . None
frusemide NN Pharmocological
frusemide NN Pharmocological
frusemide NN Pharmocological
-DOCSTART- -X- N

gadodiamide JJ Pharmocological
MR NNP Physical
imaging VBG Physical
gadodiamide JJ Pharmocological
injection NN Pharmocological
0.1 CD Pharmocological
mM/kg NNS Pharmocological
gadopentetate JJ Pharmocological
dimeglumine NN Pharmocological
. . Pharmocological
gadodiamide NN Pharmocological
gadodiamide NN Pharmocological
gadodiamide NN Pharmocological
gadodiamide JJ Pharmocological
gadopentetate NN Pharmocological
dimeglumine NN Pharmocological
-DOCSTART- -X- N

acupuncture NN Physical
acupuncture NN Physical
rehabilitation NN Physical
training NN Physical
including VBG Physical
ABA NNP Physical
training NN Physical
, , Physical
the DT Physical
Conductive NNP Physical
Education NNP Physical
Approach NNP Physical
and CC Physical
the DT Physical
training NN Physical
of IN Physical
sensory JJ Physical
integration NN Physical
acupuncture JJ Physical
treatment NN Physical
after IN Physical
the DT Physical
rehabilitation NN Physical
training NN Physical
. . Educational
Acupuncture NNP Physical
scientific JJ Physical
and CC Physical
effective JJ Physical
rehabilitation NN Physical
training NN Physical
simple JJ Physical
rehabilitation NN Physical
training NN Physical
-DOCSTART- -X- N

Marimastat NNP Pharmocological
matrix JJ None
metalloproteinase NN None
inhibitor NN None
, , None
marimastat NN Pharmocological
marimastat NN Pharmocological
( ( None
10 CD None
mg NN None
b.d NN None
. . None
) ) None
or CC None
placebo NN Control
. . None
marimastat NN Pharmocological
placebo NN Control
marimastat NN Pharmocological
marimastat NNS Pharmocological
placebo VB None
Marimastat NNP Pharmocological
placebo NN None
marimastat NN Pharmocological
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
operation NN Pharmocological
morphine NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
saline NN Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

Reduction NN None
of IN None
with IN None
nonverbal JJ Educational
differential JJ Educational
observing NN Educational
responses NNS Educational
. . None
two CD Educational
sample NN Educational
stimuli NNS Educational
differential JJ Educational
observing NN Educational
responses NNS Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
expressed VBN Pharmocological
breast NN Pharmocological
milk NN Pharmocological
placebo-controlled JJ Control
venepuncture NN Physical
5 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
distilled JJ Pharmocological
water NN Pharmocological
( ( Pharmocological
DW NNP Pharmocological
) ) Pharmocological
as IN Pharmocological
placebo NN Pharmocological
. . None
venepuncture NN Physical
. . None
EBM NNP Pharmocological
EBM NNP Pharmocological
EBM NNP Pharmocological
EBM NNP Pharmocological
venepuncture NN Physical
-DOCSTART- -X- N

concurrent JJ Pharmocological
chemoradiotherapy NN Pharmocological
radiotherapy NN Pharmocological
concurrent JJ Pharmocological
chemoradiotherapy NN Pharmocological
( ( Pharmocological
CCRT NNP Pharmocological
) ) Pharmocological
radiotherapy NN Pharmocological
( ( Pharmocological
RT NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
cisplatin NN Pharmocological
fluorouracil JJ Pharmocological
CCRT NNP Pharmocological
RT-alone NNP Pharmocological
CCRT NNP Pharmocological
RT-only JJ Pharmocological
CCRT NNP Pharmocological
RT-only JJ Pharmocological
CCRT NNP Pharmocological
CCRT NNP Pharmocological
RT VB Pharmocological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
. . None
WST-1 JJ Physical
assay NN Physical
tamoxifen NN Pharmocological
tamoxifen NN None
, , None
tamoxifen NN None
randomised VBN None
weaker JJR None
tamoxifen NN None
in IN None
decreased VBN None
tamoxifen NN None
sensitivity NN None
-DOCSTART- -X- N

surveillance NN Physical
surveillance NN Physical
surveillance VB Physical
2 CD Physical
years NNS Physical
( ( Physical
group NN Physical
A NNP Physical
) ) Physical
4 CD Physical
years NNS Physical
-DOCSTART- -X- N

Clinical JJ Physical
massage NN Physical
and CC None
modified VBD Physical
Proprioceptive NNP Physical
Neuromuscular NNP Physical
Facilitation NNP Physical
stretching VBG Physical
modified JJ Physical
Proprioceptive NNP Physical
Neuromuscular NNP Physical
Facilitation NNP Physical
( ( Physical
PNF NNP Physical
) ) Physical
stretching NN Physical
Myofascial JJ Physical
Trigger NNP Physical
Point NNP Physical
( ( Physical
MTrP NNP Physical
) ) Physical
therapy NN Physical
plus CC Physical
modified JJ Physical
PNF NNP Physical
stretching NN Physical
no DT Other
treatment NN Other
. . None
MTrP NNP Physical
therapy NN Physical
modified JJ Physical
PNF NNP Physical
stretching NN Physical
-DOCSTART- -X- N

azithromycin NN Pharmocological
antimicrobials NNS Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
doxycycline NN Pharmocological
azithromycin NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
zinc NN Pharmocological
sulfate NN Pharmocological
placebo-controlled JJ Control
with IN None
fluoxetine JJ None
plus CC None
zinc NN None
with IN None
fluoxetine JJ None
plus CC None
placebo NN None
. . None
that IN None
zinc NN None
, , None
-DOCSTART- -X- N

ball NN Educational
weight NN Educational
of IN Educational
a DT Educational
lighter JJR Educational
ball NN Educational
( ( Educational
Tachikara NNP Educational
Volley NNP Educational
Lite NNP Educational
) ) Educational
on IN Educational
tournament NN Educational
game NN Educational
play NN Educational
and CC Educational
pretest-to-posttest JJ Educational
improvement NN Educational
for IN Educational
a DT Educational
16-day JJ Educational
volleyball NN Educational
practice NN Educational
period NN Educational
. . None
lighter JJR Educational
balls NNS Educational
regulation NN Educational
balls NNS Educational
. . None
regulation NN Educational
balls NNS Educational
lighter JJR Educational
balls NNS Educational
regulation NN Educational
ball NN Educational
. . None
-DOCSTART- -X- N

Transesophageal NNP Physical
echocardiography NN Physical
reamed VBN Surgical
unreamed JJ Surgical
femoral JJ Surgical
nailing NN Surgical
. . None
reamed VB Surgical
unreamed JJ Surgical
reamed VBD Surgical
unreamed JJ Surgical
nail NN Surgical
. . None
Transesophageal NNP Physical
echocardiography NN Physical
( ( Physical
TEE NNP Physical
) ) None
-DOCSTART- -X- N

surgical JJ Surgical
or CC None
endovascular JJ Pharmocological
Follow-up NNP Physical
angiography NN Physical
MRI NNP Physical
-DOCSTART- -X- N

rehabilitation VB Physical
training NN Physical
. . None
physical JJ Physical
training NN Physical
, , None
discharged VBD Control
home NN Control
exercises NNS Physical
every DT Physical
day NN Physical
: : Physical
on IN Physical
bicycle NN Physical
ergometer NN Physical
during IN Physical
30 CD Physical
minutes NNS Physical
( ( Physical
5 CD Physical
times NNS Physical
a DT Physical
week NN Physical
) ) Physical
, , Physical
overall-conditioning JJ Physical
exercises NNS Physical
for IN Physical
30 CD Physical
minutes NNS Physical
daily RB Physical
and CC Physical
30 CD Physical
to TO Physical
60 CD Physical
minutes NNS Physical
of IN Physical
walking VBG Physical
each DT Physical
day NN Physical
. . None
Before IN Physical
administering VBG Physical
of IN Physical
the DT Physical
therapy NN Physical
and CC Physical
3 CD Physical
weeks NNS Physical
later RB Physical
all DT Physical
performed VBD Physical
the DT Physical
bicycle NN Physical
ergometer NN Physical
exercise NN Physical
test NN Physical
until IN Physical
the DT Physical
was VBD Physical
reached VBN Physical
. . None
Before IN None
that DT None
test NN None
and CC None
3 CD None
minutes NNS None
after IN None
its PRP$ None
termination NN None
capillary NN None
and CC None
venous JJ None
blood NN None
samples NNS None
were VBD None
drawn VBN None
. . None
In IN None
the DT None
capillary JJ None
blood NN None
samples NNS None
were VBD None
determined VBN None
. . None
-DOCSTART- -X- N

naftopidil NN Pharmocological
then RB None
50 CD None
mg NN None
of IN None
naftopidil NN Pharmocological
was VBD None
given VBN None
once RB None
a DT None
day NN None
after IN None
breakfast NN None
or CC None
supper NN None
for IN None
8 CD None
weeks NNS None
. . None
Naftopidil NNP Pharmocological
-DOCSTART- -X- N

strength NN Physical
training NN Physical
strength NN Physical
training NN Physical
( ( Physical
ST NNP Physical
) ) Physical
ST NNP Physical
ST NNP Physical
as IN Control
a DT Control
control NN Control
group NN Control
aerobic JJ Physical
exercise NN Physical
ST NNP Physical
-DOCSTART- -X- N

nootropic JJ Pharmocological
therapy NN Pharmocological
Actovegin NNP Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
with IN Pharmocological
250 CD Pharmocological
ml NNS Pharmocological
20 CD Pharmocological
% NN Pharmocological
Actovegin NNP Pharmocological
and CC None
250 CD Control
ml NNS Control
placebo JJ Control
daily RB None
. . None
Auditory NNP Physical
ERPs NNP Physical
placebo VB None
. . None
placebo VB None
. . None
-DOCSTART- -X- N

( ( None
conventional JJ Surgical
liver NN Surgical
resection NN Surgical
versus IN None
anterior JJ Physical
approach NN Physical
) ) None
Surgical NNP Surgical
hepatic JJ Surgical
resection NN Surgical
liver JJ Surgical
resection NN Surgical
techniques NNS Surgical
of IN Surgical
liver NN Surgical
metastases NNS Surgical
anterior JJ Physical
approach NN Physical
technique NN Physical
conventional JJ Physical
resection NN Physical
-DOCSTART- -X- N

early JJ Pharmocological
enteral JJ Pharmocological
nutrition NN Pharmocological
with IN Pharmocological
addition NN Pharmocological
of IN Pharmocological
probiotics NNS Pharmocological
early JJ Pharmocological
enteral JJ Pharmocological
nutrition NN Pharmocological
( ( Pharmocological
EN NNP Pharmocological
) ) Pharmocological
supplemented VBD Pharmocological
with IN Pharmocological
probiotics NNS Pharmocological
( ( Pharmocological
bifidobacterium NN Pharmocological
) ) Pharmocological
P+EN NNP Pharmocological
EN NNP Pharmocological
probiotics NNS Pharmocological
( ( Pharmocological
bifidobacterium NN Pharmocological
anti-infection NN Pharmocological
and CC Pharmocological
anti-acid JJ Pharmocological
agents NNS Pharmocological
P+EN NNP None
group NN None
PN NNP None
EN NNP None
than IN None
that DT None
in IN None
PN NNP None
between IN None
P+EN NNP None
group NN None
and CC None
PN NNP None
P+EN NNP None
, , None
EN NNP None
, , None
PN NNP None
groups NNS None
PN NNP None
and CC None
EN NNP None
groups NNS None
that IN None
early JJ None
EN NNP None
with IN None
addition NN None
of IN None
probiotics NNS None
( ( None
bifidobacterium NN None
) ) None
resulted VBD None
-DOCSTART- -X- N

Hemolytic JJ Pharmocological
streptococcus NN Pharmocological
preparation NN Pharmocological
OK-432 NNP Pharmocological
; : None
hemolytic JJ Pharmocological
streptococcus NN Pharmocological
preparation NN Pharmocological
3 CD None
groups NNS None
: : None
-DOCSTART- -X- N

Racial JJ None
differences NNS None
in IN None
multihospital NN None
study NN None
. . None
lower JJR None
or CC None
angioplasty NN None
amputation NN Educational
revascularization NN None
amputation NN Educational
amputation NN Educational
Chronic NNP None
disease NN None
prevalence NN None
and CC None
severity NN None
, , None
preadmission NN None
functional JJ None
status NN None
, , None
clinical JJ None
presentation NN None
, , None
and CC None
vascular JJ None
history NN None
amputation NN Educational
-DOCSTART- -X- N

flecainide NN Pharmocological
placebo-controlled JJ Control
flecainide NN Pharmocological
or CC None
placebo VB Control
placebo NN Control
flecainide NN Pharmocological
. . None
flecainide NN Pharmocological
) ) None
flecainide NN Pharmocological
flecainide NN Pharmocological
-DOCSTART- -X- N

, , None
sorbitol NN Pharmocological
and CC None
xylitol NNP Pharmocological
] NNP None
fructose VBP Pharmocological
, , None
sorbitol JJ Pharmocological
and CC None
xylitol NNS Pharmocological
25 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
each DT Pharmocological
sugar NN Pharmocological
sorbitol NN Pharmocological
fructose JJ Pharmocological
xylitol NNP Pharmocological
sorbitol NN Pharmocological
versus NN None
fructose NN Pharmocological
and CC None
xylitol NN Pharmocological
) ) None
sorbitol NN Pharmocological
fructose JJ Pharmocological
xylitol NN Pharmocological
xylitol NN Pharmocological
fructose JJ Pharmocological
sorbitol NN Pharmocological
. . None
-DOCSTART- -X- N

sublingual JJ Pharmocological
and CC Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
sublingual JJ Pharmocological
or CC Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
400 CD Pharmocological
microg NN Pharmocological
misoprostol NN Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
misoprostol NN Pharmocological
Vaginal NNP Pharmocological
misoprostol NN Pharmocological
sublingual JJ Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

cytarabine NN Pharmocological
cisplatin JJ Pharmocological
cytarabine NN Pharmocological
cisplatin NN Pharmocological
cytarabine NN Pharmocological
cisplatin-5-fluorouracil NN Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
1000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
cytarabine NN Pharmocological
cisplatin NN Pharmocological
infusion NN Pharmocological
cisplatin NN Pharmocological
cisplatin NNS Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
irradiation+/-surgery NN Surgical
cytarabine NN Pharmocological
cisplatin NN Pharmocological
. . None
-DOCSTART- -X- N

pentoxifylline JJ Pharmocological
pentoxifylline NN Pharmocological
( ( Pharmocological
PTF NNP Pharmocological
) ) Pharmocological
PTF NNP Pharmocological
control NN Control
PTF NNP Pharmocological
PTF NNP Pharmocological
-DOCSTART- -X- N

Intravenous JJ Pharmocological
fibrinolysis NN Pharmocological
( ( Pharmocological
IVF NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
rt-PA NN Pharmocological
( ( Pharmocological
alteplase NN Pharmocological
) ) Pharmocological
Intra-arterial JJ Pharmocological
fibrinolysis NN Pharmocological
( ( Pharmocological
IAF NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
pro-urokinase NN Pharmocological
IVF NNP Pharmocological
IAF NNP Pharmocological
IVF NNP Pharmocological
IAF NNP Pharmocological
urokinase JJ Pharmocological
IVF NNP Pharmocological
-DOCSTART- -X- N

energy NN Pharmocological
supplementation NN Pharmocological
programs NNS Pharmocological
and CC Pharmocological
amount NN Pharmocological
of IN Pharmocological
starch NN Pharmocological
CP NNP Pharmocological
supplement NN Pharmocological
CP NNP Pharmocological
supplement/d NN Pharmocological
and CC Pharmocological
pasture NN Pharmocological
a DT Pharmocological
high-starch NN Pharmocological
( ( Pharmocological
HS NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
( ( Pharmocological
73 CD Pharmocological
% NN Pharmocological
HS NNP Pharmocological
diet JJ Pharmocological
fed NN Pharmocological
in IN Pharmocological
drylot NN Pharmocological
a DT Pharmocological
low-starch NN Pharmocological
( ( Pharmocological
LS NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
self-fed NN Educational
on IN Educational
pasture NN Educational
HS-60 JJ Pharmocological
HS-30 JJ Pharmocological
LS-30 JJ Pharmocological
High-starch-60 JJ None
42 CD Pharmocological
% NN Pharmocological
CP NNP Pharmocological
supplement/d NN Pharmocological
SBM NNP Pharmocological
supplement/d NN Pharmocological
; : None
distiller NN Pharmocological
's POS Pharmocological
grain NN Pharmocological
and CC Pharmocological
soybean JJ Pharmocological
hull-based JJ Pharmocological
diet NN Pharmocological
limited-fed JJ Pharmocological
a DT Pharmocological
corn-based JJ Pharmocological
diet NN Pharmocological
LS NNP Pharmocological
or CC None
a DT None
HS NNP Pharmocological
diet NN Pharmocological
-DOCSTART- -X- N

JASPER NNP Educational
intervention NN Educational
( ( Educational
JASPER NNP Educational
, , Educational
Joint NNP Educational
Attention NNP Educational
Symbolic NNP Educational
Play NNP Educational
Engagement NNP Educational
and CC Educational
Regulation NNP Educational
) ) Educational
were VBD None
randomized VBN None
to TO None
a DT None
control NN None
group NN None
( ( None
treatment NN None
as IN None
usual JJ None
, , None
30 CD None
h NN None
of IN None
ABA-based JJ None
therapy NN None
per IN None
week NN None
) ) None
or CC None
a DT None
treatment NN None
group NN None
( ( None
substitution NN None
of IN None
30 CD None
min NN None
of IN None
JASPER NNP None
treatment NN None
, , None
twice RB None
weekly RB None
during IN None
their PRP$ None
regular JJ None
program NN None
) ) None
. . None
A DT None
JASPER NNP None
treatment NN None
-DOCSTART- -X- N

Bupropion NNP Pharmocological
SR NNP Pharmocological
and CC None
counseling VBG Educational
for IN Educational
standard JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
bupropion NN Pharmocological
SR NNP Pharmocological
bupropion NN Pharmocological
SR NNP Pharmocological
bupropion NN Pharmocological
SR NNP Pharmocological
behavioral JJ Educational
counseling NN Educational
( ( Educational
tailored JJ Educational
mailings NNS Educational
or CC Educational
proactive JJ Educational
telephone NN Educational
counseling NN Educational
) ) Educational
bupropion NN Pharmocological
SR NNP Pharmocological
-DOCSTART- -X- N

sunitinib NN Pharmocological
37.5 CD Pharmocological
mg/d NN Pharmocological
continuously RB None
or CC None
placebo VB Control
. . None
oral JJ Pharmocological
prednisone NN Pharmocological
5 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
. . None
-DOCSTART- -X- N

aquatic JJ Physical
exercise NN Physical
aquatic JJ Physical
exercise NN Physical
classes NNS Physical
aquatic JJ Physical
classes NNS Physical
aquatic JJ Physical
classes NNS Physical
Aquatic JJ Physical
exercisers NNS Physical
Aquatic NNP Physical
exercise NN Physical
aquatic JJ Physical
exercise NN Physical
-DOCSTART- -X- N

Anesthesia NNP Pharmocological
was VBD None
induced VBN None
with IN None
thiopental JJ None
and CC None
remifentanil NN Pharmocological
( ( Pharmocological
1.0 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
bolus NN Pharmocological
and CC None
a DT None
1 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
infusion NN Pharmocological
) ) Pharmocological
or CC None
fentanyl NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
bolus NN Pharmocological
and CC None
a DT None
1.0 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
infusion NN Pharmocological
) ) None
. . None
The DT None
opioid JJ Pharmocological
infusion NN Pharmocological
continued VBD None
until IN None
the DT None
level NN None
of IN None
anesthesia NN Pharmocological
was VBD None
deemed VBN None
appropriate JJ None
for IN None
intubation NN None
. . None
Anesthesia NNP Pharmocological
was VBD None
maintained VBN None
with IN None
N NNP None
( ( None
2 CD None
) ) None
O/O NNP None
( ( None
2 CD None
) ) None
, , None
isoflurane $ Pharmocological
0.5 CD Pharmocological
MAC NNP Pharmocological
and CC None
remifentanil VB Pharmocological
0.2 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 JJ Pharmocological
) ) Pharmocological
or CC None
fentanyl $ Pharmocological
0.04 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
. . None
At IN Physical
bone NN Physical
flap NN Physical
replacement NN Physical
, , None
either DT Pharmocological
morphine NN Pharmocological
0.08 CD Pharmocological
mg NN Pharmocological
x NN None
kg NN None
( ( None
-1 NN None
) ) None
( ( None
remifentanil JJ Pharmocological
group NN Pharmocological
) ) Pharmocological
or CC None
saline NN Pharmocological
( ( None
fentanyl JJ None
group NN None
) ) None
was VBD None
given VBN None
. . None
-DOCSTART- -X- N

cytokine-induced JJ Pharmocological
killer NN Pharmocological
cells NNS Pharmocological
therapy VBP Pharmocological
Adoptive JJ Pharmocological
immunotherapy NN Pharmocological
Autologous JJ Pharmocological
cytokine-induced JJ Pharmocological
killer NN Pharmocological
( ( Pharmocological
CIK NNP Pharmocological
) ) Pharmocological
cells NNS Pharmocological
were VBD None
transfused VBN None
CIK NNP Pharmocological
cell NN Pharmocological
CIK NNP Pharmocological
cell NN Pharmocological
transfusion NN Pharmocological
-DOCSTART- -X- N

anal JJ Physical
dilator NN Physical
anal JJ Physical
stretch NN Physical
with IN None
or CC None
without IN None
continued JJ Physical
dilatation NN Physical
anal JJ Physical
stretch NN Physical
-DOCSTART- -X- N

Citalopram NNP Pharmocological
9-week JJ Pharmocological
study NN Pharmocological
a DT Pharmocological
median NN Pharmocological
of IN Pharmocological
168 CD Pharmocological
days NNS Pharmocological
( ( Pharmocological
range VB Pharmocological
6-913 NNP Pharmocological
) ) Pharmocological
post NN Pharmocological
stroke NN Pharmocological
and CC Pharmocological
were VBD Pharmocological
treated VBN Pharmocological
with IN Pharmocological
citalopram JJ Pharmocological
10-20 JJ Pharmocological
mg NNS Pharmocological
daily RB Pharmocological
for IN Pharmocological
3 CD Pharmocological
weeks NNS Pharmocological
. . None
citalopram NN Pharmocological
-DOCSTART- -X- N

coronary JJ Surgical
bypass NN Surgical
surgery NN Surgical
angioplasty NN Surgical
Coronary-artery JJ Surgical
bypass NN Surgical
grafting NN Surgical
( ( Surgical
CABG NNP Surgical
) ) Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
( ( Surgical
PTCA NNP Surgical
) ) Surgical
CABG NNP Surgical
PTCA NNP Surgical
CABG NNP Surgical
PTCA NNP Surgical
. . None
-DOCSTART- -X- N

Etomidate NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
flumazenil JJ Pharmocological
anesthesia NN Pharmocological
etomidate JJ Pharmocological
administration NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
flumazenil NNS Pharmocological
the DT Pharmocological
flumazenil NN Pharmocological
group NN Pharmocological
the DT Pharmocological
etomidate NN Pharmocological
group NN Pharmocological
etomidate NN Pharmocological
. . None
etomidate NN Pharmocological
flumazenil NNS Pharmocological
placebo NN Control
. . None
flumazenil NN Pharmocological
Etomidate NNP Pharmocological
flumazenil RB Pharmocological
-DOCSTART- -X- N

immediate JJ Pharmocological
antimicrobial JJ Pharmocological
treatment NN Pharmocological
versus NN None
watchful JJ Physical
waiting VBG Physical
amoxicillin-clavulanate NN Pharmocological
or CC None
placebo NN Control
amoxicillin-clavulanate NN Pharmocological
placebo NN Control
amoxicillin-clavulanate JJ Pharmocological
placebo NN Control
amoxicillin-clavulanate JJ Pharmocological
placebo NN Control
amoxicillin-clavulanate JJ Pharmocological
placebo NN Control
: : None
placebo NN Control
. . None
amoxicillin-clavulanate NN Pharmocological
. . None
amoxicillin-clavulanate NN Pharmocological
-DOCSTART- -X- N

Rifampicin NNP Pharmocological
plus CC Pharmocological
isoniazid NN Pharmocological
isoniazid NN Pharmocological
( ( Pharmocological
6H CD Pharmocological
) ) Pharmocological
isoniazid JJ Pharmocological
plus CC Pharmocological
rifampicin JJ Pharmocological
( ( Pharmocological
3RH CD Pharmocological
) ) Pharmocological
. . None
3RH CD Pharmocological
regimen NNS Pharmocological
-DOCSTART- -X- N

polyunsaturated JJ Pharmocological
Fatty NNP Pharmocological
acids NNS Pharmocological
dietary JJ Pharmocological
supplementation NN Pharmocological
of IN Pharmocological
polyunsaturated JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
PUFA NNP Pharmocological
) ) Pharmocological
PUFA NNP Pharmocological
PUFA NNP Pharmocological
PUFA NNP Pharmocological
placebo NN Control
PUFA NNP Pharmocological
. . Pharmocological
PUFA NNP Pharmocological
placebo NN Control
. . Control
PUFA NNP Pharmocological
placebo NN Control
Polyunsaturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
placebo VB Control
) ) None
Dietary NNP Pharmocological
PUFA NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Project NNP Physical
SEARCH NNP Physical
plus CC Physical
ASD NNP Physical
Supports NNP Physical
-DOCSTART- -X- N

Engagement NN Educational
with IN Educational
electronic JJ Educational
screen JJ Educational
media NNS Educational
electronic JJ Educational
screen JJ Educational
media NNS Educational
( ( Educational
ESM NNP Educational
) ) Educational
: : Educational
animated VBN Educational
video NN Educational
, , Educational
video NN Educational
of IN Educational
self NN Educational
, , Educational
video NN Educational
of IN Educational
a DT Educational
familiar JJ Educational
person NN Educational
engaged VBD Educational
with IN Educational
an DT Educational
immersive JJ Educational
virtual JJ Educational
reality NN Educational
( ( Educational
VR NNP Educational
) ) Educational
game NN Educational
, , Educational
and CC Educational
immersion NN Educational
of IN Educational
self NN Educational
in IN Educational
the DT Educational
VR NNP Educational
game NN Educational
. . Educational
ESM NNP Educational
-DOCSTART- -X- N

intravenous JJ Pharmocological
iron NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
low-dose JJ Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
parenteral JJ None
iron NN None
and CC None
recombinant JJ None
human JJ None
erythropoietin-? NN None
( ( None
rHuEPO-? JJ None
) ) None
administered VBN None
( ( None
control NN None
) ) None
or CC None
( ( None
200 CD None
mg NN None
of IN None
iron NN None
sucrose NN None
intravenously RB None
over IN None
1 CD None
hr NNS None
and CC None
3000 CD None
IU NNP None
of IN None
rHuEPO-? JJ None
subcutaneously NN None
parenteral JJ None
iron NN None
and CC None
low-dose JJ None
rHuEPO-? NN None
in IN None
bilateral JJ None
-DOCSTART- -X- N

brain NN Physical
MRI NNP Physical
-DOCSTART- -X- N

standard VB Control
pain NN Control
treatment NN Control
, , None
the DT Physical
SCION-PAIN JJ Physical
program NN Physical
consisting NN Physical
of IN Physical
3 CD Physical
modules NNS Physical
: : Physical
pharmacologic NN Physical
pain NN Physical
management NN Physical
, , Physical
nonpharmacologic RB Physical
pain JJ Physical
management NN Physical
and CC Physical
discharge NN Physical
management NN Physical
. . None
patient JJ Educational
education NN Educational
, , Educational
skills NNS Educational
training NN Educational
and CC Educational
counseling NN Educational
to TO Educational
improve VB Educational
self PRP Educational
care VB Educational
regarding VBG Educational
pain JJ Educational
management NN Educational
beginning VBG Educational
with IN Educational
admission NN Educational
followed VBN Educational
by IN Educational
booster NN Educational
session NN Educational
every DT Educational
3rd CD Educational
day NN Educational
and CC Educational
one CD Educational
follow VBP Educational
up RP Educational
telephone NN Educational
counseling NN Educational
within IN Educational
2 CD Educational
to TO Educational
3 CD Educational
days NNS Educational
after IN Educational
discharge NN Educational
. . None
-DOCSTART- -X- N

acellular JJ Pharmocological
diphtheria NN Pharmocological
, , Pharmocological
pertussis NN Pharmocological
and CC Pharmocological
tetanus NN Pharmocological
freeze-dried JJ Pharmocological
and CC Pharmocological
liquid JJ Pharmocological
vaccines NNS Pharmocological
whole-cell JJ Pharmocological
diphtheria-pertussis-tetanus NN Pharmocological
( ( Pharmocological
DPT NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
. . Pharmocological
acellular JJ Pharmocological
vaccine NN Pharmocological
acellular JJ Pharmocological
vaccine NN Pharmocological
whole-cell JJ Physical
DPT NNP Physical
( ( Physical
WCDPT NNP Physical
) ) Physical
ADPT NNP Pharmocological
vaccines NNS Pharmocological
WCDPT NNP Pharmocological
vaccine NN Pharmocological
ADPT NNP None
WCDPT NNP None
-DOCSTART- -X- N

new JJ Pharmocological
and CC Pharmocological
commercially RB Pharmocological
available JJ Pharmocological
drugs NNS Pharmocological
surgery NN Surgical
and/or NN None
radiation NN Physical
therapy NN Physical
18 CD Other
agents NNS Other
chemotherapy VB Physical
radiation NN Physical
therapy NN Physical
-DOCSTART- -X- N

Propranolol NNP Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
propranolol- JJ Pharmocological
placebo-treated JJ Control
propranolol NN Pharmocological
-DOCSTART- -X- N

Counselling NN Educational
6 CD Educational
weekly JJ Educational
, , Educational
counselling VBG Educational
visits NNS Educational
by IN Educational
the DT Educational
Child NNP Educational
Health NNP Educational
Clinic NNP Educational
nurse NN Educational
and CC Educational
the DT Educational
control NN Educational
group NN Educational
received VBD Educational
routine JJ Control
primary NN Control
care NN Control
. . Educational
Counselling VBG Educational
-DOCSTART- -X- N

brovincamine NN Pharmocological
oral JJ Pharmocological
brovincamine NN Pharmocological
cerebral JJ Physical
vasodilator NN Physical
oral JJ Pharmocological
brovincamine NN Pharmocological
untreated JJ Control
control NN Control
group NN Control
. . Control
visual JJ Control
field NN Control
examinations NNS Control
brovincamine NN Pharmocological
brovincamine NN Pharmocological
brovincamine NN Pharmocological
brovincamine NN Pharmocological
brovincamine NN Pharmocological
Oral NNP Pharmocological
brovincamine NN Pharmocological
-DOCSTART- -X- N

Korean JJ None
version NN None
of IN None
the DT None
PEERS NNP None
( ( None
? . None
) ) None
parent-assisted JJ None
social JJ None
skills NNS None
training VBG None
program NN None
PEERS NNS None
( ( None
? . None
) ) None
( ( None
Program NNP None
for IN None
the DT None
Education NNP None
and CC None
Enrichment NNP None
of IN None
Relational NNP None
Skills NNP None
) ) None
is VBZ None
a DT None
Korean JJ None
version NN None
of IN None
PEERS NNP None
( ( None
? . None
) ) None
for IN None
PEERS NNP None
( ( None
? . None
) ) None
Treatment NN None
delayed VBN None
treatment NN None
control NN None
group NN None
-DOCSTART- -X- N

intubation NN Physical
. . None
Tracheal NNP Physical
tube JJ Physical
placement NN Physical
gum-elastic JJ Physical
bougie NN Physical
. . None
tracheal NN Physical
tube NN Physical
rotation NN Physical
simulated VBN Other
laryngoscope NN Physical
-DOCSTART- -X- N

pegylated VBN Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
HCl NNP Pharmocological
( ( Pharmocological
CAELYX/Doxil NNP Pharmocological
) ) Pharmocological
conventional JJ Pharmocological
doxorubicin NN Pharmocological
CAELYX NNP Pharmocological
[ NNP Pharmocological
pegylated VBD Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
HCl NNP Pharmocological
( ( Pharmocological
PLD NNP Pharmocological
) ) Pharmocological
] NN None
doxorubicin VB Pharmocological
PLD NNP Pharmocological
doxorubicin $ Pharmocological
60 CD Pharmocological
mg/m2 NN Pharmocological
anthracycline NN Pharmocological
PLD NNP Pharmocological
doxorubicin NNS Pharmocological
doxorubicin NN Pharmocological
PLD NNP Pharmocological
PLD NNP Pharmocological
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
PLD NNP Pharmocological
. . None
PLD NNP Pharmocological
doxorubicin NN Pharmocological
. . None
PLD NNP Pharmocological
doxorubicin VB Pharmocological
-DOCSTART- -X- N

caudal JJ Physical
block NN Physical
diclofenac NN Pharmocological
suppository NN Pharmocological
caudal JJ Pharmocological
block NN Pharmocological
diclofenac JJ Pharmocological
suppository NN Pharmocological
and CC None
local JJ Pharmocological
anesthetic JJ Pharmocological
infiltration NN Pharmocological
Anesthesia NNP Pharmocological
was VBD None
carried VBN None
out RP None
using VBG None
the DT None
standard JJ None
procedure NN None
. . None
caudal JJ Pharmocological
block NN Pharmocological
with IN Pharmocological
bupivacaine NN Pharmocological
1 CD Pharmocological
mL/kg NN Pharmocological
after IN Pharmocological
anesthetic JJ Pharmocological
induction NN Pharmocological
. . None
diclofenac JJ Pharmocological
suppository JJ Pharmocological
3 CD Pharmocological
mg/kg JJ Pharmocological
postinduction NN Pharmocological
and CC Pharmocological
local JJ Pharmocological
anesthetic JJ Pharmocological
infiltration NN Pharmocological
at IN Pharmocological
the DT Pharmocological
port NN Pharmocological
sites VBZ Pharmocological
diclofenac JJ Pharmocological
suppository NN Pharmocological
anesthetic JJ Pharmocological
infiltration NN Pharmocological
diclofenac JJ Pharmocological
suppository NN Pharmocological
anesthetic JJ None
infiltration NN None
-DOCSTART- -X- N

high JJ Pharmocological
fat NN Pharmocological
diet JJ Pharmocological
rich JJ Pharmocological
in IN Pharmocological
monounsaturated JJ Pharmocological
fat NN Pharmocological
( ( Pharmocological
MUFA-diet NNP Pharmocological
) ) Pharmocological
moderate JJ Pharmocological
fat NN Pharmocological
diet JJ Pharmocological
rich JJ Pharmocological
in IN Pharmocological
polyunsaturated JJ Pharmocological
fat NN Pharmocological
( ( Pharmocological
PUFA-diet NNP Pharmocological
) ) Pharmocological
PUFA-rich JJ Pharmocological
MUFA NNP Pharmocological
. . None
-DOCSTART- -X- N

antibiotics NNS Pharmocological
prophylactic JJ Pharmocological
antibiotics NNS Pharmocological
. . None
prophylactic JJ Pharmocological
antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

Pravastatin NNP Pharmocological
Pravastatin NNP Pharmocological
placebo-controlled JJ Control
pravastatin NN Control
pravastatin NN Pharmocological
pravastatin NNS Pharmocological
placebo-in JJ Control
-DOCSTART- -X- N

phenylephrine NN Pharmocological
phenylephrine JJ Pharmocological
saline NN Pharmocological
or CC Pharmocological
phenylephrine NN Pharmocological
infusion NN Pharmocological
( ( Pharmocological
PE NNP Pharmocological
) ) Pharmocological
phenylephrine NN Pharmocological
-DOCSTART- -X- N

nursing-led JJ Other
inpatient NN Other
unit NN Other
The DT Other
nursing-led JJ Other
inpatient NN Other
unit NN Other
nursing-led JJ Other
inpatient NN Other
unit NN Other
nursing-led JJ Other
inpatient NN Other
unit NN Other
-DOCSTART- -X- N

Statin NNP Pharmocological
treatment NN Pharmocological
withdrawal NN None
statin NN Pharmocological
pretreatment NN Pharmocological
and CC None
its PRP$ None
withdrawal NN None
statin VB Pharmocological
withdrawal NN None
for IN None
the DT None
first JJ None
3 CD None
days NNS None
after IN None
admission NN None
( ( None
n JJ None
= NNP None
46 CD None
) ) None
or CC None
to TO None
immediately RB None
receive VB None
atorvastatin NN Pharmocological
20 CD None
mg/day NN None
( ( None
n JJ None
= NNP None
43 CD None
) ) None
non-statin-withdrawal JJ None
Statin NNP Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
L-carnosine NNP Pharmocological
supplementation NN Pharmocological
L-Carnosine NNP Pharmocological
, , None
a DT None
dipeptide NN Pharmocological
L-carnosine JJ Pharmocological
placebo NN Control
. . None
placebo NN Control
L-carnosine NNP Pharmocological
L-carnosine NNP Pharmocological
-DOCSTART- -X- N

simvastatin VB Pharmocological
simvastatin NN None
on IN None
mg NNS None
of IN None
simvastatin NN None
or CC None
placebo NN None
the DT None
simvastatin NN None
and CC None
placebo NN None
of IN None
simvastatin NN None
. . None
The DT None
joint JJ None
-DOCSTART- -X- N

5 CD Pharmocological
mg NNS Pharmocological
finasteride RB Pharmocological
( ( None
n JJ None
= NNP None
81 CD None
) ) None
or CC None
placebo NN Control
( ( None
n JJ None
= NNP None
40 CD None
) ) None
for IN None
12 CD None
months NNS None
; : None
all DT None
patients NNS None
continuing VBG None
into IN None
an DT None
open JJ None
extension NN None
received VBD None
finasteride RB Pharmocological
during IN None
the DT None
second JJ None
12 CD None
months NNS None
of IN None
therapy NN None
. . None
-DOCSTART- -X- N

telephone NN None
appointing VBG None
telephone NN Other
appointments NNS Other
telephone NN Other
call NN Other
from IN Other
the DT Other
practice NN Other
receptionist NN Other
intervention NN None
control NN Control
intervention NN None
group NN None
controlgroup NN Control
intervention NN None
-DOCSTART- -X- N

Clonidine NN Pharmocological
clonidine NN Pharmocological
saline NN Control
2-micrograms/kg JJ None
bolus NN None
of IN None
clonidine NN Pharmocological
-DOCSTART- -X- N

PVB NNP Pharmocological
, , Pharmocological
VAB-6 NNP Pharmocological
, , Pharmocological
BVP NNP Pharmocological
regimen VBP Pharmocological
versus NN Pharmocological
PEB NNP Pharmocological
chemotherapy NN Pharmocological
PVB NNP Pharmocological
, , Pharmocological
VAB-6 NNP Pharmocological
, , Pharmocological
BVP NNP Pharmocological
regimen NNS Pharmocological
without IN None
etoposide JJ Pharmocological
versus NN None
PEB NNP Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
bleomycin NN Pharmocological
, , Pharmocological
etoposide RB Pharmocological
and CC Pharmocological
cisplatinum NN Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
surgery NN Surgical
-DOCSTART- -X- N

pentazocine NN Pharmocological
morphine JJ Pharmocological
morphine NN Pharmocological
and CC Pharmocological
pentazocine NN Pharmocological
-DOCSTART- -X- N

stentless JJ Physical
conventional JJ Surgical
conventional JJ Surgical
biological JJ Surgical
versus NN None
stentless NN Surgical
aortic JJ Surgical
valve NN Surgical
replacement NN Surgical
. . None
stentless NN Physical
bioprostheses NNS Physical
-DOCSTART- -X- N

Oral JJ Pharmocological
ribavirin NN Pharmocological
treatment NN Pharmocological
administration NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
ribavirin NN Pharmocological
ribavirin NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

active JJ None
symptom NNS None
control NN None
regular JJ None
follow-up NN None
in IN None
a DT None
specialist NN None
clinic NN None
; : None
( ( None
2 CD None
) ) None
structured VBD None
assessments NNS None
of IN None
physical JJ None
, , None
psychological JJ None
and CC None
social JJ None
problems NNS None
with IN None
appropriate JJ None
action NN None
; : None
( ( None
3 CD None
) ) None
rapid JJ None
involvement NN None
of IN None
additional JJ None
specialists NNS None
; : None
and CC None
( ( None
4 CD None
) ) None
parallel NN None
nursing VBG None
support NN None
. . None
ASC NNP Other
alone RB Other
, , None
( ( None
2 CD None
) ) None
ASC NNP Pharmocological
plus CC Pharmocological
mitomycin JJ Pharmocological
vinblastine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
MVP NNP Pharmocological
) ) Pharmocological
, , None
and CC None
( ( None
3 CD None
) ) None
ASC NNP Pharmocological
plus CC Pharmocological
vinorelbine NN Pharmocological
-DOCSTART- -X- N

Naftidrofuryl NNP Pharmocological
placebo-controlled JJ Control
Naftidrofuryl NNP Pharmocological
placebo NN Pharmocological
Naftidrofuryl NNP None
placebo NN None
placebo NN None
Naftidrofuryl NNP Pharmocological
-DOCSTART- -X- N

ranitidine NN Pharmocological
and CC None
amoxicillin JJ Pharmocological
plus CC None
metronidazole JJ Pharmocological
amoxicillin NN Pharmocological
metronidazole JJ Pharmocological
identical-appearing JJ Control
placebos NN Control
ranitidine NN Pharmocological
placebo NN Control
antibiotics NNS Pharmocological
placebo NN Control
antibiotics NNS Pharmocological
. . None
antibiotics NNS Pharmocological
placebo NN Control
-DOCSTART- -X- N

joint JJ Physical
attention NN Physical
play NN Physical
interventions NNS Physical
joint JJ Physical
attention NN Physical
( ( Physical
JA NNP Physical
) ) Physical
symbolic JJ Physical
play NN Physical
( ( Physical
SP NNP Physical
) ) Physical
JA NNP Educational
SP NNP Educational
JA NNP Educational
SP NNP Physical
JA NNP Educational
SP NNP Physical
-DOCSTART- -X- N

Tiotropium NNP Pharmocological
Tiotropium NNP Pharmocological
bromide NN Pharmocological
tiotropium VBP Pharmocological
Respimat NNP Pharmocological
Soft NNP Pharmocological
Mist NNP Pharmocological
inhaler NN Pharmocological
tiotropium NN Pharmocological
HandiHaler NNP Pharmocological
tiotropium NN Pharmocological
's POS Pharmocological
tiotropium NN None
Respimat NNP None
5 CD None
?g NNP None
with IN None
tiotropium NN None
HandiHaler NNP None
18 CD None
? . None
once RB None
daily JJ None
( ( None
marketed VBN None
that IN None
tiotropium NN None
Respimat NNP None
5 CD None
Respimat NNP None
2.5 CD None
non-inferior JJ None
to TO None
HandiHaler NNP None
in IN None
terms NNS None
tiotropium NN None
Respimat NNP None
5 CD None
?g NNP None
superior JJ None
to TO None
HandiHaler NNP None
in IN None
terms NNS None
Respimat NNP None
and CC None
HandiHaler NNP None
formulations NNS None
of IN None
tiotropium NN None
, , None
assess JJ None
-DOCSTART- -X- N

isosorbide NN Pharmocological
dinitrate NN Pharmocological
placebo NNS Control
or CC None
isosorbide VB Pharmocological
dinitrate NN Pharmocological
( ( Pharmocological
ISDN NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

indirect JJ Physical
laser NN Physical
photocoagulation NN Physical
or CC None
cryotherapy NN Physical
. . None
-DOCSTART- -X- N

Moist NN Pharmocological
Exposed VBD Pharmocological
Burn NNP Pharmocological
Ointment NNP Pharmocological
( ( Pharmocological
MEBO NNP Pharmocological
) ) Pharmocological
dermaheal NN Pharmocological
( ( Pharmocological
MEBO NNP Pharmocological
) ) Pharmocological
( ( None
MEBO NNP Pharmocological
) ) None
MEBO NNP Pharmocological
Flammazine NNP Pharmocological
MEBO NNP Pharmocological
. . None
MEBO NNP Pharmocological
ointment NN Pharmocological
-DOCSTART- -X- N

Three NNP Psychological
Component NNP Psychological
Model NNP Psychological
( ( Psychological
3CM CD Psychological
) ) Psychological
usual JJ Control
care NN Control
usual JJ Control
care NN Control
usual JJ Educational
care NN Educational
plus CC Educational
3CM CD Educational
3CM CD Psychological
telephone NN Educational
care NN Educational
management NN Educational
3CM CD Educational
3CM CD Educational
-DOCSTART- -X- N

Multimodal NNP Educational
Anxiety NNP Educational
and CC Educational
Social NNP Psychological
Skill NNP Psychological
Intervention NNP Psychological
Multimodal NNP Educational
Anxiety NNP Educational
and CC Educational
Social NNP Psychological
Skills NNP Psychological
Intervention NNP Psychological
( ( Psychological
MASSI NNP Psychological
) ) Psychological
program NN Psychological
MASSI NNP Psychological
-DOCSTART- -X- N

rapacuronium NN Pharmocological
and CC None
rocuronium NN Pharmocological
anaesthesia NN None
with IN None
propofol JJ None
2.5 CD None
mg JJ None
kg-1 NN None
, , None
either CC None
rapacuronium NN Pharmocological
1.5 CD None
mg NN None
kg-1 NN None
( ( None
n JJ None
= NNP None
30 CD None
) ) None
or CC None
rocuronium $ Pharmocological
0.6 CD None
mg JJ None
kg-1 NN None
( ( None
n JJ None
= NNP None
30 CD None
) ) None
was VBD None
administered VBN None
to TO None
facilitate VB None
tracheal JJ None
intubation NN None
. . None
Anaesthesia NNP None
was VBD None
maintained VBN None
with IN None
either CC None
a DT None
propofol JJ Physical
infusion NN Physical
( ( Physical
100 CD Physical
micrograms NNS Pharmocological
kg-1 JJ Physical
min-1 JJ Physical
) ) Physical
or CC None
sevoflurane NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
% NN Pharmocological
end-tidal JJ Pharmocological
) ) Pharmocological
with IN Pharmocological
66 CD Pharmocological
% NN Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
N2O NNP Pharmocological
) ) Pharmocological
, , None
n JJ None
= VBP None
15 CD None
in IN None
each DT None
subgroup NN None
. . None
was VBD None
performed VBN None
using VBG None
an DT None
electromyographic JJ Physical
( ( None
EMG NNP None
) ) None
device NN None
( ( None
Datex NNP None
Relaxograph NNP None
) ) None
. . None
-DOCSTART- -X- N

PNU-142633 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
selective JJ Pharmocological
5-HT1D JJ Pharmocological
agonist NN Pharmocological
50-mg JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
a DT Pharmocological
5-HT JJ Pharmocological
( ( Pharmocological
1D CD Pharmocological
) ) Pharmocological
agonist NN Pharmocological
, , Pharmocological
PNU-142633 NNP Pharmocological
( ( None
n JJ None
= NNP None
34 CD None
) ) None
, , None
or CC None
matching VBG Control
placebo NN Control
PNU-142633 NNP Pharmocological
placebo NN None
PNU-142633 NNP None
placebo NN None
PNU-142633 NNP None
5-HT JJ None
( ( None
1D CD None
) ) None
5-HT JJ Pharmocological
agonist JJ Pharmocological
-DOCSTART- -X- N

Tromethamine NNP Pharmocological
buffer NN Pharmocological
tromethamine NN Pharmocological
( ( Pharmocological
THAM NNP Pharmocological
) ) Pharmocological
THAM NNP Pharmocological
THAM NNP Pharmocological
. . None
-DOCSTART- -X- N

Movement-related JJ Physical
potentials NNS Physical
temporal JJ Other
and CC Other
spatial JJ Other
cues NNS Other
. . None
movement-related JJ Physical
potentials NNS Physical
( ( Physical
MRPs NNP Physical
) ) Physical
Movement-related JJ Educational
potentials NNS Educational
associated VBN Educational
with IN Educational
sequential JJ Educational
movements NNS Educational
were VBD Educational
investigated VBN Educational
under IN Educational
various JJ Educational
cueing VBG Educational
conditions NNS Educational
( ( None
non-cued JJ Physical
externally RB Physical
cued VBN Physical
, , None
predictable JJ Physical
not RB Educational
unpredictable JJ Educational
( ( None
non-cued JJ Other
not RB Physical
externally RB Physical
cued VBN Physical
external JJ None
cues NNS None
are VBP None
given VBN None
. . None
external JJ None
cues NNS None
timing VBG Physical
cues NNS Physical
not RB None
spatial JJ None
cues NNS None
non-cued JJ None
-DOCSTART- -X- N

placebo VB Control
cetirizine NN Pharmocological
pseudoephedrine NN Pharmocological
cetirizine NN Pharmocological
pseudoephedrine NN Pharmocological
placebo VB Control
cetirizine/PSE NN Pharmocological
cetirizine/PSE NN Pharmocological
placebo VB Control
cetirizine/PSE NN Pharmocological
placebo NN Control
placebo VB Control
cetirizine/PSE NN Pharmocological
-DOCSTART- -X- N

COMPASS NNP Educational
intervention NN Educational
-DOCSTART- -X- N

radiolabelled JJ Pharmocological
anti-carcinoembryonic JJ Pharmocological
antigen NN Pharmocological
I PRP Pharmocological
( ( Pharmocological
131 CD Pharmocological
) ) Pharmocological
KAb201 NNP Pharmocological
( ( None
gemcitabine NN Physical
based VBN Physical
chemotherapy NN Physical
) ) None
KAb201 NNP Pharmocological
KAb201 NNP Pharmocological
-DOCSTART- -X- N

ciprofloxacin NN Pharmocological
intra-peritoneal JJ Pharmocological
vancomycin NN Pharmocological
gentamicin NN Pharmocological
oral JJ Pharmocological
ciprofloxacin NN Pharmocological
and CC None
intraperitoneal JJ Pharmocological
vancomycin/gentamicin NN Pharmocological
ciprofloxacin NN Pharmocological
-DOCSTART- -X- N

Antibiotic JJ Pharmocological
prophylaxis NN Pharmocological
one-day JJ Pharmocological
five-day JJ Pharmocological
therapy NN Pharmocological
. . None
antibiotic JJ Pharmocological
prophylaxis NN Pharmocological
. . None
cefoperazone NN Pharmocological
sodium NN Pharmocological
24 CD None
hours NNS None
or CC None
120 CD None
hours NNS None
. . None
perioperative JJ Pharmocological
antibiotic JJ Pharmocological
prophylaxis NN Pharmocological
. . None
antibiotics NNS Pharmocological
-DOCSTART- -X- N

snacks NNS Physical
no DT Physical
snacks NNS Physical
vs VBP None
three CD Physical
snacks NNS Physical
3 CD Physical
meals/day NN Physical
( ( Physical
3M CD Physical
) ) Physical
3 CD Physical
meals NNS Physical
and CC Physical
3 CD Physical
snacks/day NN Physical
3M CD Pharmocological
3+3M CD Pharmocological
( ( None
3M CD Pharmocological
3+3M=-4.1+/-6.1 JJ Pharmocological
3M CD Pharmocological
3+3M CD Pharmocological
-DOCSTART- -X- N

epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
receptor NN Pharmocological
-DOCSTART- -X- N

sensory JJ Psychological
integration NN Psychological
therapy NN Psychological
program NN Psychological
sensory JJ Psychological
integration NN Psychological
therapy NN Psychological
program NN Psychological
sensory JJ Psychological
integration NN Psychological
therapy NN Psychological
program NN Psychological
-DOCSTART- -X- N

Alpha NNP Pharmocological
interferon NN Pharmocological
placebo-controlled JJ Control
alpha-2 JJ Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

bupivacaine NN Pharmocological
diamorphine NN Pharmocological
. . None
a DT None
control NN None
group NN None
, , None
a DT None
group NN None
who WP None
received VBD None
a DT None
caudal JJ None
injection NN None
of IN None
20 CD None
ml NNS None
bupivacaine VBP Pharmocological
0.5 CD None
% NN None
plain NN None
and CC None
a DT None
group NN None
who WP None
received VBD None
diamorphine JJ Pharmocological
2.5 CD None
mg NN None
in IN None
10 CD None
ml NNS None
normal JJ None
saline NN None
by IN None
caudal JJ Pharmocological
injection NN Pharmocological
; : None
a DT None
comparison NN None
was VBD None
then RB None
made VBN None
of IN None
postoperative JJ None
analgesia NN None
requirements NNS None
. . None
bupivacaine NN Pharmocological
diamorphine NN Pharmocological
diamorphine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
diamorphine NN Pharmocological
-DOCSTART- -X- N

adrenocorticotrophic JJ Pharmocological
hormone NN Pharmocological
( ( Pharmocological
4-9 JJ Pharmocological
) ) Pharmocological
analog NN Pharmocological
ORG IN Pharmocological
2766 CD Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
. . Pharmocological
-DOCSTART- -X- N

estrogens NNS Pharmocological
systemic JJ Physical
hormone NN Physical
therapy NN Physical
( ( Physical
HT NNP Physical
) ) Physical
placebo NN Control
HT NNP Pharmocological
plus CC Pharmocological
vaginal JJ Pharmocological
estriol NN Pharmocological
0.5 CD Pharmocological
mg/day NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Tegaserod NNP Pharmocological
, , Pharmocological
a DT Pharmocological
5-hydroxytryptamine JJ Pharmocological
type NN Pharmocological
4 CD Pharmocological
receptor NN Pharmocological
partial JJ Pharmocological
agonist NN Pharmocological
GI NNP Pharmocological
prokinetic JJ Pharmocological
agents NNS Pharmocological
selective JJ Pharmocological
5-hydroxytryptamine JJ Pharmocological
type NN Pharmocological
4 CD Pharmocological
receptor NN Pharmocological
partial JJ Pharmocological
agonist NN Pharmocological
tegaserod NN Pharmocological
tegaserod NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

HIV NNP None
risk NN None
reduction NN None
intervention NN None
community-based JJ None
, , None
small JJ None
group NN None
HIV NNP None
risk NN None
reduction NN None
intervention NN None
theoretically-guided JJ Educational
intervention NN Educational
HIV-related JJ None
intervention NN None
control NN Control
( ( Control
health NN Control
promotion NN Control
) ) Control
intervention NN Control
. . None
HIV NNP None
intervention NN None
-DOCSTART- -X- N

amphotericin NN Pharmocological
B NNP Pharmocological
deoxycholate NN Pharmocological
amphotericin JJ Pharmocological
B NNP Pharmocological
( ( Pharmocological
AMB NNP Pharmocological
) ) Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
-DOCSTART- -X- N

Injection NNP Pharmocological
sclerotherapy NN Pharmocological
versus NN Physical
electrocoagulation NN Physical
injection NN Pharmocological
sclerotherapy NN Pharmocological
( ( Pharmocological
IS NNP Pharmocological
) ) Pharmocological
with IN None
electrocoagulation NN Physical
( ( Physical
EC NNP Physical
) ) Physical
phenol NN Pharmocological
in IN Pharmocological
almond NN Pharmocological
oil NN Pharmocological
sclerotherapy NN None
( ( None
IS NNP None
) ) None
-DOCSTART- -X- N

warfarin NN Pharmocological
warfarin NN Pharmocological
warfarin NN Pharmocological
control NN Control
Warfarin NNP Pharmocological
verapamil NNS Pharmocological
other JJ Pharmocological
antianginal JJ Pharmocological
drugs NNS Pharmocological
Low JJ Pharmocological
molecular JJ Pharmocological
weight NN Pharmocological
dextran NN Pharmocological
and CC Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
warfarin NN Pharmocological
control NN None
warfarin NN Pharmocological
verapamil NN Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
amoxycillin NN Pharmocological
( ( None
placebo NN Control
amoxycillin NN Pharmocological
) ) None
placebo NN None
placebo NN Control
amoxicillin NN Pharmocological
amoxycillin NN Pharmocological
standard JJ Pharmocological
bronchodilator NN Pharmocological
therapy NN Pharmocological
. . None
amoxycillin NN Pharmocological
amoxycillin NN Pharmocological
amoxycillin NN Pharmocological
. . None
-DOCSTART- -X- N

Low-dose JJ Pharmocological
oral JJ Pharmocological
etoposide-based JJ Pharmocological
low-dose JJ Pharmocological
etoposide NN Pharmocological
epipodophyllotoxins NNS Pharmocological
during IN Pharmocological
frontline JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
patients NNS None
received VBD None
etoposide RB Pharmocological
( ( None
50 CD None
mg/m NN None
( ( None
2 CD None
) ) None
per IN None
day NN None
) ) None
administered VBD None
orally RB None
as IN None
a DT None
single JJ None
agent NN None
once RB None
or CC None
twice RB None
daily RB None
. . None
dexamethasone NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
and CC Pharmocological
L-asparaginase NNP Pharmocological
. . None
Etoposide NNP Pharmocological
was VBD None
administered VBN None
until IN None
Day NNP None
22 CD None
. . None
Two CD None
courses NNS None
of IN None
consolidation NN None
therapy NN None
were VBD None
followed VBN None
by IN None
continuation NN Physical
therapy NN Physical
or CC Physical
hematopoietic JJ Physical
stem NN Physical
cell NN Physical
transplantation NN Physical
. . None
low-dose JJ Pharmocological
etoposide NN Pharmocological
-DOCSTART- -X- N

Topical JJ Physical
anesthesia NN Physical
topical JJ Physical
anesthesia NN Physical
normal JJ Pharmocological
saline NN Pharmocological
or CC Pharmocological
proparacaine NN Pharmocological
HCl NNP Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
eye NN Pharmocological
drops VBZ Pharmocological
anesthetic JJ Pharmocological
-DOCSTART- -X- N

faropenem JJ Pharmocological
daloxate NN Pharmocological
and CC Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
( ( Pharmocological
300 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC Pharmocological
a DT Pharmocological
twice JJ Pharmocological
daily JJ Pharmocological
oral JJ Pharmocological
regimen NNS Pharmocological
of IN Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
treatment NN Pharmocological
cefuroxime VB Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
group NN Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem NN Pharmocological
daloxate NN Pharmocological
and CC Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
groups NNS Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
and CC Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate-treated JJ Pharmocological
cefuroxime RB Pharmocological
axetil JJ Pharmocological
. . None
faropenem JJ Pharmocological
daloxate NN Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
channel NN Pharmocological
blockers NNS Pharmocological
, , None
verapamil NN Pharmocological
and CC None
nifedipine NN Pharmocological
. . None
calcium NN Physical
channel NN Physical
blocking VBG Physical
agents NNS Physical
nifedipine NN Pharmocological
verapamil NN Pharmocological
placebos NNS Control
placebo NN Control
. . None
calcium NN Physical
channel NN Physical
blockers NNS Physical
-DOCSTART- -X- N

aversive JJ Physical
stimulation NN Physical
and CC Physical
failure NN Physical
aversive JJ Physical
stimulus NN Physical
and CC Physical
simultaneous JJ Physical
failure NN Physical
on IN Physical
a DT Physical
bogus JJ Physical
intelligence NN Physical
test NN Physical
( ( None
aversive JJ Physical
or CC Physical
nonaversive JJ Physical
) ) None
aversive JJ Physical
or CC Physical
nonaversive JJ Physical
acoustic JJ Physical
signal NN Physical
-DOCSTART- -X- N

diuresis NN Pharmocological
with IN Pharmocological
i.v NN Pharmocological
. . Pharmocological
crystalloid NN Pharmocological
, , Pharmocological
furosemide RB Pharmocological
, , Pharmocological
mannitol NN Pharmocological
( ( Pharmocological
if IN Pharmocological
pulmonary JJ Pharmocological
capillary JJ Pharmocological
wedge NN Pharmocological
pressure NN Pharmocological
was VBD Pharmocological
< JJ Pharmocological
20 CD Pharmocological
mmHg NN Pharmocological
) ) Pharmocological
, , Pharmocological
and CC None
low JJ Pharmocological
dose JJ Pharmocological
dopamine NN Pharmocological
versus NN Pharmocological
intravenous JJ Pharmocological
crystalloid NN Pharmocological
and CC None
matching VBG Control
placebos NNS Control
. . None
-DOCSTART- -X- N

racemic JJ Pharmocological
epinephrine NN Pharmocological
Racemic NNP Pharmocological
epinephrine NN Pharmocological
saline NN Pharmocological
or CC Pharmocological
racemic JJ Pharmocological
epinephrine NN Pharmocological
racemic JJ Pharmocological
epinephrine NN Pharmocological
Racemic NNP Pharmocological
epinephrine NN Pharmocological
racemic JJ Pharmocological
epinephrine NN Pharmocological
-DOCSTART- -X- N

antilymphocyte JJ Pharmocological
globulin NN Pharmocological
, , Pharmocological
cyclosporine NN Pharmocological
and CC Pharmocological
two CD Pharmocological
different JJ Pharmocological
granulocyte NNS Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
regimens NNS Pharmocological
: : Pharmocological
5 CD Pharmocological
micro NN Pharmocological
g/kg/day NN Pharmocological
higher JJR None
dose NN None
of IN None
G-CSF NNP Physical
( ( None
10 CD None
micro NNS None
g/kg/day NN None
) ) None
receive VB Pharmocological
G-CSF NNP Pharmocological
5 CD Pharmocological
micro NN Pharmocological
g/kg/day NN Pharmocological
( ( Pharmocological
n=38 JJ Pharmocological
, , Pharmocological
group NN Pharmocological
A NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
10 CD Pharmocological
micro NNS Pharmocological
g/kg/day NN Pharmocological
( ( Pharmocological
n=39 JJ Pharmocological
, , Pharmocological
group NN Pharmocological
B NNP Pharmocological
) ) Pharmocological
from IN Pharmocological
day NN Pharmocological
+1 CD Pharmocological
to TO Pharmocological
day NN Pharmocological
+30 NNP Pharmocological
. . Pharmocological
All DT None
patients NNS None
then RB None
received VBD None
G-CSF NNP Pharmocological
5 CD Pharmocological
micro NN None
g/kg/day NN None
from IN None
day NN None
+31 CD None
to TO None
day NN None
+90 NNP None
. . None
G-CSF NNP Physical
-DOCSTART- -X- N

multi-component JJ Educational
social JJ Educational
skills NNS Educational
intervention NN Educational
Junior NNP Educational
Detective NNP Educational
Training NNP Educational
Program NNP Educational
multi-component JJ Educational
social JJ Educational
skills NNS Educational
intervention NN Educational
Junior NNP Educational
Detective NNP Educational
Training NNP Educational
Program NNP Educational
-DOCSTART- -X- N

error NN Educational
prevention NN Educational
error NN Educational
correction NN Educational
teaching NN Educational
procedures NNS Educational
. . Educational
teaching VBG Educational
procedures NNS Educational
teaching NN Educational
procedures NNS Educational
, , Educational
an DT Educational
error NN Educational
prevention NN Educational
procedure NN Educational
and CC Educational
an DT Educational
error NN Educational
correction NN Educational
procedure NN Educational
, , Educational
for IN Educational
teaching VBG Educational
relations NNS Educational
between IN Educational
objects NNS Educational
and CC Educational
pictures NNS Educational
. . Educational
an DT Educational
error NN Educational
correction NN Educational
method NN Educational
an DT Educational
error NN Educational
prevention NN Educational
method NN Educational
. . Educational
prevention-based JJ Educational
teaching NN Educational
prevention NN Educational
teaching NN Educational
procedure NN Educational
-DOCSTART- -X- N

bacillus NN None
Calmette-Gu?rin NNP None
vaccination NN None
without IN None
bacillus JJ None
Calmette-Gu?rin NNP None
( ( None
BCG NNP None
) ) None
after IN None
BCG NNP None
in IN None
with IN None
BCG NNP None
from IN None
-DOCSTART- -X- N

macronutrient JJ Physical
fat NN Physical
in IN Physical
the DT Physical
diet JJ Physical
high-fat JJ Other
diet NN Other
( ( Other
HFD NNP Other
) ) Other
( ( Other
65 CD Other
% NN Other
of IN Other
energy NN Other
content NN Other
fat NN Other
, , Other
15 CD Other
% NN Other
protein NN Other
, , Other
20 CD Other
% NN Other
carbohydrate NN Other
) ) Other
or CC Other
a DT Other
high-carbohydrate JJ Other
diet NN Other
( ( Other
HCD NNP Other
) ) Other
( ( Other
70 CD Other
% NN Other
carbohydrate NN Other
, , Other
15 CD Other
% NN Other
protein NN Other
, , Other
15 CD Other
% NN Other
fat NN Other
) ) Other
for IN Other
5 CD Other
days NNS Other
, , Other
with IN Other
a DT Other
washout JJ Other
period NN Other
of IN Other
10 CD Other
days NNS Other
between IN Other
the DT Other
diets NNS Other
. . Other
isoprenaline NN Pharmocological
epinephrine NN Pharmocological
aerobic JJ Physical
exercise NN Physical
HFD NNP Physical
-DOCSTART- -X- N

Pelvic NNP None
lymphadenectomy NN None
laparotomy JJ None
extraperitoneal NN None
, , None
transperitoneal NN None
or CC None
laparoscopic NN None
transperitoneal NN None
, , None
extraperitoneal NN None
and CC None
laparoscopic NN None
pelvic JJ None
lymphadenectomy NN None
transperitoneal VB Surgical
( ( Surgical
TPL NNP Surgical
) ) Surgical
, , Surgical
extraperitoneal FW Surgical
( ( Surgical
EPL NNP Surgical
) ) Surgical
or CC Surgical
laparoscopic JJ Surgical
pelvic JJ Surgical
lymphadenectomy NN Surgical
( ( Surgical
LPL NNP Surgical
) ) Surgical
. . Surgical
( ( None
TPL NNP Surgical
EPL NNP Surgical
TPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
, , None
EPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
, , None
EPL NNP Surgical
and CC None
LPL NNP Surgical
group NN None
( ( None
TPL NNP Surgical
EPL NNP Surgical
TPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
, , None
EPL NNP Surgical
LPL NNP Surgical
EPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
LPL NNP Surgical
EPL NNP Surgical
LPL NNP Surgical
-DOCSTART- -X- N

placebo-controlled JJ Control
risperidone NN Pharmocological
plus CC Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
to TO Pharmocological
risperidone VB Pharmocological
risperidone JJ Pharmocological
plus CC Pharmocological
amantadine JJ Pharmocological
, , None
and CC None
the DT None
other JJ None
group NN None
received VBD None
risperidone JJ Pharmocological
plus CC Pharmocological
placebo NN Control
. . None
amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
-DOCSTART- -X- N

hepatitis NN Pharmocological
B NNP Pharmocological
surface NN Pharmocological
antigen NN Pharmocological
( ( Pharmocological
HBsAg NNP Pharmocological
) ) Pharmocological
vaccines NNS Pharmocological
. . Pharmocological
( ( Pharmocological
HBsAg NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

intervention NN Educational
program NN Educational
( ( None
a DT Educational
special JJ Educational
behavior JJ Educational
therapy NN Educational
group NN Educational
behavior JJ Educational
therapy NN Educational
special JJ Psychological
behavior JJ Psychological
therapy NN Psychological
regular JJ Educational
behavior NN Educational
therapy NN Educational
psychotherapy NN Educational
-DOCSTART- -X- N

trandolapril NN Pharmocological
verapamil NN Pharmocological
trandolapril NN Pharmocological
( ( Pharmocological
T NNP Pharmocological
) ) Pharmocological
verapamil NN Pharmocological
( ( Pharmocological
FDTV NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
FDTV NNP Pharmocological
) ) Pharmocological
T NNP Pharmocological
trandolapril-verapamil JJ Pharmocological
-DOCSTART- -X- N

Simvastatin NNP Pharmocological
simvastatin NN Pharmocological
simvastatin NN None
( ( None
80 CD None
mg/day NN None
) ) None
or CC None
placebo NN None
. . None
RESULTS NNP None
Simvastatin NNP None
-DOCSTART- -X- N

marine NN Pharmocological
oils NNS Pharmocological
supplementation NN Pharmocological
oil NN Pharmocological
from IN Pharmocological
blubber NN Pharmocological
of IN Pharmocological
seal NN Pharmocological
, , Pharmocological
cod NN Pharmocological
liver NN Pharmocological
, , Pharmocological
seal/cod NN Pharmocological
liver NN Pharmocological
, , Physical
blubber NN Pharmocological
of IN Pharmocological
Minke NNP Pharmocological
whale NN Pharmocological
, , None
or CC None
no DT Control
oil NN Control
seal/cod NN Pharmocological
liver NN Pharmocological
oil NN Pharmocological
whale JJ Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

whole JJ Physical
body NN Physical
vibration NN Physical
whole JJ Physical
body NN Physical
vibration NN Physical
( ( None
control VB None
condition NN None
) ) None
( ( None
treatment NN None
condition NN None
) ) None
-DOCSTART- -X- N

ibuprofen NN Pharmocological
ibuprofen NN Pharmocological
ibuprofen NN Pharmocological
or CC None
ibuprofen-arginate NN Pharmocological
Endoscopies NNS Physical
ELISA NNP Physical
-DOCSTART- -X- N

purified JJ Pharmocological
chick JJ Pharmocological
embryo NN Pharmocological
cell NN Pharmocological
culture NN Pharmocological
rabies VBZ Pharmocological
vaccine NN Pharmocological
human JJ Pharmocological
diploid NN Pharmocological
cell NN Pharmocological
vaccine NN Pharmocological
: : None
purified JJ Pharmocological
chick JJ Pharmocological
embryo NN Pharmocological
cell NN Pharmocological
culture NN Pharmocological
rabies VBZ Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
PCECV NNP Pharmocological
) ) Pharmocological
human JJ Pharmocological
diploid NN Pharmocological
cell NN Pharmocological
strain NN Pharmocological
rabies NNS Pharmocological
vaccine VBP Pharmocological
( ( Pharmocological
HDCSV NNP Pharmocological
) ) Pharmocological
PCECV NNP Pharmocological
HDCSV NNP Pharmocological
. . None
PCECV NNP Pharmocological
. . None
-DOCSTART- -X- N

amantadine NN None
pemoline NN None
Amantadine NNP Pharmocological
hydrochloride NN Pharmocological
pemoline NN None
amantadine NN Pharmocological
and CC Pharmocological
pemoline NN Pharmocological
amantadine NN None
, , None
pemoline NN None
, , None
or CC None
placebo NN Control
amantadine JJ Pharmocological
pemoline JJ Pharmocological
placebo NN Control
. . Control
-DOCSTART- -X- N

hyaluronic JJ Pharmocological
acid NN Pharmocological
exercise VB Physical
therapy NN Physical
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
exercise NN Physical
therapy NN Physical
three CD Pharmocological
intra-articular JJ Pharmocological
HA NNP Pharmocological
injections NNS Pharmocological
exercise NN Physical
therapy NN Physical
HA NNP Pharmocological
exercise NN Physical
therapy NN Physical
HA NNP Pharmocological
exercise NN Physical
therapy NN Physical
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
: : None
recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
r-HuEPO JJ Pharmocological
) ) Pharmocological
r-HuEPO NN Pharmocological
intravenous JJ Pharmocological
iron NN Pharmocological
gluconate NN Pharmocological
-DOCSTART- -X- N

Paromomycin NNP Pharmocological
paromomycin NN Pharmocological
paromomycin VB Pharmocological
or CC None
placebo VB Control
paromomycin NN Pharmocological
placebo NNS Control
drug NN Pharmocological
placebo NN Control
Paromomycin NNP Pharmocological
-DOCSTART- -X- N

Abacavir NNP Pharmocological
lamivudine NN Pharmocological
and CC Pharmocological
efavirenz NN Pharmocological
Ziagen NNP Pharmocological
abacavir NN Pharmocological
( ( Pharmocological
ABC NNP Pharmocological
) ) Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
lamivudine NN Pharmocological
( ( Pharmocological
3TC CD Pharmocological
) ) Pharmocological
efavirenz NN Pharmocological
( ( Pharmocological
EFV NNP Pharmocological
) ) Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
ABC NNP Pharmocological
3TC CD Pharmocological
EFV NNP Pharmocological
ABC NNP Pharmocological
3TC CD Pharmocological
EFV NNP Pharmocological
-DOCSTART- -X- N

Questionnaire NNP None
responses NNS None
changes NNS Educational
in IN Educational
epilepsy NN Educational
management NN Educational
. . Educational
usual JJ Control
care NN Control
-DOCSTART- -X- N

depot-pilocarpine NN Pharmocological
. . None
new JJ Pharmocological
pilocarpine NN Pharmocological
polymer NN Pharmocological
( ( Pharmocological
Polym NNP Pharmocological
) ) Pharmocological
traditional JJ Pharmocological
pilocarpine NN Pharmocological
salt NN Pharmocological
solution NN Pharmocological
( ( Pharmocological
Plc NNP Pharmocological
) ) Pharmocological
given VBN None
1 CD None
drop NN None
into IN None
each DT None
eye NN None
: : None
1 CD None
drop NN None
every DT None
12 CD None
hours NNS None
for IN None
Polym NNP None
, , None
1 CD None
drop NN None
every DT None
6 CD None
hours NNS None
for IN None
Plc NNP None
. . None
The DT None
patients NNS None
were VBD None
observed VBN None
for IN None
a DT None
period NN None
of IN None
24 CD None
hours NNS None
. . None
Polym NNP Pharmocological
Plc NNP Pharmocological
) ) None
pilocarpine JJ Pharmocological
Plc NNP Pharmocological
pilocarpine NN Pharmocological
Polym NNP Pharmocological
. . None
Polym NNP Pharmocological
Plc VB Pharmocological
pilocarpine JJ Pharmocological
pilocarpine NN Pharmocological
salt NN Pharmocological
pilocarpine JJ Pharmocological
polymer NN Pharmocological
-DOCSTART- -X- N

single-dose JJ Pharmocological
conventional-dose JJ Control
antibiotic JJ Control
treatment NN Control
single-dose JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
7-10 JJ Pharmocological
day NN Pharmocological
courses NNS Pharmocological
of IN Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
. . None
single-dose JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

cyclical JJ Pharmocological
clodronate NN Pharmocological
therapies NNS Pharmocological
clodronate NN Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
, , Pharmocological
1000 CD Pharmocological
mg/day NN Pharmocological
; : Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
plus CC Pharmocological
oral JJ Pharmocological
clodronate NN Pharmocological
, , Pharmocological
400 CD Pharmocological
mg/day NN Pharmocological
; : Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
plus CC Pharmocological
oral JJ Pharmocological
clodronate NN Pharmocological
, , Pharmocological
400 CD Pharmocological
mg/day NN Pharmocological
for IN Pharmocological
30 CD Pharmocological
days NNS Pharmocological
, , Pharmocological
followed VBN Pharmocological
by IN Pharmocological
a DT Pharmocological
60-day JJ Pharmocological
period NN Pharmocological
of IN Pharmocological
calcium JJ Pharmocological
supplement NN Pharmocological
alone RB Pharmocological
. . Pharmocological
clodronate-treated JJ Pharmocological
cyclical JJ Pharmocological
clodronate NN Pharmocological
Continuous JJ Pharmocological
clodronate NN Pharmocological
treatment NN Pharmocological
clodronate NN Pharmocological
-DOCSTART- -X- N

mild JJ Physical
endurance NN Physical
exercise NN Physical
training NN Physical
pravastatin NN Pharmocological
Exercise NNP Physical
training NN Physical
mild JJ Physical
exercise NN Physical
training NN Physical
statin NN Pharmocological
therapy NN Pharmocological
statin NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
pravastatin NN Pharmocological
exercise NN Physical
training NN Physical
therapy NN Physical
( ( None
mild JJ None
endurance NN None
exercise NN None
three CD None
or CC None
more JJR None
times NNS None
a DT None
week NN None
) ) None
Cardiopulmonary NNP Physical
exercise NN Physical
pravastatin NN Pharmocological
therapy NN None
Exercise NN Physical
training NN Physical
pravastatin-treated JJ Pharmocological
pravastatin NNS Pharmocological
mild JJ Physical
endurance NN Physical
exercise NN Physical
training NN Physical
mild JJ Physical
endurance NN Physical
exercise NN Physical
training NN Physical
pravastatin NN Pharmocological
-DOCSTART- -X- N

cytoflavin NN Pharmocological
-DOCSTART- -X- N

fasting VBG Physical
fasting VBG Other
ate VBP Physical
a DT Physical
standard JJ Physical
supper NN Physical
but CC Physical
fasted VBD Physical
for IN Physical
24 CD Physical
h NN Physical
thereafter RB Physical
. . None
standard JJ Physical
supper NN Physical
, , Physical
snacks NNS Physical
, , Physical
breakfast NN Physical
and CC Physical
lunch NN Physical
. . None
-DOCSTART- -X- N

phonophoresis NN Physical
iontophoresis NN Physical
dexamethasone NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
Dexamethasone NNP Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
DEX-P NNP Pharmocological
) ) Pharmocological
phonophoresis NN Physical
( ( Physical
PH NNP Physical
) ) Physical
0.4 CD Pharmocological
% NN Pharmocological
DEX-P JJ Pharmocological
iontophoresis NN Physical
( ( Physical
ION NNP Physical
) ) Physical
therapy NN Pharmocological
PH NNP Physical
ION NNP Physical
DEX-P JJ Pharmocological
phonophoresis NN Physical
DEX-P JJ Pharmocological
iontophoresis NN Physical
-DOCSTART- -X- N

radiation NN Surgical
therapy NN Surgical
split VB Surgical
course NN Surgical
radiation NN Surgical
therapy NN Surgical
combined VBN None
with IN None
mitomycin JJ Pharmocological
C NNP Pharmocological
and CC None
5 CD Pharmocological
fluorouracil NN Pharmocological
radiotherapy NN Surgical
, , None
50 CD None
Gy NNP None
in IN None
20 CD None
fractions NNS None
in IN None
28 CD None
days NNS None
split JJ Surgical
course NN Surgical
radiotherapy NN Surgical
and CC None
concurrent NN Pharmocological
chemotherapy NN Pharmocological
, , None
25 CD None
Gy NNP None
in IN None
10 CD None
fractions NNS None
in IN None
14 CD None
days NNS None
followed VBN None
by IN None
a DT None
4 CD None
week NN None
rest NN None
and CC None
a DT None
further JJ None
25 CD None
Gy NNP None
in IN None
10 CD None
fractions NNS None
in IN None
14 CD None
days NNS None
starting VBG None
on IN None
day NN None
43 CD None
; : None
Mitomycin NNP Pharmocological
C NNP Pharmocological
was VBD None
given VBN None
on IN None
day NN None
1 CD None
and CC None
day NN None
43 CD None
and CC None
5FU CD Pharmocological
continuous JJ None
infusions NNS None
on IN None
days NNS None
1 CD None
-- : None
4 CD None
and CC None
days NNS None
43 CD None
-- : None
46 CD None
. . None
radiotherapy NN Surgical
concurrent JJ Pharmocological
chemotherapy NN Pharmocological
with IN None
Mitomycin NNP Pharmocological
C NNP Pharmocological
and CC None
5 CD Pharmocological
Fluorouracil NNP Pharmocological
-DOCSTART- -X- N

monodisperse JJ Pharmocological
10 CD Pharmocological
microM NN Pharmocological
MMAD NNP Pharmocological
aerosol NN Pharmocological
of IN Pharmocological
H2SO4 NNP Pharmocological
nominal JJ None
concentration NN None
acid VB Control
or CC Control
control VB Control
equiosmolar JJ Control
NaCl NNP Control
aerosol NN Control
-DOCSTART- -X- N

tipifarnib JJ Pharmocological
plus CC Pharmocological
etoposide JJ Pharmocological
-DOCSTART- -X- N

'Senokot NNP Pharmocological
' POS None
Senokot NNP Pharmocological
behavioural JJ None
approach NN None
and CC Pharmocological
either DT Pharmocological
Senokot NNP Pharmocological
, , None
placebo NN Control
or CC Pharmocological
no DT Pharmocological
medication NN Pharmocological
. . None
-DOCSTART- -X- N

Peritoneovenous JJ Physical
shunting VBG Physical
medical JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

dual-axis JJ Physical
rotational JJ Physical
coronary NN Physical
angiography NN Physical
( ( Physical
XPERSWING NN Physical
) ) Physical
conventional JJ Physical
angiography NN Physical
Rotational JJ Physical
angiography NN Physical
conventional JJ Physical
coronary JJ Physical
angiography NN Physical
( ( Physical
A DT Physical
) ) Physical
vs FW Physical
rotational JJ Physical
angiography NN Physical
rotational JJ Physical
angiography NN Physical
conventional JJ Physical
coronary JJ Physical
angiography NN Physical
. . None
-DOCSTART- -X- N

interactive JJ Educational
vs. FW Educational
lecture-based JJ Educational
programs NNS Educational
. . None
patient JJ Educational
education NN Educational
interactive JJ Educational
, , Educational
patient-oriented JJ Educational
group NN Educational
program NN Educational
to TO None
a DT None
lecture-based JJ Educational
, , Educational
information-only JJ Educational
program NN Educational
interactive JJ Educational
intervention NN Educational
or CC Educational
lectures VBZ Educational
providing VBG Educational
information NN Educational
. . Educational
interactive JJ Educational
patient NN Educational
education NN Educational
-DOCSTART- -X- N

aspirin JJ Pharmocological
aspirin NN Pharmocological
placebo NN Control
. . Control
aspirin JJ Pharmocological
-DOCSTART- -X- N

Limbal NNP Surgical
epithelial NN Surgical
autograft NN Surgical
transplantation NN Surgical
limbal JJ Surgical
epithelial JJ Surgical
autograft NN Surgical
transplantation NN Surgical
pterygium NN Surgical
excision NN Surgical
excision NN Surgical
of IN Surgical
pterygium NN Surgical
limbal JJ Surgical
epithelial JJ Surgical
autograft NN Surgical
transplantation NN Surgical
surgery NN Surgical
simple JJ Surgical
pterygium NN Surgical
excision NN Surgical
limbal JJ Surgical
epithelial JJ Surgical
autograft NN Surgical
transplantation NN Surgical
-DOCSTART- -X- N

brisk JJ Physical
walking VBG Physical
in IN Physical
two CD Physical
different JJ Physical
environments NNS Physical
: : Physical
30 CD Physical
minute NN Physical
brisk NN Physical
walk VBP Physical
-DOCSTART- -X- N

practice NN Psychological
on IN Psychological
the DT Psychological
lateralization NN Psychological
of IN Psychological
mental JJ Psychological
rotation NN Psychological
skills NNS Psychological
. . None
trials NNS None
in IN None
a DT None
lateralized JJ Psychological
mental JJ Psychological
rotation NN Psychological
task NN Psychological
. . None
-DOCSTART- -X- N

diethylcarbamazine NN Pharmocological
ivermectin NN Pharmocological
chemotherapy NN Pharmocological
annual JJ Pharmocological
community-wide JJ Pharmocological
single-dose JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
diethylcarbamazine JJ Pharmocological
alone NN Pharmocological
or CC Pharmocological
with IN Pharmocological
ivermectin JJ Pharmocological
diethylcarbamazine JJ Pharmocological
ivermectin JJ Pharmocological
diethylcarbamazine VBP Pharmocological
diethylcarbamazine JJ Pharmocological
Annual JJ None
single-dose JJ None
community-wide JJ None
treatment NN None
with IN None
diethylcarbamazine JJ None
alone NN None
or CC None
with IN None
ivermectin NN None
-DOCSTART- -X- N

factor NN Pharmocological
Xa NNP Pharmocological
inhibitor NN Pharmocological
fondaparinux NN Pharmocological
fondaparinux NN Pharmocological
fondaparinux NN Pharmocological
Fondaparinux NNP Pharmocological
-DOCSTART- -X- N

Leukocyte-depleted JJ Physical
reperfusion NN Physical
leukocyte-depleted JJ Physical
reperfusion NN Physical
or CC None
warm JJ Physical
leukocyte-depleted JJ Physical
blood NN Physical
reperfusion NN Physical
Reperfusion NN Pharmocological
with IN Pharmocological
leukocyte-depleted JJ Pharmocological
blood NN Pharmocological
or CC None
whole JJ Pharmocological
blood NN Pharmocological
Leukocyte-depleted JJ Physical
reperfusion NN Physical
-DOCSTART- -X- N

spironolactone NN Pharmocological
Spironolactone NNP Pharmocological
mineral JJ Pharmocological
corticoid NN Pharmocological
antagonist NN Pharmocological
aldosterone NN Pharmocological
antagonist NN Pharmocological
placebo NN Control
150 CD Pharmocological
mg NNS Pharmocological
Spironolactone CD Pharmocological
per IN Pharmocological
day NN Pharmocological
; : Pharmocological
placebo NN Control
Spironolactone NNP Pharmocological
Spironolactone NNP Pharmocological
. . None
Spironolactone NNP Pharmocological
-DOCSTART- -X- N

dopexamine NN Pharmocological
dopexamine JJ Pharmocological
did VBD Control
not RB Control
receive VB Control
a DT Control
dopexamine JJ Control
infusion NN Control
. . None
dopexamine NN Pharmocological
-DOCSTART- -X- N

parent-implemented JJ Educational
imitation NN Educational
intervention NN Educational
Reciprocal JJ Educational
imitation NN Educational
training NN Educational
( ( Educational
RIT NNP Educational
) ) Educational
is VBZ None
a DT None
naturalistic JJ None
imitation NN None
intervention NN None
RIT NNP Educational
RIT NNP Educational
RIT NNP Educational
RIT NNP Educational
-DOCSTART- -X- N

Triple JJ Pharmocological
antiretroviral JJ Pharmocological
zidovudine NN Pharmocological
nevirapine JJ Pharmocological
prophylaxis NN Pharmocological
mg NNS None
zidovudine NN None
, , None
mg NN None
lamivudine NN None
, , None
mg NN None
lopinavir NN None
plus CC None
mg NN None
ritonavir NN None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
( ( None
zidovudine NN None
twice RB None
zidovudine JJ None
plus CC None
nevirapine NN None
at IN None
post-partum JJ None
zidovudine NN None
300 CD None
nevirapine NN None
at IN None
3?3-7?7 CD None
% NN None
) ) None
in IN None
the DT None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
group NN None
, , None
and CC None
in IN None
the DT None
zidovudine NN None
nevirapine NN None
group NN None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
group NN None
( ( None
p=0?017 NN None
the DT None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
group NN None
-DOCSTART- -X- N

Removal NN Surgical
of IN Surgical
hypertrophied JJ Surgical
anal JJ Surgical
papillae NN Surgical
and CC Surgical
fibrous JJ Surgical
anal JJ Surgical
polyps NN Surgical
removal NN Surgical
of IN Surgical
hypertrophied JJ Surgical
anal JJ Surgical
papillae NN Surgical
and CC Surgical
fibrous JJ Surgical
anal JJ Surgical
polyps NNS Surgical
randomized VBN None
into IN None
two CD None
groups NNS None
to TO None
have VB None
their PRP$ None
fibrous JJ None
polyps NNS None
and CC None
hypertrophied VBD None
anal JJ None
papillae NN None
either DT None
removed VBN None
by IN None
radiofrequency NN Surgical
surgery NN Surgical
or CC None
left VBN Control
intact JJ Control
. . None
Removal NNP Surgical
of IN Surgical
hypertrophied JJ Surgical
anal JJ Surgical
papillae NN Surgical
and CC Surgical
fibrous JJ Surgical
anal JJ Surgical
polyps NNS Surgical
Radiofrequency NNP Surgical
procedure NN Surgical
-DOCSTART- -X- N

salbutamol VB Pharmocological
salbutamol VB Pharmocological
histamine NN Pharmocological
or CC None
methacholine NN Pharmocological
, , None
or CC None
a DT None
sham JJ Pharmocological
challenge NN Pharmocological
with IN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
salbutamol NN Pharmocological
-DOCSTART- -X- N

glyceryl NN Pharmocological
trinitrate NN Pharmocological
isosorbide NN Pharmocological
dinitrate NN Pharmocological
treatment NN Pharmocological
30 CD Pharmocological
mg NNS Pharmocological
isosorbide JJ Pharmocological
dinitrate NN Pharmocological
( ( Pharmocological
ISDN NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
placebo VB Control
intravenous JJ None
infusion NN None
of IN None
glyceryl NN Pharmocological
trinitrate NN Pharmocological
( ( Pharmocological
GTN NNP Pharmocological
) ) Pharmocological
ISDN NNP Pharmocological
ISDN NNP Pharmocological
treatment NN Pharmocological
, , Pharmocological
GTN NNP Pharmocological
ISDN NNP Pharmocological
ISDN NNP Pharmocological
-DOCSTART- -X- N

oxytocin NN Pharmocological
oxytocin NN Pharmocological
( ( Pharmocological
OT NNP Pharmocological
) ) Pharmocological
OT NNP Pharmocological
application NN Pharmocological
placebo-controlled JJ Control
OT NNP Pharmocological
pharmacological JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

lymphadenectomy NN Physical
lymphadenectomy NN Physical
lymph NN Physical
node NN Physical
sampling VBG Physical
systematic JJ Physical
lymphadenectomy NN Physical
lymphadenectomy NN Physical
lymph NN Physical
node NN Physical
sampling NN Physical
( ( Physical
LS NNP Physical
radical JJ Physical
systematic JJ Physical
lymphadenectomy NN Physical
( ( Physical
LA NNP Physical
lymphadenectomy NN Physical
systematic JJ Physical
lymphadenectomy NN Physical
lymphadenectomy NN Physical
. . None
-DOCSTART- -X- N

supplementation NN Pharmocological
. . None
iron NN Pharmocological
and CC Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

antimicrobial JJ Pharmocological
additive NN Pharmocological
an DT Pharmocological
antimicrobial JJ Pharmocological
additive NN Pharmocological
( ( None
Microban NNP Pharmocological
) ) None
antimicrobial JJ Pharmocological
additive NN Pharmocological
-DOCSTART- -X- N

Granulocyte-colony JJ Pharmocological
stimulating NN Pharmocological
factor NN Pharmocological
stem NN Physical
cell VBP Physical
Granulocyte-colony NNP Pharmocological
stimulating VBG Pharmocological
factor NN Pharmocological
( ( Pharmocological
G-CSF NNP Pharmocological
) ) Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP None
( ( None
10 CD None
?g/kg NN None
) ) None
or CC None
placebo NN None
given VBN None
SC NNP None
versus NN None
placebo NN Control
7 CD None
placebo NN None
3.0 CD None
G-CSF NNP None
is VBZ None
safe JJ None
-DOCSTART- -X- N

acupuncture NN Physical
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
granules NNS Pharmocological
acupuncture NN Physical
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
Granules NNP Pharmocological
acupuncture NN Physical
acupuncture NN Physical
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
Granules NNP Pharmocological
; : None
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
Granules NNP Pharmocological
western JJ Pharmocological
medicine NN Pharmocological
group NN Pharmocological
Aricept NNP Pharmocological
. . None
combined JJ Physical
acupuncture NN Physical
and CC Physical
medication NN Physical
Chinese JJ Pharmocological
herb NN Pharmocological
western JJ Pharmocological
medicine NN Pharmocological
acupuncture NN Physical
and CC Physical
medication NN Physical
combined JJ Physical
acupuncture NN Physical
and CC Physical
medication NN Physical
Acupuncture NNP None
combined VBN None
with IN None
Yizhi NNP None
Jiannao NNP None
Granules NNP None
Yizhi NNP None
Jiannao NNP None
Granules NNP None
Aricept NNP None
. . None
-DOCSTART- -X- N

fluoxetine NN Pharmocological
alone RB Pharmocological
vs. FW None
fluoxetine JJ Pharmocological
plus CC None
local JJ Pharmocological
lidocaine NN Pharmocological
ointment NN Pharmocological
fluoxetine NN Pharmocological
alone RB Pharmocological
vs. FW None
fluoxetine JJ Pharmocological
plus CC None
local JJ Pharmocological
lidocaine NN Pharmocological
ointment NN Pharmocological
fluoxetine JJ Pharmocological
fluoxetine JJ Pharmocological
lidocaine JJ Pharmocological
ointment NN Pharmocological
. . None
fluoxetine JJ Pharmocological
lidocaine JJ Pharmocological
fluoxetine VB Pharmocological
-DOCSTART- -X- N

Internet-based JJ Educational
intervention NN Educational
12-week JJ Educational
educational JJ Educational
intervention NN Educational
both DT Educational
the DT Educational
cellular JJ Educational
phone NN Educational
and CC Educational
the DT Educational
Internet NNP Educational
to TO Educational
send VB Educational
short JJ Educational
message NN Educational
service NN Educational
. . None
access NN Educational
a DT Educational
Web NNP Educational
site NN Educational
by IN Educational
using VBG Educational
a DT Educational
cellular JJ Educational
phone NN Educational
or CC Educational
wire NN Educational
Internet NNP Educational
and CC Educational
input VB Educational
their PRP$ Educational
every DT Educational
day NN Educational
. . Educational
optimal JJ Educational
recommendations NNS Educational
-DOCSTART- -X- N

Carbon NNP Pharmocological
dioxide RB Pharmocological
normal JJ Control
saline NN Control
carbon NN Pharmocological
dioxide NN Pharmocological
( ( Pharmocological
CO NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
CO NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
( ( Pharmocological
group NN Pharmocological
A NNP Pharmocological
) ) Pharmocological
or CC None
normal JJ Pharmocological
saline NN Pharmocological
( ( Pharmocological
group NN Pharmocological
B NNP Pharmocological
) ) Pharmocological
endometrial JJ Surgical
biopsy NN Surgical
CO NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

TEN NNP Physical
TPN NNP Physical
enteral JJ Physical
feeding NN Physical
( ( Physical
TEN NNP Physical
) ) Physical
parenteral JJ Physical
nutrition NN Physical
( ( Physical
TPN NNP Physical
) ) Physical
TEN NNP Physical
TPN NNP Physical
TEN NN Physical
( ( None
TEN NNP Physical
TPN NNP Physical
TEN NNP Physical
TEN NNP Pharmocological
TPN NNP Pharmocological
TEN NNP Pharmocological
TEN NNP Pharmocological
TPN NNP Pharmocological
TEN NNP Pharmocological
TPN NNP Pharmocological
. . None
TEN NNP Pharmocological
-DOCSTART- -X- N

[ JJ None
Pleural NNP Surgical
tent NN Surgical
creation NN Other
of IN Other
pleural JJ Surgical
tent NN Surgical
did VBD Control
not RB Control
pleural JJ Surgical
tent NN Surgical
-DOCSTART- -X- N

of IN Physical
adjuvant JJ Physical
immunochemotherapy NN Physical
adjuvant JJ Physical
immunochemotherapy NN Physical
with IN Physical
the DT Physical
use NN Physical
of IN Physical
BCG NNP Pharmocological
( ( Pharmocological
bacille IN Pharmocological
Calmette-Guerin NNP Pharmocological
) ) Pharmocological
and CC None
FAM NNP Pharmocological
( ( None
5-fluorouracil JJ Pharmocological
, , None
adriamycin JJ Pharmocological
, , None
mitomycin JJ Pharmocological
C NNP Pharmocological
) ) None
chemotherapy NN Pharmocological
randomly RB Pharmocological
assigned VBN Pharmocological
to TO Pharmocological
three CD Pharmocological
treatment NN Pharmocological
groups NNS Pharmocological
: : Pharmocological
BCG NNP Pharmocological
+ NNP Pharmocological
FAM NNP Pharmocological
( ( None
immunochemotherapy NN Pharmocological
) ) None
, , None
FAM NNP None
( ( None
chemotherapy NN Pharmocological
) ) None
, , None
and CC None
control NN Surgical
( ( Surgical
surgery NN Surgical
only RB Surgical
) ) Surgical
. . None
Treatment NN Other
was VBD Other
continued VBN Other
for IN Other
2 CD Other
years NNS Other
or CC Other
until IN Other
death NN Other
. . None
Further NNP Other
postsurgical JJ Other
follow VBP Other
up RP Other
was VBD Other
carried VBN Other
on IN Other
for IN Other
up IN Other
to TO Other
10 CD Other
years NNS Other
. . None
FAM NNP Physical
chemotherapy NN Physical
BCG NNP Physical
+ NNP Physical
FAM NNP Physical
BCG NNP None
+ NNP None
FAM NNP None
Immunochemotherapy NNP None
FAM NNP None
adjuvant JJ None
chemotherapy NN None
. . None
-DOCSTART- -X- N

Extracorporeal NNP Physical
shock NN Physical
wave NN Physical
therapy NN Physical
( ( Physical
ESWT NNP Physical
) ) Physical
extracorporeal NN Physical
shock NN Physical
wave VBP Physical
therapy NN Physical
Heel NNP Physical
cups NNS Physical
ESWT NNP Physical
( ( None
3000 CD None
shock NN None
waves/session NN None
of IN None
0.2 CD None
mJ/mm2 NN None
) ) None
at IN None
weekly JJ None
intervals NNS None
. . None
nonsurgical JJ None
treatment NN None
( ( None
iontophoresis NN Pharmocological
with IN Pharmocological
diclofenac NN Pharmocological
and CC None
an DT None
oral JJ None
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
) ) None
-DOCSTART- -X- N

sheltered VBD Educational
workshops NNS Educational
sheltered VBN Educational
workshops NNS Educational
sheltered JJ Educational
workshops NNS Educational
non-sheltered JJ Educational
workshop NN Educational
-DOCSTART- -X- N

dual-switch JJ Physical
valve NN Physical
conventional JJ Physical
differential-pressure NN Physical
( ( Physical
DP- NNP Physical
) ) Physical
valve NN Physical
. . None
DSV NNP Physical
DSV NNP Physical
DP NNP Physical
valves NNS Physical
DP NNP Physical
valve NN Physical
DSV NNP Physical
DSV NNP Physical
DP NNP Physical
valve FW Physical
DSV NNP Physical
DSV NNP Physical
-DOCSTART- -X- N

fMRI NN Physical
-DOCSTART- -X- N

cryotherapy NN Physical
Cryotherapy NNP Physical
cryotherapy NN Physical
for IN None
treatment NN None
of IN None
retinopathy NN None
of IN None
prematurity NN None
Transscleral JJ Physical
cryotherapy NN Physical
cryotherapy NN Physical
cryotherapy NN Physical
-DOCSTART- -X- N

tegafur NN Pharmocological
uracil NN Pharmocological
tegafur NN Pharmocological
and CC Pharmocological
uracil NN Pharmocological
( ( Pharmocological
UFT NNP Pharmocological
) ) Pharmocological
no DT Control
chemotherapy NN Control
or CC Control
radiotherapy NN Control
. . None
-DOCSTART- -X- N

on IN None
the DT None
QLQ-C30 NNP Educational
SSQ NNP Educational
SSQ NNP Educational
SSQ NNP Educational
SSQ NNP Educational
SSQ NNP Educational
QLQ-C30 NNP Educational
QLQ-C30 NNP Educational
. . None
-DOCSTART- -X- N

stable JJ Pharmocological
prostacyclin NN Pharmocological
analogue NN Pharmocological
( ( Pharmocological
iloprost NN Pharmocological
) ) Pharmocological
prostacyclin NN Pharmocological
analogue NN Pharmocological
iloprost NN Pharmocological
iloprost NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

placebo-controlled JJ Control
MC-1 NNP Pharmocological
MC-1 NN Pharmocological
MC-1 NNP Pharmocological
MC-1 NNP Pharmocological
MC-1 NNP Pharmocological
placebo NNS Control
MC-1 NNP Pharmocological
-DOCSTART- -X- N

low-dose JJ Pharmocological
hydrocortisone NN Pharmocological
placebo-controlled JJ Control
hydrocortisone NN Pharmocological
therapy NN None
. . None
hydrocortisone NN Pharmocological
hydrocortisone NN Pharmocological
placebo NN Control
Hydrocortisone CD Pharmocological
Hydrocortisone NNP Pharmocological
hydrocortisone NN Pharmocological
therapy NN None
-DOCSTART- -X- N

nasal JJ Pharmocological
IgA NNP Pharmocological
Immunoglobulin NNP Pharmocological
A NNP Pharmocological
( ( Pharmocological
IgA NNP Pharmocological
) ) None
IgA NNP Pharmocological
LAIV NNP None
placebo NN Control
nasal JJ Pharmocological
IgA NNP Pharmocological
LAIV NNP Pharmocological
LAIV NNP None
in IN None
LAIV NNP None
and CC None
that IN None
LAIV-induced NNP None
immunity NN None
-DOCSTART- -X- N

-DOCSTART- -X- N

U- NNP Surgical
and CC Surgical
H-type NNP Surgical
methods NNS Surgical
of IN Surgical
the DT Surgical
TVT NNP Surgical
SECUR NNP Surgical
procedure NN Surgical
U- JJ Surgical
and CC Surgical
H-type JJ Surgical
methods NNS Surgical
of IN Surgical
the DT Surgical
TVT NNP Surgical
SECUR NNP Surgical
( ( Surgical
TVT-S NNP Surgical
) ) Surgical
procedure NN Surgical
. . Surgical
two CD None
types NNS None
of IN None
TVT-S NNP None
U- JJ Surgical
or CC Surgical
H-type JJ Surgical
method NN Surgical
of IN Surgical
TVT-S. JJ Surgical
methods NNS Surgical
of IN Surgical
TVT-S NNP Surgical
U-type JJ Surgical
method NN Surgical
. . None
-DOCSTART- -X- N

clinical JJ Physical
neurosensory JJ Physical
test NN Physical
patients NNS None
were VBD None
provided VBN None
a DT None
sensory JJ None
impairment NN None
score NN None
using VBG None
a DT None
three-level JJ None
drop-out JJ None
clinical JJ None
neurosensory NN None
test NN None
( ( None
NST NNP None
) ) None
, , None
and CC None
blind IN Surgical
comparisons NNS Surgical
were VBD Surgical
made VBN Surgical
with IN Surgical
the DT Surgical
surgical JJ Surgical
findings NNS Surgical
postoperatively RB Surgical
. . None
NST NNP Physical
NST NNP None
-DOCSTART- -X- N

Galactomannan NNP Pharmocological
and CC None
PCR NNP Pharmocological
standard JJ Psychological
diagnostic JJ Psychological
strategy NN Psychological
biomarker-based JJ Pharmocological
diagnostic JJ Pharmocological
strategy NN Pharmocological
( ( Pharmocological
aspergillus JJ Pharmocological
galactomannan NN Pharmocological
and CC Pharmocological
PCR NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

all-norgestrel NN Pharmocological
dl-norgestrel NN Pharmocological
alone RB Pharmocological
estradiol-17 JJ Pharmocological
beta NN Pharmocological
alone RB Pharmocological
combined JJ Pharmocological
hormones NNS Pharmocological
placebo NN Control
control NN None
dl-norgestrel JJ Pharmocological
dl-norgestrel JJ Pharmocological
-DOCSTART- -X- N

silodosin NN Pharmocological
silodosin NN Pharmocological
placebo NN Control
controlled VBD Control
silodosin NN Pharmocological
silodosin NN Pharmocological
-DOCSTART- -X- N

Transthoracic NNP Physical
contrast NN Physical
examinations NNS Physical
contrast NN Pharmocological
agent NN Pharmocological
injections NNS Pharmocological
( ( Pharmocological
10 CD Pharmocological
ml NN Pharmocological
dextrose NN Pharmocological
in IN Pharmocological
water/0.25 NN Pharmocological
ml NNP Pharmocological
air NN Pharmocological
) ) Pharmocological
Femoral NNP Physical
vein NNP Physical
contrast NN Physical
delivery NN Physical
-DOCSTART- -X- N

cognitive-behavioral JJ Educational
intervention NN Educational
cognitive-behavioral JJ Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
-DOCSTART- -X- N

conventional JJ Control
and CC None
complementary/alternative JJ Other
treatments NNS Other
conventional JJ Control
treatments NNS Control
and CC None
utilization NN None
of IN None
complementary JJ Pharmocological
and CC Pharmocological
alternative JJ Pharmocological
medicine NN Pharmocological
CAM NNP Pharmocological
conventional JJ Physical
services NNS Physical
CAM NNP Pharmocological
CAM NNP Pharmocological
. . None
CAM NNP Pharmocological
CAM NNP Pharmocological
. . None
CAM NNP Pharmocological
CAM NNP Pharmocological
-DOCSTART- -X- N

methadone NN Pharmocological
interim JJ None
clinic NN None
or CC None
a DT None
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

liquid-polish JJ Pharmocological
coating NN Pharmocological
crown NN Other
confocal JJ Pharmocological
laser NN Pharmocological
scanning VBG Pharmocological
microscope NN Pharmocological
scanning VBG Pharmocological
electron NN Pharmocological
microscope NN Pharmocological
-DOCSTART- -X- N

group NN Educational
vs. FW None
individual JJ Physical
care NN Physical
Training NN Educational
of IN Educational
physicians NNS Educational
, , Educational
nurses NNS Educational
and CC Educational
dietitians NNS Educational
included VBD Educational
preparation NN Educational
of IN Educational
operating VBG Educational
manual JJ Educational
and CC Educational
videos NNS Educational
, , Educational
interactive JJ Educational
sessions NNS Educational
, , Educational
and CC Educational
evaluation NN Educational
of IN Educational
local JJ Educational
facilities NNS Educational
and CC Educational
resources NNS Educational
. . None
-DOCSTART- -X- N

antidepressant JJ Pharmocological
treatment NN Pharmocological
. . None
antidepressant VB Pharmocological
treatment NN Pharmocological
. . None
baseline JJ Physical
MRIs NNP Physical
sertraline NN Pharmocological
and CC None
nortriptyline NN Pharmocological
in IN None
the DT None
antidepressant JJ None
treatment NN None
compared VBN None
-DOCSTART- -X- N

patient JJ Physical
position NN Physical
patient JJ Physical
position NN Physical
supine NN Physical
45-degree JJ Physical
upright JJ Physical
position NN Physical
45-degree JJ Physical
upright JJ Physical
position NN Physical
supine NN Physical
flat JJ Physical
position NN Physical
-DOCSTART- -X- N

Oral JJ Pharmocological
magnesium NN Pharmocological
supplementation NN Pharmocological
magnesium NN Pharmocological
30 CD None
mL NN None
of IN None
MgCl2 NNP Pharmocological
5 CD None
% NN None
solution NN None
( ( None
equivalent JJ None
to TO None
382 CD None
mg NN None
of IN None
magnesium NN Pharmocological
) ) None
and CC None
individuals NNS None
in IN None
the DT None
control NN None
group NN None
30 CD Control
mL NN Control
of IN Control
placebo JJ Control
solution NN Control
, , Control
once RB Control
daily JJ Control
during IN Control
4 CD Control
months NNS Control
. . None
received VBD None
MgCl2 NNP None
compared VBN None
individuals NNS None
in IN None
the DT None
control NN None
group NN None
CONCLUSIONS NNP None
Oral NNP None
magnesium NN None
-DOCSTART- -X- N

Albendazole JJ Pharmocological
albendazole NN Pharmocological
dexamethasone NN Pharmocological
albendazole JJ Pharmocological
corticosteroids NNS Pharmocological
-DOCSTART- -X- N

intensive JJ Educational
early JJ Educational
intervention NN Educational
intensive VB Control
treatment NN Control
parent NN Educational
training NN Educational
intensive JJ None
treatment NN None
parent NN Educational
training NN Educational
parent NN Educational
training NN Educational
intensive JJ None
treatment NN None
parent NN Educational
training VBG Educational
-DOCSTART- -X- N

tamoxifen NN Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
to TO Pharmocological
receive VB Pharmocological
: : Pharmocological
A DT Pharmocological
) ) Pharmocological
tamoxifen NN Pharmocological
( ( Pharmocological
TAM NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/die NN Pharmocological
) ) Pharmocological
until IN Pharmocological
progression NN Pharmocological
or CC Pharmocological
B NNP Pharmocological
) ) Pharmocological
TAM NNP Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/die NN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
then RB Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
1500 CD Pharmocological
mg/die NN Pharmocological
p.o NN Pharmocological
. . Pharmocological
for IN Control
14 CD Control
days NNS Control
) ) Control
followed VBN Control
by IN Control
7 CD Control
days NNS Control
of IN Control
wash-out NN Control
before IN Control
repeating VBG Control
the DT Control
TAM/MPA NNP Control
treatment NN Control
. . Control
when WRB Educational
possible JJ Educational
a DT Educational
second JJ Educational
was VBD Educational
performed VBN Educational
after IN Educational
the DT Educational
initial JJ Educational
14 CD Educational
day NN Educational
cycle NN Educational
of IN Educational
TAM NNP Educational
. . Educational
-DOCSTART- -X- N

doxorubicin NN Pharmocological
pegylated VBN Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
( ( None
DOX NNP None
) ) None
pegylated JJ Pharmocological
liposomal JJ Pharmocological
formulation NN Pharmocological
( ( Pharmocological
PLD NNP Pharmocological
) ) Pharmocological
DOX NNP Pharmocological
PLD NNP Pharmocological
DOX NNP Pharmocological
PLD NNP Pharmocological
-DOCSTART- -X- N

face NN Educational
expertise NN Educational
training NN Educational
expertise NN Educational
training NN Educational
with IN Educational
faces VBZ Educational
computerized JJ Educational
training NN Educational
program NN Educational
involving VBG Educational
either CC Educational
faces VBZ Educational
or CC Educational
houses NNS Educational
. . None
training NN Educational
. . None
-DOCSTART- -X- N

parsalmide NN Pharmocological
parsalmide NN Pharmocological
-DOCSTART- -X- N

intensive JJ None
moderate JJ Pharmocological
blood NN Pharmocological
pressure NN Pharmocological
control NN Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
( ( Pharmocological
nisoldipine JJ Pharmocological
) ) Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
enalapril NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

captopril NN Pharmocological
, , None
atenolol NN Pharmocological
and CC None
pravastatin NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
life NN Pharmocological
style NN Pharmocological
intervention NN Pharmocological
. . None
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
captopril NN Pharmocological
) ) Pharmocological
, , None
and CC None
a DT None
beta-receptor NN Pharmocological
blocking NN Pharmocological
agent NN Pharmocological
( ( Pharmocological
atenolol NN Pharmocological
) ) Pharmocological
, , None
given VBN None
alone RB None
or CC None
in IN None
combination NN None
with IN None
a DT None
cholesterol NN Pharmocological
reducing VBG Pharmocological
drug NN Pharmocological
, , None
the DT None
beta-hydroxy-methylglutaryl-coenzyme NN Pharmocological
A DT Pharmocological
reductase NN Pharmocological
inhibitor NN Pharmocological
pravastatin NN Pharmocological
Lifestyle JJ Educational
intervention NN Educational
alone RB Educational
. . None
Continued JJ Pharmocological
lifestyle JJ Pharmocological
intervention NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
captopril NN Pharmocological
or CC Pharmocological
atenolol NN Pharmocological
. . None
Continued JJ Pharmocological
lifestyle JJ Other
intervention NN Other
combined VBN Other
with IN Other
the DT Other
same JJ Other
drugs NNS Other
as IN Other
in IN Other
phase NN Other
II NNP Other
and CC None
in IN None
addition NN None
pravastatin NN Pharmocological
or CC None
placebo NN Other
. . None
captopril NN Pharmocological
and CC None
atenolol NN Pharmocological
pravastatin NN Pharmocological
. . None
pravastatin NN Pharmocological
captopril NN Pharmocological
or CC None
atenolol NN Pharmocological
. . None
Pravastatin NNP Pharmocological
captopril NN Pharmocological
or CC None
atenolol NN Pharmocological
-DOCSTART- -X- N

home NN Physical
strength NN Physical
training NN Physical
and CC Physical
stretching VBG Physical
versus NN None
stretching VBG Physical
alone RB Physical
combined JJ Physical
strength NN Physical
and CC Physical
stretching NN Physical
home NN Physical
exercise NN Physical
regimen NNS Physical
versus IN None
stretching VBG Physical
alone RB Physical
combined JJ Physical
strength NN Physical
training NN Physical
and CC Physical
stretching VBG Physical
group NN Physical
control NN Control
group NN Control
strength NN Physical
training NN Physical
stretching NN Physical
and CC Physical
stabilization NN Physical
exercises NNS Physical
-DOCSTART- -X- N

fenretinide NN Pharmocological
synthetic JJ Pharmocological
retinoid NN Pharmocological
fenretinide NN Pharmocological
fenretinide NN Pharmocological
( ( None
200 CD None
mg NNS None
day NN None
p.o NN None
. . None
for IN None
24 CD None
months NNS None
) ) None
or CC None
no DT Control
intervention NN Control
. . None
fenretinide JJ Pharmocological
-DOCSTART- -X- N

metoclopramide NN Pharmocological
high-dose JJ Pharmocological
metoclopramide NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
mg/kg NN Pharmocological
, , None
4 CD None
times NNS None
every DT None
2 CD None
hours NNS None
) ) None
metoclopramide NN Pharmocological
metoclopramide JJ Pharmocological
-DOCSTART- -X- N

fish-oil JJ Pharmocological
and CC Pharmocological
vegetable-oil JJ Pharmocological
formula NN Pharmocological
liquid JJ Pharmocological
formula NN Pharmocological
containing VBG Pharmocological
either CC Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
enriched VBN Pharmocological
in IN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
or CC None
vegetable JJ Pharmocological
oil NN Pharmocological
enriched VBN Pharmocological
in IN Pharmocological
oleic JJ Pharmocological
acid NN Pharmocological
two CD None
groups NNS None
over IN None
a DT None
42-d JJ None
period NN None
. . None
fish-oil JJ Pharmocological
consumption NN Pharmocological
. . None
vegetable JJ Pharmocological
oil NN Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

Famotidine NNP Pharmocological
famotidine NN Pharmocological
oral JJ Pharmocological
famotidine NN Pharmocological
was VBD Pharmocological
2 CD Pharmocological
mg/kg/day NN Pharmocological
( ( Pharmocological
given VBN Pharmocological
in IN Pharmocological
two CD Pharmocological
divided JJ Pharmocological
doses NNS Pharmocological
) ) Pharmocological
; : Pharmocological
the DT Pharmocological
maximum JJ Pharmocological
total JJ Pharmocological
daily JJ Pharmocological
dose NN Pharmocological
was VBD Pharmocological
100 CD Pharmocological
mg NN Pharmocological
. . Pharmocological
famotidine NN Pharmocological
-DOCSTART- -X- N

ofloxacin NN Pharmocological
and CC None
ciprofloxacin NN Pharmocological
topical JJ Pharmocological
ofloxacin NN Pharmocological
or CC None
topical JJ Pharmocological
ciprofloxacin NN Pharmocological
surgery NN Surgical
) ) None
( ( Pharmocological
ciprofloxacin JJ Pharmocological
hydrochloride NN Pharmocological
, , Pharmocological
four CD Pharmocological
100-mg JJ Pharmocological
tablets NNS Pharmocological
, , None
or CC None
ofloxacin RB Pharmocological
, , Pharmocological
one CD Pharmocological
400-mg JJ Pharmocological
tablet NN Pharmocological
surgery NN Surgical
) ) None
ciprofloxacin NN Pharmocological
topical JJ Pharmocological
and CC Pharmocological
oral JJ Pharmocological
therapy NN Pharmocological
with IN Pharmocological
ofloxacin NN Pharmocological
-DOCSTART- -X- N

massage NN Physical
combined VBN Physical
Chinese JJ Physical
materia NNS Physical
medica VBP Physical
footbath JJ Physical
fumigation NN Physical
and CC Physical
washing VBG Physical
] NNP None
massage NN Physical
combined VBN Physical
Chinese JJ Physical
materia NNS Physical
medica NN Physical
( ( Physical
CMM NNP Physical
) ) Physical
footbath NN Physical
fumigation NN Physical
and CC Physical
washing NN Physical
massage NN Physical
combined VBN Physical
CMM NNP Physical
footbath JJ Physical
fumigation NN Physical
and CC Physical
washing NN Physical
oral JJ None
administration NN None
of IN None
meloxicam NNS Pharmocological
. . None
Massage NNP Physical
combined VBD Physical
CMM NNP Physical
footbath NN Physical
fumigation NN Physical
and CC Physical
washing NN Physical
-DOCSTART- -X- N

cooperation NN Other
radioiodine JJ Pharmocological
treatment NN None
radioiodine NN Pharmocological
substitution NN None
therapy NN None
radioiodine NN Pharmocological
radioiodine NN Pharmocological
radiation NN Physical
therapy NN Physical
cooperation NN Other
-DOCSTART- -X- N

docetaxel NN Pharmocological
docetaxel NN Pharmocological
. . Physical
randomized VBN None
to TO None
receive VB None
nab-paclitaxel JJ Pharmocological
300 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
q3w NN None
, , None
nab-paclitaxel JJ Pharmocological
100 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
or CC None
150 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
the DT None
first JJ None
3 CD None
of IN None
4 CD None
weeks NNS None
( ( None
qw VB None
3/4 CD None
) ) None
, , None
or CC None
docetaxel VB Pharmocological
100 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
q3w NN None
. . None
docetaxel NN Pharmocological
docetaxel NN None
docetaxel NN Pharmocological
. . None
-DOCSTART- -X- N

risperidone NN Pharmocological
-DOCSTART- -X- N

ibopamine NN Pharmocological
Ibopamine NNP Pharmocological
ibopamine NN Pharmocological
placebo NN Control
Ibopamine NNP Pharmocological
was VBD Pharmocological
employed VBN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
100 CD Pharmocological
mg NN Pharmocological
t.i.d NN Pharmocological
. . Pharmocological
in IN Physical
in IN Pharmocological
basal NN Pharmocological
conditions NNS Pharmocological
and CC Pharmocological
following VBG Pharmocological
7 CD Pharmocological
days NNS Pharmocological
of IN Pharmocological
ibopamine NN Pharmocological
and CC None
placebo NN None
treatment NN None
. . None
-DOCSTART- -X- N

telehealth NN Educational
intervention NN Educational
telehealth NN Educational
intervention NN Educational
Health NNP Physical
Buddy NNP Physical
( ( Physical
R NNP Physical
) ) Physical
telehealth NN Educational
intervention NN Educational
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHu-EPO JJ Pharmocological
) ) Pharmocological
treatment NN None
. . None
rHu-EPO JJ Pharmocological
rHu JJ Pharmocological
EPO NNP Pharmocological
-DOCSTART- -X- N

new JJ Other
softcyte NN Other
a DT None
conventional JJ Other
endocyte NN Other
. . None
endocyte NN Other
softcyte NN Other
endocyte NN Other
. . Other
softcyte NN Other
endocyte NN Other
-DOCSTART- -X- N

styrene NN Pharmocological
maleic NN Pharmocological
acid NN Pharmocological
oily RB Pharmocological
carcinostatic JJ Pharmocological
agents NNS Pharmocological
4 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
styrene NN Pharmocological
maleic NN Pharmocological
acid NN Pharmocological
neocarzinostatin NN Pharmocological
in IN Pharmocological
4 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
Lipiodol NNP Pharmocological
100 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
epirubicin NN Pharmocological
in IN Pharmocological
4 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
Lipiodol NNP Pharmocological
styrene NN Pharmocological
maleic NN Pharmocological
acid NN Pharmocological
neocarzinostatin NN Pharmocological
epirubicin VB Pharmocological
Lipiodol NNP Pharmocological
-DOCSTART- -X- N

everolimus-eluting JJ Surgical
and CC Surgical
paclitaxel-eluting JJ Surgical
stents NNS Surgical
: : None
everolimus-eluting JJ Surgical
stent NN Surgical
( ( Surgical
EES NNP Surgical
) ) Surgical
paclitaxel-eluting JJ Surgical
stent NN Surgical
( ( Surgical
PES NNP Surgical
) ) Surgical
EES NNP Surgical
PES NNP Surgical
. . None
-DOCSTART- -X- N

virulent JJ Physical
NIA-3 NNP Pharmocological
strain NN Pharmocological
or CC None
the DT None
avirulent JJ Pharmocological
Bartha NNP Pharmocological
strain NN Pharmocological
, , None
or CC None
they PRP None
were VBD None
inoculated VBN None
IM NNP Pharmocological
with IN Pharmocological
an DT Pharmocological
inactivated JJ Pharmocological
vaccine NN Pharmocological
containing VBG Pharmocological
the DT Pharmocological
Phylaxia NNP Pharmocological
strain NN Pharmocological
. . None
challenge-exposed JJ Physical
intranasally RB Pharmocological
with IN Pharmocological
strain JJ Pharmocological
NIA-3 NNP Pharmocological
. . None
-DOCSTART- -X- N

artesunate JJ Pharmocological
plus CC Pharmocological
amodiaquine JJ Pharmocological
Artesunate NNP None
plus CC None
amodiaquine NN None
amodiaquine JJ Pharmocological
-DOCSTART- -X- N

training NN Educational
intervention NN Educational
with IN Educational
emphases NNS Educational
on IN Educational
the DT Educational
control NN Educational
of IN Educational
lumbar JJ Educational
neutral JJ Educational
zone NN Educational
behavior JJ Educational
modeling NN Educational
cognitive JJ Educational
behavior NN Educational
interventions NNS Educational
control VB Control
group NN Control
exercise NN Other
and CC Other
daily JJ Other
self-care NN Other
-DOCSTART- -X- N

nedocromil JJ Pharmocological
sodium NN Pharmocological
( ( Pharmocological
NS NNP Pharmocological
) ) Pharmocological
, , None
beclomethasone JJ Pharmocological
dipropionate NN Pharmocological
( ( Pharmocological
BDP NNP Pharmocological
) ) Pharmocological
and CC None
beclomethasone NN Pharmocological
dipropionate NN Pharmocological
plus CC Pharmocological
salmeterol NN Pharmocological
( ( Pharmocological
BDP NNP Pharmocological
+ NNP Pharmocological
S NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

rosuvastatin NN Pharmocological
rosuvastatin NN Pharmocological
rosuvastatin NN Pharmocological
placebo NN Control
or CC None
rosuvastatin VB Pharmocological
20 CD None
mg NN None
Rosuvastatin NNP Pharmocological
Rosuvastatin NNPS Pharmocological
rosuvastatin VBP Pharmocological
rosuvastatin NN Pharmocological
-DOCSTART- -X- N

conventional JJ Physical
arm NN Physical
exercise NN Physical
program NN Physical
robot-assisted JJ Physical
planar NN Physical
reaching NN Physical
( ( Physical
gravity NN Physical
compensated VBN Physical
) ) Physical
, , None
combined VBN Physical
planar NN Physical
with IN Physical
vertical JJ Physical
robot-assisted JJ Physical
reaching NN Physical
intensive JJ Physical
conventional JJ Physical
arm NN Physical
exercise NN Physical
program NN Physical
. . None
-DOCSTART- -X- N

retroperitoneal JJ Physical
partial JJ Physical
no-closure NN Physical
retroperitoneal JJ Physical
partial JJ Physical
no-closure NN Physical
retroperitoneal JJ Physical
partial JJ Physical
no-closure JJ Physical
group NN Physical
or CC None
a DT Surgical
closure NN Physical
group NN Physical
. . None
Retroperitoneal NNP Physical
partial JJ Physical
no-closure NN Physical
retroperitoneal JJ Surgical
lymphadenectomy NN Surgical
. . None
-DOCSTART- -X- N

Regional JJ Physical
ischemic JJ Physical
preconditioning NN Physical
occluding VBG Physical
the DT Physical
LAD NNP Physical
twice NN Physical
for IN Physical
a DT Physical
2-min JJ Physical
period NN Physical
followed VBN Physical
by IN Physical
3-min JJ Physical
LAD NNP Physical
reperfusion NN Physical
before IN Physical
bypass NN Physical
grafting NN Physical
of IN Physical
the DT Physical
first JJ Physical
coronary JJ Physical
vessel NN Physical
. . Physical
-DOCSTART- -X- N

transbronchial JJ Surgical
needle JJ Surgical
aspiration NN Surgical
endobronchial JJ Surgical
ultrasonography NN Surgical
( ( Surgical
EBUS NNP Surgical
) ) Surgical
-guided VBD Surgical
transbronchial JJ Surgical
needle JJ Surgical
aspiration NN Surgical
( ( Surgical
TBNA NNP Surgical
) ) Surgical
transbronchial JJ Physical
biopsy NN Physical
-DOCSTART- -X- N

Fibrin NNP Pharmocological
application NN Pharmocological
fibrin JJ Pharmocological
glue NN Pharmocological
treated VBN Pharmocological
with IN Pharmocological
fibrin JJ Pharmocological
glue NN Pharmocological
or CC None
not RB Control
. . None
Serial JJ Physical
computed JJ Physical
tomography NN Physical
( ( Physical
CT NNP Physical
) ) Physical
scans NNS Physical
fibrin JJ Pharmocological
glue NN Pharmocological
-DOCSTART- -X- N

Treadmill NNP Physical
exercise NN Physical
testing VBG Physical
-DOCSTART- -X- N

patient JJ Educational
education NN Educational
and CC None
supervised VBD Physical
exercise NN Physical
patient JJ Educational
education NN Educational
alone RB Educational
patient JJ Educational
education NN Educational
and CC None
supervised VBD Other
exercise NN Other
patient JJ Educational
education NN Educational
alone RB Educational
Patient NNP Educational
education NN Educational
( ( Educational
PE NNP Educational
) ) Educational
. . None
Patient JJ Educational
education NN Educational
and CC None
supervised VBN Physical
exercise NN Physical
( ( None
PE+SE NNP None
) ) None
. . None
PE+SE NNP Physical
PE NNP Educational
PE NNP Educational
and CC None
SE NNP Physical
. . None
PE NNP Educational
program NN Educational
12-week JJ None
SE NNP None
program NN None
between IN None
PE+SE NNP None
vs NNP None
PE NNP None
alone RB None
. . None
Adding VBG None
SE NNP None
to TO None
PE NNP None
may MD None
-DOCSTART- -X- N

electroacupuncture NN Physical
arthroscopic JJ Physical
debridement NN Physical
] NN None
electroacupuncture NN Physical
arthroscopic JJ Physical
debridement NN Physical
. . None
arthroscopic JJ Physical
debridement NN Physical
combined VBN None
with IN None
electroacupuncture NN Physical
after IN None
operation NN None
. . None
arthroscopic JJ Physical
debridment NN Physical
. . None
isometric JJ Physical
quadriceps NNS Physical
femoris JJ Physical
contraction NN Physical
exercise NN Physical
and CC None
knee NN Physical
flexion NN Physical
and CC None
extension NN Physical
activities NNS Physical
after IN None
operation NN None
. . None
-DOCSTART- -X- N

ofloxacin JJ Pharmocological
otic JJ Pharmocological
drops NNS Pharmocological
neomycin-polymyxin JJ Pharmocological
B-hydrocortisone NNP Pharmocological
otic JJ Pharmocological
drops NNS Pharmocological
antibiotics NNS Pharmocological
ofloxacin JJ Pharmocological
and CC None
neomycin-polymyxin JJ Pharmocological
B NNP Pharmocological
ofloxacin NN Pharmocological
eardrops NNS Pharmocological
ofloxacin JJ Pharmocological
eardrops NNS Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
usual JJ Pharmocological
care NN Pharmocological
placebo NN Control
physiotherapy NN Control
exercise NN Physical
therapy NN Physical
exercise NN Physical
therapy NN Physical
Exercise NNP Physical
therapy NN Physical
exercise NN Physical
therapy NN Physical
placebo NN Control
usual JJ Pharmocological
care NN Pharmocological
exercise NN Physical
therapy NN Physical
group NN Physical
exercise NN Physical
group NN Physical
usual JJ Pharmocological
care NN Pharmocological
placebo NN Control
Exercise NNP Physical
therapy NN Physical
-DOCSTART- -X- N

demand-control JJ None
model NN None
of IN None
job NN None
strain NN None
The DT Other
demand-control NN Other
( ( Other
D-C NNP Other
) ) Other
model NN Other
of IN Other
job NN Other
strain NN Other
D-C NNP Physical
model NN Physical
of IN Physical
job NN Physical
strain NN Physical
D-C NNP Physical
model NN Physical
D-C JJ Physical
model NN Physical
D-C NNP Physical
model NN Physical
demand-control JJ Physical
model NN Physical
of IN Physical
job NN Physical
strain NN Physical
-DOCSTART- -X- N

physical JJ Physical
activity NN Physical
intervention NN Physical
physical JJ Physical
activity NN Physical
intervention NN Physical
wait JJ Control
list NN Control
control NN Control
physical JJ Physical
activity NN Physical
intervention NN Physical
will MD Physical
consist VB Physical
of IN Physical
a DT Physical
number NN Physical
of IN Physical
strategies NNS Physical
including VBG Physical
: : None
delivering NN Physical
structured VBD Physical
fundamental JJ Physical
movement NN Physical
skill NN Physical
activities NNS Physical
, , Physical
increasing VBG Physical
physical JJ Physical
activity NN Physical
opportunities NNS Physical
, , Physical
increasing VBG Physical
staff NN Physical
role NN Physical
modelling NN Physical
, , Physical
providing VBG Physical
children NNS Physical
with IN Physical
a DT Physical
physical JJ Physical
activity NN Physical
promoting VBG Physical
indoor NN Physical
and CC Physical
outdoor JJ Physical
environment NN Physical
and CC Physical
limiting VBG Physical
children NNS Physical
's POS Physical
small JJ Physical
screen JJ Physical
recreation NN Physical
and CC Physical
sedentary JJ Physical
behaviours NNS Physical
. . None
-DOCSTART- -X- N

antifibrinolytic JJ Pharmocological
tranexamic JJ Pharmocological
acid NN Pharmocological
tranexamic JJ Pharmocological
acid NN Pharmocological
tranexamic JJ None
acid NN None
) ) None
intravenous JJ Physical
intraoperative NN Surgical
dose NN Surgical
( ( Surgical
IO NNP Surgical
) ) Surgical
given VBN None
before IN None
tourniquet JJ None
deflation NN None
, , None
( ( None
2 CD None
) ) None
additional JJ Pharmocological
preoperative NN Pharmocological
dose NN Pharmocological
( ( Pharmocological
POIO NNP Pharmocological
) ) Pharmocological
, , None
( ( None
3 CD None
) ) None
additional JJ Pharmocological
postoperative NN Pharmocological
dose NN Pharmocological
( ( Pharmocological
IOPO NNP Pharmocological
) ) Pharmocological
, , None
and CC None
( ( None
4 CD None
) ) None
all DT None
three CD None
doses NNS None
( ( None
POIOPO NNP None
) ) None
local JJ Pharmocological
application NN Pharmocological
tranexamic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Blood NNP Physical
transfusions NNS Physical
standard JJ Physical
care NN Physical
or CC Physical
transfusions NNS Physical
Transfusion NNP Physical
-DOCSTART- -X- N

denbufylline NN Pharmocological
denbufylline JJ Pharmocological
placebo NN Control
Denbufylline NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

moderate JJ Pharmocological
dose JJ Pharmocological
multivitamin/mineral JJ Pharmocological
supplement NN Pharmocological
multivitamin/mineral JJ Pharmocological
supplement NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
vitamin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
6 CD Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

aspirin NN Pharmocological
aspirin NNS Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
vitamin NN Pharmocological
E NN Pharmocological
aspirin VB Pharmocological
aspirin JJ Pharmocological
aspirin JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

Vancomycin NNP Pharmocological
ceftazidime NN Pharmocological
plus CC Pharmocological
amikacin NN Pharmocological
( ( Pharmocological
CA NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
vancomycin NN Pharmocological
( ( Pharmocological
V NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

caffeine JJ Pharmocological
ingestion NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

smoking-cessation NN Educational
therapy NN Educational
Generalized NNP None
linear JJ None
regression NN None
models NNS None
were VBD None
used VBN None
to TO None
analyze VB None
on IN None
smoking-cessation JJ Educational
therapy NN Educational
-DOCSTART- -X- N

anesthetics NNS Physical
saline NN Pharmocological
, , Pharmocological
bupivacaine NN Pharmocological
lignocaine NN Pharmocological
placebo NN Control
isotonic JJ Pharmocological
saline NN Pharmocological
irrigation NN Pharmocological
bupivacaine JJ Pharmocological
irrigation NN Pharmocological
lignocaine JJ Pharmocological
irrigation NN Pharmocological
. . None
bupivacaine NN Pharmocological
Lignocaine NNP None
saline NN Pharmocological
bupivacaine NN None
. . None
saline NN None
, , None
bupivacaine NN None
lignocaine NN None
Lignocaine NNP None
-DOCSTART- -X- N

temafloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
temafloxacin NN Pharmocological
and CC None
ciprofloxacin NN Pharmocological
183mg CD Pharmocological
once-daily JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
caffeine NN Pharmocological
placebo NN Pharmocological
, , None
temafloxacin CC Pharmocological
600mg CD Pharmocological
and CC None
ciprofloxacin VB Pharmocological
750mg CD Pharmocological
caffeine NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
and CC None
theophylline NN Pharmocological
. . None
temafloxacin NN Pharmocological
temafloxacin JJ Pharmocological
-DOCSTART- -X- N

preoperative JJ Pharmocological
to TO Pharmocological
perioperative JJ Pharmocological
chemotherapy NN Pharmocological
preoperative JJ Pharmocological
( ( Pharmocological
PRE NNP Pharmocological
) ) Pharmocological
as IN Pharmocological
opposed VBN Pharmocological
to TO Pharmocological
perioperative VB Pharmocological
( ( Pharmocological
PERI NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
two CD None
chemotherapy NN None
regimens NNS None
( ( None
gemcitabine-cisplatin JJ None
[ NNP None
GP NNP None
] NNP None
versus IN None
paclitaxel-carboplatin JJ None
[ NNP None
TC NNP None
] NNP None
) ) None
. . None
The DT None
PRE NNP None
the DT None
PERI NNP None
receiving VBG None
preoperative JJ None
and CC None
perioperative JJ None
chemotherapy NN None
-DOCSTART- -X- N

CRF NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
receptor NN Pharmocological
antagonist JJ Pharmocological
R317573 NNP Pharmocological
Corticotropin-releasing NNP Pharmocological
factor NN Pharmocological
receptor NN Pharmocological
type NN Pharmocological
1 CD Pharmocological
( ( Pharmocological
CRF NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
CRF NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
antagonist NN Pharmocological
R317573 NNP Pharmocological
[ NNP None
( ( None
18 CD None
) ) None
F NNP None
] JJ None
fluoro-2-deoxy-D NN Physical
: : Physical
-glucose NN Physical
( ( Physical
FDG NNP Physical
) ) Physical
positron NN Physical
emission NN Physical
tomography NN Physical
( ( Physical
PET NNP Physical
) ) Physical
R317573 NNP Pharmocological
R317573 NNP Pharmocological
rCMglu NN Pharmocological
FDG-PET NNP Physical
-DOCSTART- -X- N

Naltrexone NN Pharmocological
naltrexone JJ Pharmocological
Naltrexone NNP Pharmocological
naltrexone NN Pharmocological
naltrexone RB Pharmocological
placebo NN Control
naltrexone NN Pharmocological
placebo NN Control
. . None
Naltrexone NNP Pharmocological
-DOCSTART- -X- N

MSL-109 NNP Pharmocological
adjuvant JJ Pharmocological
therapy NN Pharmocological
MSL-109 NNP Pharmocological
MSL-109 NNP Pharmocological
placebo NN Control
. . None
Primary JJ Pharmocological
drug NN Pharmocological
therapy NN Pharmocological
MSL-109-treated NNP Pharmocological
placebo-treated JJ Control
MSL-109-treated NNP Pharmocological
MSL-109-treated NNP Pharmocological
placebo-treated JJ Control
MSL-109-treated NNP Pharmocological
( ( None
MSL-109 NNP Pharmocological
placebo NN Control
placebo-treated JJ Control
MSL-109 NNP Pharmocological
MSL-109-treated NNP Pharmocological
-DOCSTART- -X- N

Seven-star NNP Physical
needle JJ Physical
stimulation NN Physical
Seven-star NNP Physical
Needle NNP Physical
Stimulation NNP Physical
30 CD Physical
sessions NNS Physical
of IN Physical
Seven-star NNP Physical
Needle NNP Physical
Stimulation NNP Physical
Seven-star JJ Physical
Needles NNP Physical
. . None
Seven-star NNP Physical
Needle NNP Physical
Stimulation NNP Physical
-DOCSTART- -X- N

prostaglandin NN Pharmocological
E1 NNP Pharmocological
placebo-controlled JJ Control
early JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
PGE1 NNP Pharmocological
( ( Pharmocological
PGE1 NNP Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
) ) None
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
ciliary JJ Pharmocological
neurotrophic JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
rHCNTF NN Pharmocological
) ) Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
ciliary JJ Pharmocological
neurotrophic JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
rHCNTF NN Pharmocological
) ) Pharmocological
placebo VB Control
CNTF NNP Pharmocological
rHCNTF NN Pharmocological
rHCNTF NN Pharmocological
-DOCSTART- -X- N

Tomato NNP Pharmocological
paste NN Pharmocological
rich JJ Pharmocological
in IN Pharmocological
lycopene JJ Pharmocological
tomato NN Pharmocological
paste NN Pharmocological
-- : Pharmocological
rich JJ Pharmocological
in IN Pharmocological
lycopene NN Pharmocological
55 CD Physical
g NN Physical
tomato NN Physical
paste NN Physical
( ( Physical
16 CD Physical
mg RB Physical
lycopene NN Physical
) ) Physical
in IN Physical
olive JJ Physical
oil NN Physical
, , Physical
or CC Physical
olive JJ Physical
oil NN Physical
alone RB Physical
, , Physical
daily JJ Physical
for IN Physical
12 CD Physical
weeks NNS Physical
. . Physical
tomato JJ None
paste NN None
( ( None
P NNP None
= NNP None
0?01 CD None
CONCLUSIONS NNP None
Tomato NNP None
paste NN None
-DOCSTART- -X- N

Verapamil NNP Pharmocological
lithium NN Pharmocological
treatment NN None
lithium VB Pharmocological
( ( Pharmocological
lithium NN Pharmocological
, , Pharmocological
valproate NN Pharmocological
) ) Pharmocological
and CC None
some DT Pharmocological
novel NN Pharmocological
( ( Pharmocological
tamoxifen NN Pharmocological
) ) Pharmocological
antimanic JJ Pharmocological
agents NNS Pharmocological
. . None
Verapamil NNP Pharmocological
Verapamil NNP Pharmocological
verapamil NN Pharmocological
, , Pharmocological
used VBD Pharmocological
alone RB Pharmocological
or CC Pharmocological
as IN Pharmocological
an DT Pharmocological
adjunctive JJ Pharmocological
treatment NN Pharmocological
lithium NN Pharmocological
verapamil NN Pharmocological
continued-lithium NN Pharmocological
combined VB Pharmocological
verapamil/lithium NN Pharmocological
verapamil NNS Pharmocological
continued-lithium NN Pharmocological
. . None
verapamil JJ Pharmocological
verapamil JJ Pharmocological
plus CC Pharmocological
lithium NN Pharmocological
verapamil NN Pharmocological
lithium NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

-DOCSTART- -X- N

postural JJ Physical
supports NNS Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
and/or VBZ None
a DT None
postural JJ Physical
support NN Physical
roll NN Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
, , None
postural JJ Physical
support NN Physical
nappy JJ Physical
and CC Physical
postural JJ Physical
support NN Physical
roll NN Physical
, , None
or CC None
disposable JJ Physical
nappy JJ Physical
and CC Physical
postural JJ Physical
support NN Physical
roll NN Physical
. . None
postural JJ Physical
support NN Physical
roll NN Physical
and CC Physical
a DT Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
postural JJ Physical
support NN Physical
roll NN Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
postural JJ Physical
support NN Physical
roll NN Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
postural JJ Physical
support NN Physical
roll NN Physical
-DOCSTART- -X- N

new JJ Educational
computer NN Educational
intervention NN Educational
new JJ Educational
computer NN Educational
program NN Educational
one CD Educational
group NN Educational
used VBD Educational
the DT Educational
computer NN Educational
program NN Educational
for IN Educational
10 CD Educational
half-hour JJ Educational
sessions NNS Educational
over IN Educational
2 CD Educational
weeks NNS Educational
. . None
computer NN Educational
program NN Educational
-DOCSTART- -X- N

dietetic JJ Physical
treatment NN Physical
dietetic JJ Physical
treatment NN Physical
the DT None
intervention NN None
( ( None
referral JJ None
to TO None
and CC None
treatment NN None
by IN None
a DT None
trained JJ None
dietitian NN None
) ) None
or CC None
control VB None
group NN None
( ( None
no DT None
a DT None
dietetic JJ None
treatment NN None
by IN None
trained JJ None
dietitians NNS None
does VBZ None
not RB None
-DOCSTART- -X- N

angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
imidapril NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
imidapril NN Pharmocological
imidapril NN Pharmocological
placebo NN Control
imidapril NN Pharmocological
placebo NN Control
placebo NN Control
imidapril NN Pharmocological
-DOCSTART- -X- N

Villalta-Prandoni NNP Other
scale NN Other
venous JJ Other
clinical JJ Other
severity NN Other
score NN Other
graduated JJ Physical
compressive JJ Physical
stockings NNS Physical
30-40 JJ Physical
mm NN Physical
Hg NNP Physical
graduated VBD Physical
compressive JJ Physical
stockings NNS Physical
( ( Physical
GCS NNP Physical
) ) Physical
or CC None
no DT Control
stockings NNS Control
. . None
CONCLUSION NNP None
Both NNP None
VPS NNP None
and CC None
VCSS NNP None
scoring VBG None
-DOCSTART- -X- N

tibiofibular JJ Physical
joint NN Physical
manipulation NN Physical
tibiofibular JJ Physical
joint JJ Physical
manipulation NN Physical
( ( None
proximal JJ Physical
tibiofibular NN Physical
manipulation NN Physical
, , None
distal JJ Physical
tibiofibular JJ Physical
manipulation NN Physical
, , None
or CC None
control NN Control
) ) None
tibiofibular JJ None
joint NN None
manipulation NN None
tibiofibular JJ None
joint NN None
manipulation NN None
control NN Control
-DOCSTART- -X- N

Rotigotine NNP Pharmocological
transdermal JJ Pharmocological
patch NN Pharmocological
Rotigotine NNP Pharmocological
( ( Pharmocological
Neupro NNP Pharmocological
) ) Pharmocological
patches NNS Pharmocological
were VBD None
applied VBN None
once RB None
daily JJ None
and CC None
uptitrated JJ None
to TO None
the DT None
individual JJ None
effective JJ None
dose NN None
in IN None
increments NNS None
of IN None
2 CD None
mg/24 NNS None
h RB None
every DT None
week NN None
. . None
rotigotine NN Pharmocological
rotigotine NN Pharmocological
rotigotine NN Pharmocological
rotigotine NN Pharmocological
rotigotine NN Pharmocological
-DOCSTART- -X- N

patient-controlled JJ Pharmocological
and CC None
nurse-administered JJ Pharmocological
analgesia NN Pharmocological
fentanyl NN Pharmocological
citrate NN Pharmocological
patient-controlled JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
fentanyl NN Pharmocological
administration NN Pharmocological
by IN Pharmocological
nurses NNS Pharmocological
on IN Pharmocological
request NN Pharmocological
. . Pharmocological
administration NN Pharmocological
by IN Pharmocological
the DT Pharmocological
patient NN Pharmocological
administration NN Pharmocological
by IN Pharmocological
the DT Pharmocological
nurses NNS Pharmocological
-DOCSTART- -X- N

BCAH NNP Surgical
and CC Surgical
PTFE NNP Surgical
vascular JJ Surgical
access NN Surgical
grafts NNS Surgical
PTFE NNP Surgical
grafts NNS Surgical
BCAHs NNP Surgical
BCAH NNP Surgical
PTFE NNP Surgical
grafts NNS Surgical
PTFE NNP Surgical
grafts NNS Surgical
. . Surgical
-DOCSTART- -X- N

Tailored NNP Educational
, , Educational
iterative JJ Educational
, , Educational
printed JJ Educational
dietary JJ Educational
feedback NN Educational
tailored VBN Educational
, , Educational
iterative JJ Educational
, , Educational
printed JJ Educational
dietary JJ Educational
feedback NN Educational
( ( Educational
TF NNP Educational
) ) Educational
nutrition NN Educational
education NN Educational
sessions NNS Educational
dietary JJ Educational
measures NNS Educational
and CC Educational
socio-demographic JJ Educational
questionnaires NNS Educational
TF NNP Educational
-DOCSTART- -X- N

delavirdine NN Pharmocological
mesylate NN Pharmocological
and CC None
didanosine NN Pharmocological
Didanosine NNP Pharmocological
delavirdine JJ Pharmocological
mesylate NN Pharmocological
didanosine NN Pharmocological
delavirdine NN Pharmocological
didanosine NN Pharmocological
. . None
delavirdine JJ Pharmocological
didanosine NN Pharmocological
-DOCSTART- -X- N

psychological JJ Psychological
treatment NN Psychological
manual JJ Psychological
assisted VBN Psychological
cognitive-behaviour JJ Psychological
therapy NN Psychological
( ( Psychological
MACT NNP Psychological
) ) Psychological
and CC None
treatment NN Physical
as IN Physical
usual JJ Physical
( ( Physical
TAU NNP Physical
) ) Physical
-DOCSTART- -X- N

placebo NN Control
clofibrate NN Pharmocological
clofibrate NN Pharmocological
clofibrate NN Pharmocological
clofibrate JJ Physical
therapy NN Physical
clofibrate NN Pharmocological
-DOCSTART- -X- N

levamisole VB Pharmocological
placebo VB Control
levamisole JJR Pharmocological
placebo-treated JJ Control
levamisole NN Pharmocological
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

topiroxostat NN Pharmocological
new JJ Pharmocological
xanthine JJ Pharmocological
oxidase NN Pharmocological
inhibitor NN Pharmocological
topiroxostat NN Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
topiroxostat NN Pharmocological
180 CD None
mg NN None
) ) None
, , None
moxifloxacin FW None
( ( None
400 CD None
mg NN None
) ) None
or CC None
placebo NN None
in IN None
prolonged VBN None
by IN None
moxifloxacin NN None
, , None
of IN None
which WDT None
Moxifloxacin NNP None
can MD None
be VB None
-DOCSTART- -X- N

heparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
UFH NNP Pharmocological
administration NN None
of IN None
two CD None
LMWHs NNP Pharmocological
. . None
UFH NNP Pharmocological
dalteparin NN Pharmocological
, , None
200 CD None
U/kg NNP None
once RB None
daily RB None
, , None
and CC None
enoxaparin RB Pharmocological
UFH NNP Pharmocological
UFH NNP Pharmocological
UFH NNP Pharmocological
LMWHs NNP Pharmocological
UFH NNP Pharmocological
-DOCSTART- -X- N

moxifloxacin NN Pharmocological
Roux-en-Y JJ Surgical
gastric JJ Surgical
bypass NN Surgical
surgery NN Surgical
moxifloxacin NN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
moxifloxacin NN Pharmocological
orally RB Pharmocological
or CC Pharmocological
intravenously RB Pharmocological
moxifloxacin VB None
moxifloxacin NN None
-DOCSTART- -X- N

exogenous JJ Pharmocological
insulin NN Pharmocological
protocols NNS Pharmocological
exogenous JJ Pharmocological
insulin NN Pharmocological
reduced JJ Pharmocological
glucose JJ Pharmocological
load NN Pharmocological
and CC None
a DT None
physiologic JJ Pharmocological
insulin NN Pharmocological
infusion NN Pharmocological
-DOCSTART- -X- N

Stepping VBG Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
: : Educational
parenting VBG Educational
program NN Educational
Triple NNP Educational
P NNP Educational
Positive NNP Educational
Parenting NNP Educational
Program NNP Educational
Stepping VBG Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
Stepping NNP Educational
Stones NNP Educational
Stepping VBG Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
-DOCSTART- -X- N

Modified VBN Physical
constraint-induced JJ Physical
movement NN Physical
therapy NN Physical
Constraint-induced JJ Physical
movement NN Physical
therapy NN Physical
( ( Physical
CIMT NNP Physical
) ) Physical
CIMT NNP Physical
modified JJ Physical
CIMT NNP Physical
or CC None
control VB Physical
group NN None
CIMT NNP Physical
physical JJ Physical
rehabilitation NN Physical
restrictive NN Physical
mitten VBZ Physical
modified JJ Physical
CIMT NNP Physical
CIMT NNP Physical
-DOCSTART- -X- N

amantadine NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
IFN-alpha NNP Pharmocological
plus CC Pharmocological
ribavirin JJ Pharmocological
[ NN Pharmocological
17 CD Pharmocological
] NN Pharmocological
amantadine NN Pharmocological
or CC None
placebo NN Control
amantadine NN Pharmocological
placebo NN Control
amantadine NN Pharmocological
IFN-alpha NNP Pharmocological
plus CC Pharmocological
ribavirin JJ Pharmocological
-DOCSTART- -X- N

with IN None
controlled JJ Physical
compared VBN None
to TO None
an DT None
with IN None
with IN Physical
with IN Physical
expectant JJ None
management NN None
with IN None
expectant JJ Physical
management NN Physical
-DOCSTART- -X- N

A DT None
simulation NN Educational
design NN Educational
randomly RB None
assigned VBN Educational
to TO Educational
the DT Educational
simulating NN Educational
and CC None
control NN Control
groups NNS Control
. . None
The DT None
simulation NN None
group NN None
was VBD None
directed VBN Educational
to TO Educational
imitate VB Educational
a DT Educational
person NN Educational
with IN Educational
a DT Educational
memory NN Educational
impairment NN Educational
. . None
-DOCSTART- -X- N

[ NN None
Encephalopathy NNP Physical
therapeutic JJ Physical
tongue NN Physical
acupoint NN Physical
apparatus NN Physical
encephalopathy JJ Physical
therapeutic JJ Physical
tongue NN Physical
acupoint NN Physical
apparatus NN Physical
( ( Physical
ETTAA NNP Physical
) ) Physical
tongue JJ Physical
acupuncture NN Physical
conventional JJ Educational
training NN Educational
-DOCSTART- -X- N

abstinence-contingent JJ Educational
incentives NNS Educational
detoxification NN None
contingent-voucher JJ Educational
-DOCSTART- -X- N

Clofarabine NNP Pharmocological
? . Pharmocological
fludarabine NN Pharmocological
busulfan NN None
of IN None
i.v NN None
. . None
busulfan NN None
( ( None
Bu NNP None
) ) None
and CC None
fludarabine NN Pharmocological
( ( None
Flu NNP None
) ) None
supplant VB None
Flu NNP None
with IN None
clofarabine NN Pharmocological
( ( None
Clo NNP None
) ) None
, , None
I-Clo NN None
: : None
Flu CD None
IV-single-agent NNP None
Clo NNP None
? . None
Flu NNP None
with IN None
i.v NN None
. . None
Bu NNP None
as IN None
-DOCSTART- -X- N

High-intensity NNP Physical
physical JJ Physical
training NN Physical
training VBG Physical
on IN Physical
land NN Physical
and CC Physical
in IN Physical
water NN Physical
. . None
high-intensity JJ Physical
physical JJ Physical
training NN Physical
on IN Physical
land NN Physical
as IN Physical
in IN Physical
water NN Physical
10-week JJ Physical
supervised JJ Physical
rehabilitation NN Physical
program NN Physical
with IN Physical
emphasis NN Physical
on IN Physical
physical JJ Physical
training NN Physical
. . None
-DOCSTART- -X- N

extradural JJ Pharmocological
analgesia NN Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
and CC None
eprosartan NN Pharmocological
Enalapril NNP Pharmocological
and CC None
eprosartan RB Pharmocological
placebo-controlled JJ Control
placebo NN Control
, , None
enalapril NN Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
, , None
eprosartan FW Pharmocological
( ( Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
, , None
or CC None
combination NN Pharmocological
of IN Pharmocological
both DT Pharmocological
drugs NNS Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
enalapril JJ Pharmocological
eprosartan JJ Pharmocological
eprosartan NN Pharmocological
enalapril NN Pharmocological
eprosartan NN Pharmocological
-DOCSTART- -X- N

NO-aspirin NNP Pharmocological
( ( Pharmocological
NCX-4016 NNP Pharmocological
) ) Pharmocological
NCX-4016 NNP Pharmocological
NCX-4016 NNP Pharmocological
NCX-4016 NNP Pharmocological
( ( Pharmocological
400 CD Pharmocological
and CC Pharmocological
800 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
) ) Pharmocological
, , None
equimolar JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
aspirin NN Pharmocological
( ( Pharmocological
200 CD Pharmocological
and CC Pharmocological
420 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
) ) None
, , None
or CC None
placebo NN Control
. . None
aspirin NN Pharmocological
-DOCSTART- -X- N

presyncopal JJ Physical
symptom-limited JJ Physical
lower JJR Physical
body NN Physical
negative JJ Physical
pressure NN Physical
( ( Physical
PSL-LBNP NNP Physical
) ) Physical
exposure NN Physical
protocols NNS Physical
PSL-LBNP NNP Physical
PSL-LBNP NNP Physical
PSL-LBNP NNP Physical
PSL-LBNP JJ Physical
tests NNS None
PSL-LBNP JJ Physical
-DOCSTART- -X- N

real-time JJ Physical
polymerase NN Physical
chain NN Physical
reaction NN Physical
assay NN Physical
-DOCSTART- -X- N

endocrine NN Pharmocological
radiation NN Physical
therapy NN Physical
orchiectomy NN Surgical
, , None
estrogens VBZ Pharmocological
or CC None
radiotherapy NN Physical
. . None
-DOCSTART- -X- N

oil NN Pharmocological
with IN Pharmocological
medium- NN Pharmocological
and CC Pharmocological
long-chain JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
oil NN Pharmocological
with IN Pharmocological
medium- NN Pharmocological
and CC Pharmocological
long-chain JJ Pharmocological
triglyceride NN Pharmocological
( ( Pharmocological
MLCT NNP Pharmocological
) ) Pharmocological
those DT None
that IN None
consumed VBD None
MLCT NNP None
oil NN None
and CC None
those DT None
that WDT None
consumed VBD None
long-chain JJ None
triglyceride NN None
( ( None
LCT NNP None
) ) None
oil NN None
LCT NNP Pharmocological
MLCT NNP Pharmocological
LCT NNP Pharmocological
-DOCSTART- -X- N

neuraminidase NN Pharmocological
inhibitor NN Pharmocological
oseltamivir NN Pharmocological
placebo-controlled JJ Control
inoculated VBN Other
intranasally RB Other
with IN Other
influenza JJ Other
A/Texas/36/91 NNP Other
( ( Other
H1N1 NNP Other
) ) Other
virus NN Other
. . None
oral JJ Pharmocological
oseltamivir NN Pharmocological
matching VBG None
placebo JJ Control
placebo JJ Control
-DOCSTART- -X- N

buflomedil NN Pharmocological
and CC None
dihydrogenated VBD Pharmocological
ergot JJ Pharmocological
alkaloids NNS Pharmocological
. . None
-DOCSTART- -X- N

standardized JJ Educational
pamphlet NN Educational
pamphlet NN Educational
actigraphy NN Other
device NN Other
pamphlet NN Educational
( ( None
pamphlet VB Educational
versus NN Educational
no DT Control
pamphlet NN Control
) ) None
. . None
pamphlet NN Educational
sleep JJ Educational
education NN Educational
pamphlet NN Educational
-DOCSTART- -X- N

enalapril NN Pharmocological
enalapril NN Pharmocological
enalapril NN Pharmocological
Enalapril NNP Pharmocological
placebo NN Control
enalapril NN Pharmocological
enalapril JJ Pharmocological
enalapril JJ Pharmocological
enalapril VB Pharmocological
enalapril NN Pharmocological
-DOCSTART- -X- N

sodium NN Pharmocological
controls NNS Control
versus NN Pharmocological
strict JJ Pharmocological
sodium NN Pharmocological
diet NN Pharmocological
sodium JJ Pharmocological
-DOCSTART- -X- N

subcutaneous JJ Pharmocological
interleukin-2 NN Pharmocological
( ( Pharmocological
IL-2 NNP Pharmocological
) ) Pharmocological
IL-2 NNP Pharmocological
Interleukin-2 NN Pharmocological
Subcutaneous NNP Pharmocological
IL-2 NNP Pharmocological
IL-2 NNP Pharmocological
-DOCSTART- -X- N

prednisolone NN Pharmocological
and CC None
dexamethasone NN Pharmocological
glucocorticoid JJ Pharmocological
treatment NN None
prednisolone VB Pharmocological
or CC None
dexamethasone VB Pharmocological
prednisolone NN Pharmocological
( ( None
40 CD None
mg/m2 NN None
) ) None
or CC None
dexamethasone NN Pharmocological
( ( None
6.5 CD None
mg/m2 NN None
) ) None
as IN None
part NN None
of IN None
the DT None
MRC-ALL97/99 NNP None
induction NN Pharmocological
chemotherapy NN Pharmocological
for IN None
ALL NNP None
. . None
dexamethasone NN Pharmocological
prednisolone NN Pharmocological
glucocorticoid JJ Pharmocological
treatment NN None
regimens NNS None
-DOCSTART- -X- N

perindopril-indapamide JJ Pharmocological
or CC None
placebo NN Control
. . None
perindopril-indapamide JJ Pharmocological
-DOCSTART- -X- N

ferrule NN Pharmocological
crown-lengthening JJ Pharmocological
ferrule NN Pharmocological
cast VBN Pharmocological
Ni-Cr JJ Pharmocological
alloy NN Pharmocological
dowel-core NN Pharmocological
with IN Pharmocological
no DT Pharmocological
ferrule NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
A1 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
cast VBD Pharmocological
Ni-Cr JJ Pharmocological
alloy NN Pharmocological
dowel-core NN Pharmocological
with IN Pharmocological
2.0 CD Pharmocological
mm NNS Pharmocological
ferrule NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
A2 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
prefabricated VBN Pharmocological
carbon NN Pharmocological
fiber-reinforced JJ Pharmocological
dowel-resin NN Pharmocological
core NN Pharmocological
with IN Pharmocological
no DT Pharmocological
ferrule NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
B1 NNP Pharmocological
) ) Pharmocological
carbon JJ Pharmocological
fiber-reinforced JJ Pharmocological
dowel-resin NN Pharmocological
core NN Pharmocological
with IN Pharmocological
2.0 CD Pharmocological
mm NNS Pharmocological
ferrule NN Pharmocological
cast JJ Pharmocological
Ni-Cr JJ Pharmocological
dowel-cores NNS Pharmocological
and CC Pharmocological
2.0 CD Pharmocological
mm NN Pharmocological
ferrules NNS Pharmocological
carbon NN Pharmocological
fiber-reinforced JJ Pharmocological
dowel-resin NN Pharmocological
core NN Pharmocological
system NN Pharmocological
Crown NNP None
lengthening VBG None
2.0 CD Pharmocological
mm NN Pharmocological
apical JJ Pharmocological
extended VBD Pharmocological
ferrule NN Pharmocological
-DOCSTART- -X- N

sulindac-mediated JJ Pharmocological
Sulindac NNP Pharmocological
sulindac NN Pharmocological
placebo NN Control
sulindac RB Pharmocological
sulindac NN Pharmocological
sulindac NN Pharmocological
. . None
sulindac NN Pharmocological
-DOCSTART- -X- N

HCG NNP Pharmocological
supplementation NN Pharmocological
combined VBN Pharmocological
GnRH NNP Pharmocological
agonist/HMG JJ Pharmocological
luteal-phase JJ Pharmocological
supplementation NN Pharmocological
clomiphene NN Pharmocological
human JJ Pharmocological
menopausal NN Pharmocological
gonadotrophin NN Pharmocological
( ( Pharmocological
HMG NNP Pharmocological
) ) Pharmocological
GnRH NNP Pharmocological
agonist/HMG NN Pharmocological
human JJ Pharmocological
chorionic NN Pharmocological
gonadotrophin NN Pharmocological
( ( Pharmocological
HCG NNP Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
HCG NNP Physical
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
therapy NN Pharmocological
Recombinant NNP Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHuEPO NN Pharmocological
) ) Pharmocological
rHuEPO NN Pharmocological
placebo NN Control
rHuEPO NN Pharmocological
rHuEPO VB Pharmocological
rHuEPO NN Pharmocological
-DOCSTART- -X- N

etching VBG Pharmocological
with IN Pharmocological
hydrofluoric JJ Pharmocological
acid NN Pharmocological
+ NNP Pharmocological
silane NN Pharmocological
application NN Pharmocological
or CC None
2 CD None
) ) None
tribochemical NN Pharmocological
silica NN Pharmocological
coating NN Pharmocological
. . None
-DOCSTART- -X- N

vitamin JJ Pharmocological
A-fortified NNP Pharmocological
coconut NN Pharmocological
cooking VBG Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified NNP Pharmocological
coconut NN Pharmocological
cooking VBG Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
unfortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
ration NN Pharmocological
; : None
without IN Control
cooking VBG Control
oil NN Control
ration NN Control
. . None
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

sensory JJ Surgical
integration NN Surgical
interventions NNS Surgical
sensory JJ Surgical
integration NN Surgical
( ( Surgical
SI NNP Surgical
) ) Surgical
fine JJ Surgical
motor NN Surgical
SI NNP Physical
treatment NN Physical
-DOCSTART- -X- N

insecticide-treated JJ Pharmocological
bed NN Pharmocological
nets NNS Pharmocological
( ( Pharmocological
ITN NNP Pharmocological
) ) Pharmocological
ITN NNP Pharmocological
ITN NNP Pharmocological
salivary JJ Surgical
glands NNS Surgical
were VBD Surgical
dissected VBN Surgical
microscopy NN Physical
. . None
ITN NNP Pharmocological
ITN NNP Pharmocological
-DOCSTART- -X- N

telephone NN Educational
call NN Educational
interventions NNS Educational
telephone NN Educational
call NN Educational
interventions NNS Educational
, , Educational
who WP Educational
received VBD Educational
a DT Educational
weekly JJ Educational
telephone NN Educational
call NN Educational
intervention NN Educational
in IN Educational
addition NN Educational
to TO Educational
the DT Educational
usual JJ Educational
care NN Educational
. . None
-DOCSTART- -X- N

Mefloquine NNP Pharmocological
mefloquine NN Pharmocological
hydrochloride NN Pharmocological
-DOCSTART- -X- N

Antihistamines NNS Pharmocological
antihistamines NNS Pharmocological
( ( Pharmocological
AHs NNP Pharmocological
) ) Pharmocological
. . None
autologous JJ Pharmocological
serum NN Pharmocological
( ( Pharmocological
AS IN Pharmocological
) ) Pharmocological
histamine NN Pharmocological
increased VBD None
their PRP$ None
daily JJ None
dose NN None
fexofenadine NN Pharmocological
histamine-induced JJ Pharmocological
fexofenadine NN Pharmocological
fourfold JJ None
AH NNP None
0.037 CD None
) ) None
. . None
AHs NNP None
-DOCSTART- -X- N

oral JJ Pharmocological
JAK NNP Pharmocological
inhibitor NN Pharmocological
tofacitinib NN Pharmocological
( ( Pharmocological
CP-690,550 NNP Pharmocological
) ) Pharmocological
versus NN None
placebo NN Control
background NN Pharmocological
methotrexate NN Pharmocological
oral JJ Pharmocological
tofacitinib NN Pharmocological
( ( Pharmocological
CP-690,550 NNP Pharmocological
) ) Pharmocological
with IN None
placebo NN Control
placebo NN Control
or CC None
tofacitinib NN Pharmocological
MTX NNP Pharmocological
. . None
tofacitinib NN Pharmocological
placebo NN None
( ( None
33.3 CD None
addition NN None
of IN None
tofacitinib NN None
at IN None
-DOCSTART- -X- N

compare VB Educational
dietary JJ Educational
patterns NNS Educational
diet JJ Educational
and CC Educational
exercise JJ Educational
intervention NN Educational
two CD None
45- JJ None
to TO None
60-minute JJ None
telephone NN None
surveys NNS None
, , None
which WDT None
included VBD None
two CD None
24-hour JJ None
dietary JJ None
recalls NNS None
. . None
Principal JJ None
components NNS None
analysis NN None
and CC None
multivariable JJ None
general JJ None
linear JJ None
models NNS None
were VBD None
-DOCSTART- -X- N

trivalent JJ Pharmocological
ferrum NN Pharmocological
preparation NN Pharmocological
trivalent JJ Pharmocological
ferrum NN Pharmocological
preparation NN Pharmocological
sacharose JJ Pharmocological
ferric JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
Venofer NNP Pharmocological
) ) Pharmocological
Venofer NNP Pharmocological
trivalent NN Pharmocological
saccharose VBD Pharmocological
ferric JJ Pharmocological
oxide JJ Pharmocological
-DOCSTART- -X- N

Cophenylcaine NNP Pharmocological
placebo NN Control
cophenylcaine NN Pharmocological
placebo NN Control
cophenylcaine NN Pharmocological
cophenylcaine NN Pharmocological
-DOCSTART- -X- N

concurrent JJ Pharmocological
gemcitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
sequential JJ Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
gemcitabine/cisplatin JJ Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
concurrent JJ Pharmocological
5-fluorouracil JJ Pharmocological
radiotherapy NN Pharmocological
5-fluorouracil NNP Pharmocological
radiotherapy NN Pharmocological
concurrent JJ Pharmocological
gemcitabine NN Pharmocological
cisplatin NN Pharmocological
same JJ Pharmocological
concurrent NN Pharmocological
treatment NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
sequential JJ Pharmocological
full-dose JJ Pharmocological
gemcitabine NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

risedronate NN Pharmocological
alendronate NN Pharmocological
Bisphosphonates NNPS Pharmocological
risedronate NN Pharmocological
, , Pharmocological
a DT Pharmocological
pyridinyl NN Pharmocological
bisphosphonate NN Pharmocological
, , None
or CC None
alendronate NN Pharmocological
, , Pharmocological
a DT Pharmocological
primary JJ Pharmocological
amino NN Pharmocological
bisphosphonate NN Pharmocological
risedronate NN Pharmocological
alendronate $ Pharmocological
Endoscopy NNP Surgical
risedronate NN Pharmocological
risedronate NN Pharmocological
alendronate NN Pharmocological
risedronate NN Pharmocological
alendronate NN Pharmocological
risedronate NN Pharmocological
alendronate NN Pharmocological
Risedronate NNP Pharmocological
alendronate NN Pharmocological
. . None
-DOCSTART- -X- N

intensive JJ Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
LNH-84 NNP Pharmocological
) ) Pharmocological
three CD None
or CC None
four CD None
courses NNS None
of IN None
doxorubicin NN Pharmocological
, , None
75 CD None
mg/m2 NN None
; : None
cyclophosphamide NN Pharmocological
, , None
1,200 CD None
mg/m2 NN None
; : None
vindesine NN Pharmocological
, , None
2 CD None
mg/m2 NN None
x NN None
2 CD None
; : None
bleomycin NN Pharmocological
, , None
10 CD None
mg NN None
x NN None
2 CD None
; : None
and CC None
prednisolone NN Pharmocological
, , None
60 CD None
mg/m2 NN None
x NN None
5 CD None
( ( None
ACVB NNP None
) ) None
, , None
consolidation NN None
with IN None
high-dose JJ None
methotrexate NN Pharmocological
, , None
ifosfamide NN Pharmocological
, , None
etoposide RB Pharmocological
, , None
asparaginase NN Pharmocological
, , None
and CC None
cytarabine NN Pharmocological
, , None
and CC None
a DT None
randomized VBN None
late JJ None
intensification NN None
with IN None
two CD None
courses NNS None
of IN None
cytarabine NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
teniposide NN Pharmocological
, , None
bleomycin NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( None
AraCVmB NNP None
) ) None
. . None
-DOCSTART- -X- N

everolimus NN Pharmocological
everolimus VB Pharmocological
( ( None
immediate JJ Pharmocological
everolimus NN Pharmocological
n CC None
= VB None
65 CD None
) ) None
or CC None
week NN None
5 CD None
( ( None
delayed VBN None
everolimus NN None
, , None
DE NNP None
everolimus NN None
. . None
-DOCSTART- -X- N

high JJ Pharmocological
protein NN Pharmocological
, , Pharmocological
low JJ Pharmocological
carbohydrate NN Pharmocological
diet NN Pharmocological
carbohydrate NN Pharmocological
restricted VBN Pharmocological
versus IN Pharmocological
a DT Pharmocological
low JJ Pharmocological
fat NN Pharmocological
diet NN Pharmocological
diets NNS None
: : None
a DT None
high JJ Other
protein NN Other
, , Other
low JJ Other
carbohydrate NN Other
( ( Other
20 CD Other
g/d NN Other
) ) Other
diet NN Other
( ( Other
high JJ Other
protein NN Other
, , Other
low JJ Other
carbohydrate NN Other
, , Other
HPLC NNP Other
) ) Other
or CC None
low JJ Physical
fat NN Physical
( ( Physical
30 CD Physical
% NN Physical
of IN Physical
calories NNS Physical
) ) Physical
regimen VBP Physical
for IN None
13 CD None
weeks NNS None
; : None
HPLC NNP Pharmocological
-DOCSTART- -X- N

Sucralfate NNP Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine- NN Pharmocological
sucralfate-healed JJ Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
cimetidine NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

placebo NN Control
piracetam NN Pharmocological
risperidone VB Pharmocological
piracetam NN Pharmocological
piracetam VB Pharmocological
+ NNP None
risperidone NN Pharmocological
( ( None
Group NNP None
A NNP None
) ) None
or CC None
placebo JJ Control
+ NN None
risperidone NN Pharmocological
risperidone NN Pharmocological
piracetam NN Pharmocological
-DOCSTART- -X- N

Levosulpiride NNP Pharmocological
levosulpiride NN Pharmocological
levosulpiride NN Pharmocological
domperidone NN Pharmocological
metoclopramide RB Pharmocological
placebo NN Control
levosulpiride NN Pharmocological
domperidone VB Pharmocological
, , None
metoclopramide NN Pharmocological
placebo VB Control
Active JJ Pharmocological
treatments NNS Pharmocological
placebo NNS Control
-DOCSTART- -X- N

methotrexate NN Pharmocological
or CC None
colchicine NN Pharmocological
Colchicine NNP Pharmocological
or CC None
methotrexate NN Pharmocological
colchicine NN Pharmocological
and CC None
methotrexate NN Pharmocological
. . None
methotrexate NN Pharmocological
colchicine-treated JJ Pharmocological
-DOCSTART- -X- N

Bismuth NNP Pharmocological
subsalicylate NN Pharmocological
bismuth NN Pharmocological
subsalicylate NN Pharmocological
, , None
erythromycin JJ Pharmocological
ethylsuccinate NN Pharmocological
, , None
and CC None
placebo RB Control
bismuth NN Pharmocological
active JJ Pharmocological
bismuth NN Pharmocological
erythromycin NNS Pharmocological
placebo NNS Control
. . None
bismuth NN Pharmocological
erythromycin NN Pharmocological
placebo NNS Control
. . None
bismuth RB Pharmocological
placebo NN Control
. . None
bismuth NN Pharmocological
Erythromycin NN Pharmocological
bismuth NN Pharmocological
-DOCSTART- -X- N

pegylated JJ None
interferon-?2a JJ None
and CC None
ribavirin VB None
of IN None
pegylated JJ None
interferon NN None
and CC None
ribavirin NN None
receive VB None
pegylated VBN None
interferon-?2a JJ None
270 CD None
?g/week JJ None
plus CC None
ribavirin JJ None
1,600 CD None
mg JJ None
epoetin-? JJ None
for IN None
followed VBN None
by IN None
pegylated JJ None
interferon-?2a NN None
at IN None
standard JJ None
, , None
or CC None
pegylated VBD None
interferon-?2a JJ None
plus CC None
WBR NNP None
for IN None
induction NN None
with IN None
pegylated JJ None
interferon-?2a JJ None
plus CC None
ribavirin NN None
was VBD None
associated VBN None
-DOCSTART- -X- N

Specific JJ Educational
exercises VBZ Educational
exercise NN Educational
program NN Educational
, , Educational
including VBG Educational
specific JJ Educational
stabilizing NN Educational
exercises NNS Educational
specific JJ Educational
exercise NN Educational
program NN Educational
-DOCSTART- -X- N

gammaglobulin NN Pharmocological
intravenous JJ Pharmocological
gammaglobulins NNS Pharmocological
gammaglobulins NNS Pharmocological
305 CD Pharmocological
infusions NNS Pharmocological
of IN Pharmocological
IVIG NNP Pharmocological
200 CD Pharmocological
mg/kg NN Pharmocological
; : Pharmocological
170 CD Pharmocological
infusions NNS Pharmocological
of IN Pharmocological
400 CD Pharmocological
mg/kg NNS Pharmocological
247 CD Pharmocological
infusions NNS Pharmocological
of IN Pharmocological
600 CD Pharmocological
mg/kg NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

medical JJ Pharmocological
ozone NN Pharmocological
therapy NN Pharmocological
medical JJ Pharmocological
ozone NN Pharmocological
basic JJ Physical
therapy NN Physical
basic JJ Pharmocological
therapy NN Pharmocological
plus CC Pharmocological
ozone NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Divalproex NNP Pharmocological
sodium NN Pharmocological
vs. FW None
placebo NN None
Divalproex NNP Pharmocological
divalproex NN Pharmocological
placebo-controlled JJ Control
divalproex NN Pharmocological
sodium NN Pharmocological
vs. FW None
placebo NN Control
. . None
divalproex NN Pharmocological
-DOCSTART- -X- N

hospital JJ Educational
report NN Educational
cards NNS Educational
constructed VBN Educational
using VBG Educational
linked VBN Educational
hospital NN Educational
and CC Educational
prescription NN Educational
administrative JJ Educational
databases NNS Educational
Administrative NNP Educational
Data NNP Educational
Feedback NNP Educational
for IN Educational
Effective NNP Educational
Cardiac NNP Educational
Treatment NNP Educational
confidential JJ Educational
feedback NN Educational
on IN Educational
quality NN Educational
indicators NNS Educational
constructed VBD Educational
using VBG Educational
administrative JJ Educational
data NNS Educational
. . Other
report NN Educational
card NN Educational
interventions NNS Educational
. . Other
-DOCSTART- -X- N

transurethral JJ Surgical
resection NN Surgical
room NN Physical
temperature NN Physical
irrigation NN Physical
fluid NN Physical
( ( Physical
70 CD Physical
degrees NNS Physical
F NNP Physical
) ) Physical
throughout IN None
TURP NNP Surgical
; : None
warmed JJ Pharmocological
irrigation NN Pharmocological
fluid NN Pharmocological
warm JJ Pharmocological
-DOCSTART- -X- N

small JJ Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
small JJ Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
needle-knife JJ Physical
group NN Physical
physiotherapy NN Physical
group NN Physical
needle-knife JJ Physical
small JJ Physical
needle-knife JJ Physical
releasing NN Physical
therapy NN Physical
, , Physical
blocking VBG Physical
and CC Physical
functional JJ Physical
training NN Physical
. . Physical
physiotherapy NN Physical
ultra-short JJ Physical
wave NN Physical
, , Physical
modulated VBD Physical
medium NN Physical
frequency NN Physical
current JJ Physical
, , Physical
massage NN Physical
and CC Physical
functional JJ Physical
training NN Physical
. . Physical
needle-knife JJ Physical
needle-knife JJ Physical
needle-knife JJ Physical
physiotherapy NN Physical
Small NNP Physical
needle-knife JJ Physical
comprehensive JJ Physical
therapy NN Physical
-DOCSTART- -X- N

Hydergine NNP Pharmocological
placebo NN Control
placebo NN Control
Hydergine NNP Pharmocological
Hydergine NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

amiodarone VB Pharmocological
or CC None
placebo VB Control
. . None
-DOCSTART- -X- N

parent-delivered JJ Educational
Qigong JJ Educational
massage NN Educational
program NN Educational
: : None
dual JJ Educational
parent NN Educational
and CC Educational
trainer-delivered JJ Educational
qigong JJ Educational
massage NN Educational
parent-delivered JJ Educational
program NN Educational
for IN Educational
4 CD Educational
mo NN Educational
. . None
parent NN Educational
training NN Educational
and CC Educational
support NN Educational
. . None
parent-delivered JJ Educational
component NN Educational
-DOCSTART- -X- N

bileaflet NN Surgical
prostheses NNS Surgical
bileaflet NN Surgical
prostheses NNS Surgical
prostheses NNS None
Prosthesis NNP Surgical
-DOCSTART- -X- N

griseofulvin NN Pharmocological
griseofulvin NN Pharmocological
antimycotic JJ Physical
therapy NN Physical
. . Pharmocological
griseofulvin NN Educational
Griseofulvin NNP Pharmocological
placebo NN Control
griseofulvin NN Pharmocological
placebo-treated JJ Control
griseofulvin-treated JJ Pharmocological
-DOCSTART- -X- N

lipoproteins NNS Pharmocological
lipoprotein JJ Pharmocological
subfractions NNS Pharmocological
high-density NN Pharmocological
lipoprotein NN Pharmocological
low-density NN Pharmocological
lipoprotein NN Pharmocological
lipoprotein JJ Pharmocological
subfractions NNS Pharmocological
lipoprotein JJ Physical
subfractions NNS Physical
. . None
subfractions NNS Physical
( ( None
L1 NNP Pharmocological
) ) None
L1 NNP Physical
lipoprotein JJ Physical
subfractions NNS Physical
-DOCSTART- -X- N

nanocrystalline JJ Pharmocological
hydroxyapatite JJ Pharmocological
paste NN Pharmocological
nanocrystalline NN Pharmocological
hydroxyapatite NN Pharmocological
( ( Pharmocological
nano-HA JJ Pharmocological
) ) Pharmocological
bone NN Pharmocological
graft NN Pharmocological
substitute NN Pharmocological
. . None
were VBD None
randomly RB None
selected VBN None
to TO None
receive VB None
nano-HA JJ None
paste NN None
in IN None
conjunction NN None
with IN None
papilla NN None
preservation NN None
flaps NNS None
or CC None
papilla NN None
preservation NN None
flaps NNS None
a DT None
customized JJ None
acrylic JJ None
stent NN None
measured VBN None
at IN None
baseline NN None
and CC None
again RB None
6 CD None
months NNS None
following VBG None
surgery NN None
. . None
with IN None
nano-HA JJ None
paste NN None
showed VBD None
with IN None
papilla NN None
preservation NN None
flap NN None
surgery NN None
-DOCSTART- -X- N

Steven NNP Educational
's POS Educational
psychophysical JJ Educational
method NN Educational
of IN Educational
magnitude NN Educational
estimation NN Educational
. . Educational
two-way JJ None
analyses NNS None
of IN None
variance NN None
-DOCSTART- -X- N

TXA2 NNP Pharmocological
synthetase NN Pharmocological
inhibitor NN Pharmocological
, , Pharmocological
ozagrel JJ Pharmocological
hydrochloride NN Pharmocological
thromboxane NN Pharmocological
A2 NNP Pharmocological
( ( Pharmocological
TXA2 NNP Pharmocological
) ) Pharmocological
synthetase NN Pharmocological
inhibitor NN Pharmocological
Ozagrel NNP Pharmocological
Hydrochloride NNP Pharmocological
and CC None
placebo NN Control
Ozagrel NNP Pharmocological
Hydrochloride NNP Pharmocological
-DOCSTART- -X- N

new JJ None
, , None
highly RB Pharmocological
purified VBN Pharmocological
, , Pharmocological
heat-treated JJ Pharmocological
equine NN Pharmocological
rabies NNS Pharmocological
immunoglobulin VBP Pharmocological
Vero-cell NNP Pharmocological
rabies VBZ Pharmocological
vaccine NN Pharmocological
. . Pharmocological
new JJ None
, , None
purified JJ Pharmocological
, , Pharmocological
heat-treated JJ Pharmocological
equine NN Pharmocological
rabies NNS Pharmocological
immunoglobulin VBP Pharmocological
( ( Pharmocological
PHT-Erig NNP Pharmocological
) ) Pharmocological
, , None
F NNP Pharmocological
( ( Pharmocological
ab IN Pharmocological
' POS Pharmocological
) ) Pharmocological
2 CD Pharmocological
preparation NN Pharmocological
PHT-Erig NNP Pharmocological
a DT None
commercially-available JJ None
, , None
equine JJ Pharmocological
rabies NNS Pharmocological
immune VBP Pharmocological
globulin NN Pharmocological
( ( Pharmocological
Erig NNP Pharmocological
PMC NNP Pharmocological
) ) Pharmocological
. . None
the DT None
purified JJ Pharmocological
Vero-cell NNP Pharmocological
rabies NNS Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
PVRV NNP Pharmocological
) ) Pharmocological
either DT None
Erig NNP Pharmocological
PMC NNP Pharmocological
or CC None
PHT-Erig NNP Pharmocological
. . None
